PosterSessionOnline

INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTA..

ISTH 2017 Congress

8-13 July 2017 Berlin

N. Poster

Poster title

Applicant name

Status


1-PB	ErbB Signaling Gene EGFR Centric Network Plays an Important Role in Coronary Artery Disease	Madankumar Ghatge	Received

2-PB	Immunization with Recombinant Atherosclerosis Vaccine Candidate (AHhHmR) Does Not Promote Melanoma Lung Metastasis in B6;129S-Ldlrtm1herApobtm2sgy/J Mice	xinjie Lu	Received

2-LB	A Large-scale Exome-wide Association Study of Venous Thromboembolism: Meta-analysis from the INVENT Consortium	Christopher Kabrhel	Received

3-PB	Pro-inflammatory and Pro-thrombotic Phenotype of Spontaneously Differentiated Human Monocyte-derived Macrophages in Coronary Heart Disease Patients: Implications for Plaque Morphology and Activity	Sonia Eligini	Received

5-PB	The Effect of Factor XIII on the Proliferation and Migration of Vascular Smooth Muscle Cells	Réka Bogáti	Received

6-LB	Prospective Randomized Placebo-controlled Trial of Simvastatin in the Prevention of COPD Exacerbations (STATCOPE) - Effects on Tissue Factor Pathway of Blood Coagulation	A Koneti Rao	Received

6-PB	Insights Into the Genetic Architecture of Coronary Artery Disease in Asian Indians	Jiny Nair	Received

7-PB	Oral Anticoagulants as Modulators of Arterial Calcification	Rick H. van Gorp	Received

8-LB	The Association between Genetic Variants Involved in Immune Response and Inhibitors among Persons with Hemophilia A: A Systematic Review and Meta-analysis	Amanda Payne	Received

8-PB	Involvement of PAR Signaling in Thrombin Generation on Vascular Smooth Muscle Cells from Abdominal Aortic Aneurysms	Mélusine Didelot	Received

11-LB	Platelet Count and Central Venous Catheter-related Thrombosis in Critically Ill Children: An Observational Study	Jikke Rutgers	Received

12-PB	Parameters of Complete Blood Count Do Not Predict On-treatment Platelet Reactivity in Acute Coronary Syndrome Patients	Corinne Frere	Received

13-PB	Impairment of Weight Gain and Lipoprotein Lipase Mediated-triglyceride Clearance in Integrin 3 (CD61) Deficient Mice	Xiaodong Xi	Received

14-PB	Increased Acetyl-CoA Carboxylase phosphorylation state in platelets identify high risk patients with coronary artery disease: ACCTHEROMA trial	shakeel kautbally	Received

15-PB	Recombinant Atherosclerosis Vaccine Candidate Antigen (AHhHmR)-induced Tregs in B6;129S-Ldlrtm1herApobtm2sgy/J Mice Do Not Promote Melanoma Cell (MC) Proliferation	xinjie Lu	Received

16-PB	Peripheral Immune Changes and Persistence of Tolerance to Atherosclerosis by Immune Modulation with Multi-antigenic Construct in Apobtm2Sgy Ldlrtm1Her/J Mice	LAKSHMI NARASIMHA RAO THOTA	Received

17-PB	Association of vWF Antigen/ADAMTS13 Activity Ratio with Gensini Score in Type 2 Diabetes Mellitus	SUPAKANYA LASOM	Received

20-PB	Nanoliposomes for Transfection Of CD39 mRNA: A Step towards Nanotheranostics for Delivery of Anti-inflammatory Therapeutics against Thrombosis	Meike-Kristin Abraham	Received

21-PB	Association of Plasma Soluble Thrombomodulin and HDL-C with Coronary Artery Stenosis	Nantarat Komanasin	Received

22-PB	Protective Auto Antibodies and their Inverse Correlation with Antigen Levels in Indian Patients with Acute Coronary Syndrome	Thiruvelselvan Ponnusamy	Received

25-PB	High Circulatory Level of Inflammatory Cells and their Relation to Recurrent Cardiac Events in Indian Population	Thiruvelselvan Ponnusamy	Received

26-PB	Lipoprotein a Lp(a) and Hemostatic Variables in Young and Post Menopausal Women: Are their Levels Affected by Hormones Use?	Fernanda Freire	Received

27-PB	Selected Factors of Haemostasis and Some Clinical Parameters in Patients with Peripheral Arterial Disease with Regard to Atherosclerosis	Danuta Rosc	Received

28-PB	MicroRNA Target Prioritization to Identify Potential Therapeutic Candidate in Cardiovascular Disease	VRUSHALI DESHPANDE	Received

34-PB	Myocardial Infarction is a Risk Factor for Venous Thromboembolism (VTE) Recurrence in Women with a First VTE	Nadia Arshad	Received

36-PB	Free Ubiquitin Promotes Cardiomyocytes Proliferation and Survival In vitro and In vivo via CXCR4 Pathway	Jialu Yao	Received

37-PB	Development of a Novel Flow Cytometric Immunobead Array to Quantify von Willebrand Factor Antigen and Ristocetin Cofactor Activity and its Application in Acute Myocardial Infarction	Yiming Zhao	Received

40-PB	Platelet-specific p38&945; deficiency improved cardiac function after myocardial infarction in mice	panlai shi	Received

41-PB	Identification of a Plasma microRNAs Profile Related to Arterial Thrombosis	Laura Martos	Received

42-PB	Platelet Serotonin Aggravates Myocardial Reperfusion Injury via Neutrophil Degranulation	Maximilian Mauler	Received

43-PB	Smoking and Fibrinogen Levels Modify the Risk of MI due to FXIII V34L: Results from the MAMI Study	Jessica Debattista	Received

44-PB	Levels of Beta-thromboglobulin and Platelet Factor 4 are different between NSTEMI and STEMI: Results from the MAMI Study	Julia Bonaci	Received

45-PB	CD41 Distribution within Platelet-Monocyte Complexes in Patients with Acute Myocardial Infarction	Marina Loguinova	Received

46-PB	Cardiomyocyte Extracellular Vesicles Increase after Experimental Myocardial Infarction and Promote Endothelial Dysfunction in vitro	Carmen Roncal	Received

47-PB	T Lymphocyte Microparticles Are the Major Determinant of Acute Coronary Syndrome	Songpol Haohan	Received

50-PB	"Soluble P-selectin levels are higher in patients with NSTEMI vs STEMI	Christine Agius	Received

52-PB	Ultrasound Elastography: A New Technique to Distinguish between Acute and Chronic Deep Vein Thrombosis	Francesco Dentali	Received

53-PB	General Practitioner-performed Compression Ultrasound for Deep Vein Thrombosis (Practicus Study): A Prospective, Multicenter Cohort Study	Daniela Mastroiacovo	Received

54-PB	Targeted MiR126 Therapy of Abdominal Aortic Aneurysm	Xiaowei Wang	Received

56-PB	Risk Prediction Model for Peripheral Arterial Disease Patients Undergoing Revascularization within Two Years of Diagnosis	Renske Olie	Received

57-PB	Repetitive Intravenous Thrombin Injections Result in Pulmonary Arterial Endothelial Dysfunction in a Mouse Model of Sublethal Acute Pulmonary Embolism	Venkata Subbaiah Garlapati	Received

58-PB	Lack of Association between Candidate Gene Polymorphisms and Ischemic Events in Patients with Peripheral Arterial Disease	Ales Blinc	Received

59-PB	Restenosis is a Predictor of Poor Outcome in Patients Undergoing Endovascular Intervention for Peripheral Arterial Disease	Michelangelo Sartori	Received

61-PB	Venous Thromboembolism Following Hantaviral Infection	Anne-Marie Connolly-Andersen	Received

63-PB	Thrombophilic and Cardiovascular Risk Factors for Retinal Vein Occlusion	Paolo Bucciarelli	Received

65-PB	Gene-sodium Interaction on the Developing of Hypertension: A Cohort-based Case-control Study	Bing-Fang Hwang	Received

71-PB	The Chimeric Monoclonal Antibody MHCSZ-123 against Human von Willebrand Factor A3 Domain Inhibits High Shear Arterial Thrombosis Model in Rhesus Monkeys	shundong Ji	Received

72-PB	Effects of Two Plant Protein Inhibitors on Haemostasis and Thrombosis	Maria Luiza Oliva	Received

73-PB	Slounase, a Modified Snake Venom Hemocoagulase Combined with FXa, Enhances Hemostasis and Limits Bleeding in Both Normal and Hypocoagulant Conditions	Reheman Adili	Received

74-PB	Platelet Defects Upon Surgical Liver Disease Models iin Mice	Friedrich Reusswig	Received

77-PB	Sickle Cell Red Blood Cells Alter Properties of Mouse and Human Clot	FAES Camille	Received

78-PB	Porcine Model of Methicillin-resistant Staphylococcus Aureus (MRSA) Sepsis-induced Disseminated Intravascular Coagulation (DIC) and Multiple Organ Dysfunction Syndrome (MODS)	Trung Nguyen	Received

79-PB	Role of bone morphogenetic protein receptor type II in vascular remodeling during thrombosis	Smriti Sharma	Received

80-PB	In Vivo Neutralization of Unfractionated Heparin (UFH) and a Bioengineered Heparin Dodecasccharide (12-mer) by Protamine Sulfate in a Primate Model	Walter Jeske	Received

81-PB	Hemostatic Profile in Mouse Models of Advanced Chronic Liver Disease	Natacha Dewarrat	Received

84-PB	Thromboelastography in Mice: Impact of Blood Collection Method	Maha Othman	Received

85-PB	Quantitative Proteomics of Plasma-derived Macrovesicles Identifies Early Systemic Protein Markers of a Hemophilic Bleed in Rats	Mads Kjelgaard-Hansen	Received

86-PB	Improved Anticoagulant Effect of Fucosylated Chondroitin Sulfate Orally Administered as Gastro-resistant Tablets	ROBERTO JOSE CASTRO FONSECA	Received

87-PB	Three Point Ligation of Inferior Vena Cava in Rats: Experimental Approach to Study Mechanism of Venous Thrombosis	Neha Gupta	Received

88-PB	Activated (a) factor (F) VII for hemostasis enhancement in FXI and XIa inhibitor-treated primates	Michael Wallisch	Received

89-PB	The Electrolytic IVC Model of Venous Thrombosis (EIM): A Cost-effective, Highly Reproducible, and Easily Controlled Tool to Investigate Venous Thrombosis under Flow Conditions	Olivia Palmer	Received

90-PB	A Functional and Thromboelastometric-based Micromethod for Assessing Crotoxin Anticoagulant Activity and Antiserum Relative Potency against Crotalus Durissus Terrificus Venom	Benedito Prezoto	Received

92-PB	In the Cath Lab - A Novel Rabbit Bleeding Model	Imke Meyer	Received

93-PB	Von Willebrand Factor Effects Vessel Conformation and the Expression of Integrin aV3 and Ang-2 in the Porcine Female Reproductive Tract	Carsten Detering	Received

96-PB	The Anti-factor XIa Antibody BAY 1213790 is a Novel Anticoagulant that Shows Strong Antithrombotic Efficacy without an Increased Risk of Bleeding in Rabbit Models	Anja Buchmueller	Received

99-PB	New Insights into FV-short Function and Interaction with TFPIa	Teodolinda Petrillo	Received

101-PB	Inhibition of Contact Activation by Histidine-Rich Glycoprotein is Mediated by its Histidine-Rich Domain	Tammy Truong	Received

103-PB	Factor VII Activating Protease (FSAP) and Marburg I (G534E) Polymorphism; How One Amino Acid Determines Function	Nis Valentin Nielsen	Received

106-PB	Fusion to Albumin Extends the Circulatory Half-life and Antithrombotic Effects of the Kunitz Protease Inhibitor Domain of Protease Nexin 2 in Mice	William Sheffield	Received

109-PB	The Most Significant Physiological Function of Protein S is Inhibition of Thrombin Generation	Ester Goldfeld	Received

111-PB	Validation of a FVIII Nijmegen Bethesda Assay for the Detection of Inhibitors to Porcine FVIII	Mary Robinson	Received

112-PB	Single-dose Safety and Toxicological Studies of Long-acting FVIIa (MOD-5014) in Rats and Monkeys Support the Initiation of Clinical Phase 1 Subcutaneous (SC) Study in Healthy Volunteers	Malka Hoffmann	Received

113-PB	Low Plasma FVII:C and Activated FVII as Predictive Markers for Overt Disseminated Intravascular Coagulation	Surapong Lertthammakiat	Received

116-PB	Zinc Binds and Regulates the Activity of the Natural Anticoagulant Protein Z	Tanusree Sengupta	Received

117-PB	Effects of SERPINC1, PROC, PROS1 and EPCR Polymorphisms on the Plasma Levels of Natural Anticoagulants in Healthy Individuals	Zsuzsanna Bereczky	Received

118-PB	Identification of a Novel Factor VII Activating Protease (FSAP) Zymogen-activating Peptide by Phage Display	sandip kanse	Received

120-PB	Microplate-based Method for Quantifying Polyphosphate in Biological Samples	Stephanie Smith	Received

122-PB	Clinical Significance of Prothrombin G20210A Mutation in Homozygous Patients	Inna Tsoran-rosenthal	Received

125-PB	Anti-FVIII IgG1 Antibody in Previously Untreated Patients with Hemophilia A Might Be Protective Against Inhibitor Development: Preliminary Results from the Hemfil Cohort Study	Daniel Chaves	Received

126-PB	Cost-effectiveness of Recombinant Porcine Factor VIII (OBIZUR) for Treatment of Hemorrhagic Events in Acquired Hemophilia A (AHA)	Mehdi Najafzadeh	Received

128-PB	APC-Resistance Testing Based on Genetic or Functional Assays: To Be or Not to Be ?	Anne C Brisset	Received

129-PB	Alteration of the Hemostatic System in Cirrothic Patients	CRISTINA DUBOSCQ	Received

130-PB	In vitro Antithrombin is the Main Inhibitor of Thrombin Generation at the Surface of Endothelial Cells Acting Independently to Heparan Sulfates	Jean-Luc PLANTIER	Received

132-PB	Impact of Thrombin (Dabigatran) and FXa Inhibitors (Rivaroxaban, Apixaban, Edoxaban) on Hemostasis Assays	Judith Hammelburger	Received

134-PB	Prolonged Targeted Temperature Management Causes an Impaired Coagulation: A Randomised Clinical Trial	Anni Nrgaard Jeppesen	Received

135-PB	Features of Clinical and Laboratory Diagnostics of Disturbance of Hemostasis System in Patients with Retinal Vein Occlusion on the Background of FV Leiden Mutation and LA	Tatyana Shelkovnikova	Received

136-PB	Causes of Isolated Prolonged Activated Partial Thromboplastin Time in a Haemostasis Reference Hospital	Noelia Vilalta	Received

141-PB	Characterization of Interactive Sites of the Blood Coagulation Factor VIII and the Low-density Lipoprotein Receptor using Macromolecular Docking Prediction Algorithms	Andrey Sarafanov	Received

142-PB	Comparison of Bleeding Efficacy of FIX-Albumin and FIXWT 7 Days Post-infusion	Darrel Stafford	Received

145-PB	Monoclonal Antibodies to Fc?RIIB (CD32) Modulate FVIII-specific Recall Response in vitro	Nadine Vollack	Received

148-PB	Altering FIX Zymogenicity Extends Procoagulant Function and Improves Hemostatic Function in Murine Hemophilia B	Lacramioara Ivanciu	Received

150-PB	Evaluation of Impact of Codon-Optimization on the Functional Activity of the Blood Coagulation Factor VIII by Clotting, Chromogenic and Thrombin Generation Assays	Andrey Sarafanov	Received

151-PB	An In silico and In vitro Approach to Elucidate the Impact of Residues Flanking the Cleavage Scissile Bonds of FVIII	Behnaz Pezeshkpoor	Received

152-PB	In vitro Characterization of the Factor 8 Gene Mutations Associated with Assay Discrepancy	Behnaz Pezeshkpoor	Received

153-PB	Corn Trypsin Inhibitor Mediates Differential Effects on Thrombin Generation Parameters in Hemophilic Patients Compared with Healthy Volunteers	Michelle Piot	Received

154-PB	Influence of Pharmacodynamics of Factor VIII on Bleeding Phenotype of Children under Long-term Prophylactic Regimen	Ihosvany Fernandez Bello	Received

156-PB	Novel F9 Gene Variants in Hemophilia B Patients from Turkey	Ergul Berber	Received

158-PB	Population Pharmacokinetic Analysis of Perioperative Factor IX Dosing in Hemophilia B	Tim Preijers	Received

159-PB	Which Tests Can Better Indicate Clinical Phenotype of Pediatric Patients with Hemophilia on Prophylaxis?	Yilmaz Ay	Received

160-PB	Acquired Haemophilia and Eosinophilic Fasciitis	MROUKI MAROUA	Received

162-PB	A Novel Tick Salivary Protein Modulates Fibrinolysis by Interacting with Plasminogen and Tissue Plasminogen Activator, and Prevents Arterial Thrombosis in vivo	Ivo Francischetti	Received

164-PB	Optimising the Degradation of NETs to Destabilise Fibrin Clot Structure and Promote Fibrinolysis	Locke Matthew	Received

165-PB	Extracellular Histones Enhance Fibrin Degradation by Prourokinase in a Factor Seven Activating Protease (FSAP)-dependent Manner	FABRIZIO SEMERARO	Received

166-PB	Localization of the C-terminal Cleavage Site of Human Alpha-2-antiplasmin	Shirley Uitte de Willige	Received

167-PB	PAI-1 Inhibition with MDI-2001: Towards a Safer and More Effective Treatment for Deep Vein Thrombosis	Jose Diaz	Received

168-PB	A Phase 2/3, Open-label, Repeat-Dose Study of the Pharmacokinetics, Efficacy, and Safety of Prometic Plasminogen Intravenous Infusion in Subjects with Hypoplasminogenemia (HPLG)	Joseph Parker	Received

169-PB	Colistin Dampens Fibrinolysis and Endothelial Activation during Endotoxemia: A Randomized, Double Blind Trial	Christian Schoergenhofer	Received

171-PB	Global Assay of Fibrinolysis in Sickle Cell Disease: Contrasting Results in Plasma and Whole Blood	Anton Ilich	Received

174-PB	Generation and Characterization of Monoclonal Antibodies against the N-terminus of Alpha-2-antiplasmin	Shirley Uitte de Willige	Received

175-PB	Stretching Fibrin Fibers Hampers their Lysis	Martin Guthold	Received

176-PB	Performance and Determinants of whole Blood and Plasma Fibrinolysis Assays in Patients with Mild Bleeding Symptoms	Minka Vries	Received

177-PB	Characterisation of the Different Pathways of Neutrophil Extracellular Trap (NET) Formation Triggered by Treatment with phorbol-12-myristate-13-acetate (PMA) or Calcium Ionophores	Matthew Locke	Received

178-PB	Effect of Alpha-2 Plasmin Inhibitor p.Arg6Trp Polymorphism and Antigen Level on the Risk of Myocardial Infarction in Young Patients	Éva Katona	Received

180-PB	Study of Fibrinolytic Factors along with Thrombophilia Screening Gives a Comprehensive Picture of the Cause of Venous Thrombosis in Indian Patients	Aniket Prabhudesai	Received

181-PB	Impaired Plasminogen Binding in Patients with Venous Thromboembolism: Association with Protein Carbonylation	Jakub Siudut	Received

182-PB	Ligneous Gingivitis due to Severe Plasminogen Deficiency: Results of a Prophylactic Protocol for Dental Care	Maria Teresa Sartori	Received

184-PB	Fibrinolytic Markers in Patients Undergoing Total Hip Replacement with and without Administration of Tranexamic Acid	Irina Antropova	Received

185-PB	Hyperfibrinolysis during Liver Transplantation Detected by Classical Parameters and Thromboelastometry	Sara Maggiolo	Received

187-PB	Application of the CloFAL Assay, a Global Assay which Evaluates Coagulation and Fibrinolysis in a Cohort of Venous Thromboembolism (VTE)	Silmara Montalvao	Received

188-PB	Simultaneous Thrombin Plasmin Generation Assay in Haemorrhagic and Non Haemorrhagic Caesarean Section: Pilot Study	Emmanuelle Jeanpierre	Received

189-PB	Simultaneous Thrombin Plasmin Generation Assay: Effect of Tranexamic Acid Concentration in vitro	Emmanuelle Jeanpierre	Received

190-PB	Association of Fibrinolytic Parameters with Coagulation Activity and Fibrin Clot Permeability in Patients with Hemophilia A	Marija Milos	Received

191-PB	Consequences of Tranexamic Acid on Fibrinolysis in Patients with Hereditary Bleeding Disorders Compared with Healthy Controls	Isaac Goncalves	Received

192-PB	Association of TAFI Polymorphisms and Fibrinolytic Status with Obesity in Subjects Suspected for Coronary Artery Disease	Chutima Rattanawan	Received

193-PB	Nattokinase Easily Hydrolyzed Fish Elastin and Collagen, and Produced Anti-platelet Aggregation Activity	Hiroyuki Sumi	Received

195-PB	A New Functional Food Coix-Natto for Fibrinolysis	Chieko Yatagai	Received

198-PB	Very High Production of Nattokinase by D-amino Acids	Yasuhide Yanagisawa	Received

199-PB	Evaluation of the Ankle Brachial Index in Persons with Hemophilia: Unexpected Findings	Hilde Hop	Received

201-PB	Patient, Regional and Center-level Variation in Utilization of Arthroplasty and Arthrodesis Interventions in Persons with Hemophilia: An Analysis of the American Thrombosis and Hemostasis Network (ATHN) Dataset	Tyler Buckner	Received

204-PB	Compartmental High Resolution 3D Imaging by HR-pQCT Reveals Low Bone Mineral Density in Hemophilia Patients is Attributed to Loss of Trabecular Bone	Adrienne Lee	Received

205-PB	No Association between HFE and HMOX1 Polymorphisms, Important in Iron and Heme Handling, and the Severity of Haemophilic Arthropathy	Lize van Vulpen	Received

206-PB	Factors Associated with Perception of Functional Abilities in US Adults with Hemophilia Beyond Joint Status: Analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study	Christine Kempton	Received

210-PB	Bleeding Phenotype In Non-severe Hemophilia A Has a Better Association with the One-stage Than the Chromogenic Assay	Lisette M. Schtte	Received

214-PB	Assessment of Clot Kinetics of Recombinant Human Factor VIII, Recombinant Porcine Factor VIII, Recombinant Factor VIIa and Activated Prothrombin Complex Concentrate Utilizing Thromboelastography in Patients with Hemophilia	Guy Young	Received

215-PB	Obesity in Patients with Hemophilia: Prevalence by Age, Clinical Correlates and Impact on Joint Bleeding	Chia-Yau Chang	Received

216-PB	Influence of Genetic Polymorphisms of Biological Mediators on the Phenotypic Heterogeneity in Hemophilic Arthropathy	Yeu-Chin Chen	Received

217-PB	Joint Status and Other Factors Associated with Pain Severity and Interference in US Adults with Hemophilia Beyond Joint Status: Analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) Study	David Cooper	Received

218-PB	Ranges of Risk Associated with Sports/Recreational Activities in People with Hemophilia: Results of the Activity-Intensity-Risk (AIR) Consensus Survey of US Physical Therapists	Sheba Mathew	Received

219-PB	The Impact of Switching Recombinant Factor VIII Product Concentrates on Inhibitor Development among Haemophilia A Patients in Australia	Huyen TRAN	Received

220-PB	Sociodemographic, Clinical and Psychosocial Characteristics of People with Haemophilia (PWH) in Portugal: Preliminary Results of the First National Survey	Ana Cristina Paredes	Received

221-PB	Understanding Burden of Illness of People with Hemophilia A with or without a Current Inhibitor	Daniella Babu	Received

222-PB	The Continued Use of Cryoprecipitate and Plasma to Treat Bleeding Disorders	Christine Herr	Received

223-PB	Anti-CD20 and Sirolimus for Immune Tolerance in Congenital Hemophilia A with Refractory Inhibitors	Bhavya Doshi	Received

224-PB	A Prospective Surveillance Study of Inhibitor Formation in Quebec Hemophilia A Patients Following a Population Switch to a Third-generation B-Domain-deleted Recombinant Factor VIII	Evemie Dubé	Received

225-PB	Evaluation of Reagent Substitutions in the Centers for Disease Control and Prevention Modified Nijmegen-Bethesda Assay (CDC-NBA) for Factor VIII (FVIII) Inhibitors in Hemophilia A	Connie Miller	Received

226-PB	Evaluation of an Optimized Thrombin Generation Assay for Measurement of rFVIIa in Haemophilia A Patient Plasma	Nora Viviana Butta	Received

229-PB	Frozen Autologous Platelet Gel and Fibrin Glue in Hemophilia A, B and von Willebrand Surgical Patients	Bernadeta Ceglarek	Received

230-PB	Safety and Efficacy Of Moroctocog Alfa (AF-CC) in Patients with Hemophilia A: Results of a Post-authorization Study in Usual Care Settings in China	Renchi Yang	Received

231-PB	Post-authorization Study to Evaluate Pharmacokinetics of FVIII after Moroctocog Alfa (AF-CC), as Well as Safety and Efficacy in Previously Treated Pediatric Patients with Severe Hemophilia A	Jeremy Rupon	Received

232-PB	Understanding Care Utilization and Perceptions of People with Hemophilia A with or without a Current Inhibitor	Daniella Babu	Received

234-PB	Retrospective Analysis of Hemostatic Efficacy by Continuous Infusion of Recombinant Factor VIIa: A Single Institution Study	Nobuaki Suzuki	Received

235-PB	An Evaluation of the Pharmacokinetics of Turoctocog Alfa in Relation to Body Mass Index (BMI) in Patients with Haemophilia A (HA)	Silva Zupancic-alek	Received

236-PB	Pharmacokinetic Studies of FVIII in Chinese Boys with Severe Hemophilia A	Zhenping Chen	Received

237-PB	Preliminary Results of a Personalized One-year Program to Individualize the Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Hemophilia A Patients	Juan Eduardo Megías Vericat	Received

240-PB	Validity of Angiography and Therapeutic Embolization in the Treatment of Acute Bleeding in Hemophilia Patients	YOUNG SHIL PARK	Received

241-PB	Postraumatic Anterior and Posterior Thigh Pseudotumor in Young and Adolescent with Hemophilia	Ricardo Silva	Received

243-PB	Severe Haemophilia A Patients Born between 2000- 2015 at a Single Haemophilia Centre: Characteristics and Inhibitor Development	Marta Martorell	Received

244-PB	The Effectiveness of PK-Tailored Tertiary Prophylaxis for Severe Hemophilia A Children: A Pilot Study from BCH	Zhenping Chen	Received

245-PB	Korea Hemophilia Foundation Registry Trends 1991-2015: Patient Registry, Demographics, Health Services Utilization	Soon Ki Kim	Received

246-PB	Safety and Efficacy of Nonacog Alfa in Patients with Hemophilia B: Results of a Post-authorization Study in Usual Care Settings in China	Ashley Daset	Received

247-PB	Spinal & Cranial Neurosurgical Procedures in Patients with Hemophilia	Charles Nakar	Received

248-PB	Pseudotumors in Hemophilia: Effective Surgery with Application of Frozen Autologous Platelet Gel	Bernadeta Ceglarek	Received

252-PB	Sudden Decrease of High-titer Anti-FVIII Antibodies with Anti-inhibitor Coagulant Complex in a Patient with Severe Hemophilia A and Poor Response to Immune Tolerance Induction	Inmaculada Soto	Received

254-PB	Correlation between Pharmacokinetic of Factor VIII and Bleeding Frequency of Children withsevere Hemophilia A in China - A Single Center Data Analysis	Zhenping Chen	Received

255-PB	Assessment of the Quality of Life in Korean Hemophiliacs: Impact of Disease-related Factors, Social Status and Treatment Factors on the Quality of Life of Korean Hemophiliacs	Ho-Jin Shin	Received

256-PB	Relevance of Polypharmacy for the Clinical Outcome of Patients Receiving Oral Anticoagulation Therapy - Results from the thrombEVAL Study	Lisa Eggebrecht	Received

257-PB	Thromboembolic and Bleeding Risk of Patients with Left-sided Mechanical Heart Prosthesis: The FCSA-START-Valvole Study	Emilia Antonucci	Received

258-PB	Warfarin Binds to a Hydrophobic Pocket within the Oxidized Open State Human VKORC1 Conformation	Katrin Czogalla	Received

260-PB	Assessment of the Efficacy of a Novel Tailored Vitamin K Dosing Regimen in Lowering INR in Over-anticoagulated Patients	Emmanouela Kampouraki	Received

261-PB	Clinical Usefulness of the SAMe-TT2R2 Score: A Systematic Review and Meta-analysis	Jasper van Miert	Received

262-PB	Safety of Long Term Warfarin Therapy in Real Clinical Practice: Predictors of Major and Non-Major Clinically Relevant Bleedings	Elizaveta Panchenko	Received

263-PB	Decreased Bone Mineral Density in Fontan Patients Receiving Long-term Warfarin	Chantal Attard	Received

264-PB	Predicting Recurrent Venous Thromboembolism in Patients with Deep-vein Thrombosis: Development and Internal Validation of an Simply Applicable Prediction Model (Continu-8)	Michael Nagler	Received

266-PB	Anticoagulation Control in Premenopausal Women with Mechanical Heart Valves Using Vitamin K Antagonists: Room for Improvement	C.S.B. Veen	Received

267-PB	Involvement of Antithrombotic Therapy in Intracranial Bleeding: A Tertiary Hospital Experience	Veronica Pons	Received

268-PB	One-year Medical Costs and Predictors of Costs of Pulmonary Embolism: A Prospective Study	Jean-Philippe Galanaud	Received

269-PB	The Impact of Antiphospholipid Syndrome and Related Comorbidities in the Quality of Oral Anticoagulation	Gabriela Goes Yamaguti-Hayakawa	Received

270-PB	Predicting Recurrent Venous Thromboembolism in Patients with Deep-vein Thrombosis: External Validation of a Prediction Model	Michael Nagler	Received

271-PB	Clinical Characteristics Associated with Diagnostic Delay of Pulmonary Embolism in Primary Care: A Retrospective Observational Study	Janneke Hendriksen	Received

272-PB	Variability in Calculation of Time in Therapeutic Range for Quality Control Measurement of Warfarin	Safia Siddiqui	Received

273-PB	D-dimer Levels Predict Clinical Outcomes in Patients with Mechanical Heart Valve Replacement during Oral Anticoagulation Therapy	Litao Zhang	Received

275-PB	Has the Introduction of the DOACs Moved Patients with Labile INRs from Warfarin Therapy?	Thomas O Halloran	Received

276-PB	Long-Term Risk of Recurrence After Stopping Anticoagulants for Acute Unprovoked Venous Thromboembolism: Systematic Review and Meta-Analysis	Faizan Khan	Received

277-PB	Outcome of Vitamin K Antagonist Associated Bleeding in Patients Treated with Prothrombin Complex Concentrate	Marjolein P.A. Brekelmans	Received

278-PB	Association of 5-untranslated Region / Exonic VKORC1 Mutations with Vitamin K Antagonist Resistance: Results of the GFHT Cohort Study	Elodie Lesteven	Received

279-PB	Repeated Serial D-Dimer (DD) Measurement after Anticoagulation Therapy (AT) withdrawal to Identify Patients (PTS) at Risk for Venous Thromboembolism (VTE) Recurrence	Benilde Cosmi	Received

281-PB	AF Patients on VKAs: Heart Failure is Associated with Worst Quality of Anticoagulation and Higher Bleeding Risk. Results from the START Register	Emilia Antonucci	Received

282-PB	Thrombotic Complication Rates Following Anticoagulation Reversal: A Retrospective Evaluation of Prothrombin Complex Concentrates	Joseph Shaw	Received

287-PB	Thrombin Generation Test: A Reliable Tool to Evaluate the Pharmacodynamics of Vitamin K Antagonist Rodenticides in Rats	Georges JOURDI	Received

288-PB	The Efficacy of 3-mg versus 5-mg Warfarin Initiating Dose and Corresponding Dosing Schedule in Thai Patients Diagnosed with Venous Thromboembolism	Bundarika Suwanawiboon	Received

289-PB	Barriers to Implementing an Extended INR Testing Interval Policy for Stable Warfarin Patients: A Mixed Methods Study in Five Anticoagulation Clinics	Geoffrey Barnes	Received

290-PB	Vitamin K Antagonists Compared to Low-molecular-weight Heparins for Treatment of Cancer-associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice	Frederikus Albertus Klok	Received

291-PB	External Quality Assessment of the POCT Prothrombin Time Determination - the 6-Year Experience with the Evaluation of the Postanalytical Phase	Petr Kessler	Received

292-PB	The Incidence of Thromboembolic and hEMorrhagic (ITEM) Complications in Patients on Anticoagulant Therapy. A Dynamic Parallel-group Cohort Study	Sophie Testa	Received

293-PB	Specific Inhibition of Endogenous VKOR Enzymes by Oral Anticoagulants Reveals Lower VKORC1L1 Susceptibility due to Different Binding Site	Kerstin Liphardt	Received

294-PB	A comparison of management strategies for patients with warfarin-induced bleeding	Paul Dobesh	Received

295-PB	Provision of External Quality Assurance for Post Analytical Assessment of Point of Care Haemostasis Tests	Ian Jennings	Received

296-PB	Warfarin Toxicities: Risk Factors and Management - Data from a Developing Country	Sidra Asad Ali	Received

297-PB	Use of a 4-factor Prothrombin Complex Concentrate for Warfarin Reversal prior to Urgent Surgery	Brian Trevarrow	Received

298-PB	Can Results Be Improved on Vitamin K Antagonists (AVKs) Therapy ?	ALICIA VILASECA	Received

299-PB	Genetically Determined Hypersensitivity to Vitamin K Antagonists Caused by a c.109GA (p.Ala37Thr) Mutation in the Factor IX Propeptide: The First Case Identified in Poland	Edyta Odnoczko	Received

301-PB	Prothrombinex-VF versus Vitamin K alone for warfarin reversal prior to emergency surgery in Western Australias Tertiary Orthopaedic Departments.	Rachael Stokes	Received

303-PB	Utility of a new Point of Care system, Coag S, for Vitamin K Antagonist Therapy in a Rural Family Practice	József Antal	Received

304-PB	Duration of anticoagulation, recurrence predictors and treatment pathways in first venous thromboembolism in a tertiary referral centre	Laith Tafesh	Received

305-PB	Out of Range INR Values Increase Healthcare Interaction Time in Four Large Anticoagulation Clinics	Geoffrey Barnes	Received

309-PB	Ex Vivo Haemostatic Capacity of Thawed Plasma Beyond 24 Hours: Comparison between FFP and RTFP24	Ai Leen Ang	Received

311-PB	Coagulation Parameters and Need for Transfusion in Patients with Veno-arterial Extracorporeal Membrane Oxygenation in Clinical Hospital Center Rijeka	Nada Vukelic-Damijani	Received

314-PB	Knowledge, Attitude and Practice Regarding the Voluntary Blood Donation among the Young Student Population of Karachi	Bipin Nepal	Received

315-PB	Burden of Hemoglobinopathies on the Blood Bank of a Tertiary Care Setting	Romana Akbar	Received

316-PB	Major Blood Groups and A2 Sub-group in Mixed Pakistani Population of Karachi	Bipin Nepal	Received

321-PB	Characterization of a Universal Reversal Agent for Anticoagulants	Kamran Bakhtiari	Received

323-PB	Extracellular Nucleosome Levels in the Etiopathogenesis of Sepsis-associated Coagulopathy	Amanda Walborn	Received

324-PB	Mediators of Inflammation and Infection in Sepsis Associated Disseminated Intravascular Coagulation and Their Prognostic Role	Priya Patel	Received

326-PB	Evaluation of the Diagnostic Utility of Individual Parameters in the Disseminated Intravascular Coagulation (DIC) Panel for Use in Under-resourced Settings	Susan Louw	Received

327-PB	Circulating Nucleosomes and Neutrophil Activation Predict for Disseminated Intravascular Coagulation but Not for Mortality in Patients with Severe Sepsis or Septic Shock	Mandy Lauw	Received

328-PB	A Prospective Observational Study for the Evaluation of New Diagnostic Criteria for Disseminated Intravascular Coagulation by the Japanese Society on Thrombosis and Hemostasis	Seiji Madoiwa	Received

329-PB	A comparison of Disseminated Intravascular Coagulation (DIC) Screening Parameters with and without Human Immunodeficiency Virus Infection in an African Academic Hospital Setting	Elizabeth Mayne	Received

330-PB	International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treated and Those with Disseminated Intravascular Coagulation	Debra Hoppensteadt	Received

331-PB	Epidemiological Evaluation of Patients Presenting with Disseminated Intravascular Coagulation (DIC) at an Academic Hospital in an African Middle-income Country	Elizabeth Mayne	Received

333-PB	Fulminant Disseminated Intravascular Coagulation as Initial Manifestation of Pulmonary Adenocarcinoma	Sofia Teixeira	Received

334-PB	Platelet-mimicking Synthetic Nanoparticles (SynthoPlateTM) Improve Hemostasis and Survival Following Uncontrolled Hemorrhage	Matthew Neal	Received

338-PB	Antifibrinolytic Therapy to Prevent Oral Bleeding in People on Anticoagulants Undergoing Oral or Dental Procedures: A Cochrane Systematic Review	Eveline Engelen	Received

339-PB	Management of Rivaroxaban or Apixaban Associated Major Bleeding with Prothrombin Concentrate: A Prospective Cohort Study	Ammar Majeed	Received

341-PB	Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors	Sam Schulman	Received

342-PB	Reversal of Dabigatran-associated Major Bleeding with Activated Prothrombin Concentrate: A Prospective Cohort Study	Sam Schulman	Received

343-PB	A Randomized Study of 4-factor Prothrombin Complex Concentrate and Tranexamic Acid on Bleeding, Thrombin Generation, and Pharmacodynamics after Punch Biopsies in Rivaroxaban Treated Subjects with Supratherapeutic Drug Levels	Connie Comella	Received

344-PB	Idarucizumab for Dabigatran Reversal in Daily Practice - First Experiences from Slovenia	Nina Vene	Received

345-PB	The Influence of Histones on the Generation of Factor XIa in Trauma Patient Blood	Shannon Prior	Received

349-PB	Development and Validation of the Warfarin-Aspirin Bleeding Assessment Tool (WA-BAT)	Chantal Attard	Received

351-PB	Chemical Composition of Malian Medicinal Plants Used to Treat Bleeding Events	DIALLO Yacouba L.	Received

352-PB	First Italian Experience of Clinical Use of Obizur, Recombinant Porcine Sequence Factor VIII (RPFVIII), for Acquired Haemophilia A (AHA)	Corrado Lodigiani	Received

353-PB	The Effect of PCC on ROTEM Parameters in Patients with Coagulopathy of Liver Disease	Colleen Hamid	Received

354-PB	Factor VIII and von Willebrand levels at Desmopressin (DDAVP) Challenge Test: A Single Center Results	Claudia Casas	Received

355-PB	Correlation between Platelet Count and Platelet Component in Thromboelastometry	Marija Milic	Received

357-PB	Towards a Clinically Relevant Hybrid Adenovirus-Sleeping Beauty Transposon Vector for Gene Therapy for von Willebrand Disease	Irina Portier	Received

358-PB	Comprehensive Functional and Structural Studies to Characterize von Willebrand Factor Propeptide Novel Missense Variants with Unknown Pathological Significance	Hamideh Yadegari	Received

359-PB	Triggering Receptor Expressed on Myeloid Cells Like Transcript-1 (TLT-1) is a Novel Ligand for von Willebrand Factor	Angela Doerr	Received

362-PB	Axial Structure and Collagen Binding of the von Willebrand Factor Multimer	Maria Csilla Csanyi	Received

364-PB	Recombinant Activated Factor VII-Induced Correction of Bleeding Tendency in Genetically-engineered von Willebrand Disease Type 2B Mice Evaluated Using New Tail Transection Bleeding Models	valerie proulle	Received

365-PB	VWF DD3 Mutations Associated with Type 1 von Willebrand Disease Demonstrate Impaired Gp1B?-VWF Binding under High Shear Stress	Christopher Ng	Received

366-PB	Diagnostic Challenges of Acquired von Willebrand Syndrome	Sonja Schneppenheim	Received

367-PB	Multimer Size Distribution and Multimerization Defects of von Willebrand Factor Investigated at the Single-molecule Level by AFM Imaging	Achim Lf	Received

368-PB	Exploration of Interim Bleeding Scores in VWD Subjects from Irish LoVIC, Canada and the US Zimmerman Program	Pamela Christopherson	Received

369-PB	Does Ageing Modify Hemostatic Parameters in Type 1 von Willebrand Disease (VWD-1)?	Giuseppe Guglielmini	Received

370-PB	Common Single Nucleotide Variants in the von Willebrand Factor Gene Associate with Mutation Negative Type 1 VWD	Colleen Notley	Received

371-PB	Functional Polymorphisms of the von Willebrand Factor Gene in Patients with Mild to Moderate Bleeding Tendency and Low von Willebrand Factor Antigen or von Willebrand Factor Ristocetin Cofactor	Stefanie Hofer	Received

373-PB	Quantitative ELISA Assay for in vivo Proteolysis of von Willebrand Factor and Bleeding: A Pilot Study in Type 2A (IIA) von Willebrand Disease	Antoine Rauch	Received

374-PB	Bleeding Symptoms in Patients Previously Diagnosed as Type 3 von Willebrand Disease: Results from a Multicenter, Multinational Cross-sectional Study	Alberto Tosetto	Received

375-PB	Fluorescence Intensity-based Analysis of the Shear-dependent Internalization of Von Willebrand Factor Mutants by Macrophages	Ulrike Klemm	Received

376-PB	Von Willebrand Factor Multimer Analysis in 255 Patients Previously Diagnosed as VWD Type 3 from the Iranian Republic and Nine European Countries (3WINTERS-IPS Study)	Ulrich Budde	Received

377-PB	Interaction between the A3 and A2 Domains of von Willebrand Factor Reduces the Binding of the A1 Domain to Glycoprotein Iba	Miguel Cruz	Received

379-PB	Perioperative Management of Replacement Therapy in von Willebrand disease: Steps towards Individualization of Treatment?	Marjon Cnossen	Received

380-PB	Deficiency of von Willebrand Factor (VWF) High Molecular Weight Multimers (HMWM) in the Presence of Normal/Increased Activity of both VWF Cofactor Activity (VWF:RCo) and VWF Antigen (VWF:Ag) in Patients with Severe Aortic Stenosis	Bernadeta Ceglarek	Received

381-PB	Usefulness of VWF Propeptide in the Differential Diagnosis between Patients with VWD and AVWS	Francesca Stufano	Received

384-PB	Laboratory Diagnosis of von Willebrand Disease Type 2A versus LVAD-Induced Acquired von Willebrand Syndrome	Shannen Deconinck	Received

385-PB	Elevated Levels of vWF Antigen and Activities, Factor VIII and Fibrinogen Inversely Correlated with the Estimated Glomerular Filtration Rate in Patients with Non-dialysis Chronic Kidney Disease	Bundarika Suwanawiboon	Received

386-PB	Measurement of Platelet von Willebrand Factor (VWF) Antigen Concentration and Activity Using Automated Latex-immunoturbidometric (LIA) Assays	Heiko Ruehl	Received

389-PB	Profile of Mutations Identified in the 3WINTERS-IPS Project on Iranian Patients with Previously Diagnosed Type 3 von Willebrand Disease	Luciano Baronciani	Received

390-PB	Self-reported Experiences with Menorrhagia in Women with von Willebrand Disease: A Patient-oriented Survey Study	Ariela Marshall	Received

392-PB	Ristocetin Cofactor Latex Immunoassay, High Sensibility to Acquired von Willebrand Disease with Subtle Loss of High Molecular Weight Multimers	Barbara Montaruli	Received

393-PB	Von Willebrand Factor Antigen Levels in 255 Patients Previously Diagnosed as VWD Type 3 from the Iranian Republic and Nine European Countries (3WINTERS-IPS Study)	Ulrich Budde	Received

395-PB	Clinical Evaluation of the Sebia Hydragel von Willebrand Factor Assay in Comparison to Electrophoresis and blotting based Multimer Analysis	Holger Seidel	Received

396-PB	Can a One-time von Willebrand Testing Rule out Type 1 von Willebrand Disease in Young Women with Menorrhagia?	Shiu-Ki Hui	Received

397-PB	Screening of von Willebrands Disease in a Region of High Consanguinity	YAMINA OUARHLENT	Received

398-PB	Management of a Spontaneous Ileo-psoas Haematoma in a Girl with Type 3 von Willebrand Disease and Alloantibodies to von Willebrand Factor	Chiara Ambaglio	Received

400-PB	Residual Vein Thrombus Does Not Predict for Recurrent Vein Thrombosis in the ASPIRE Study	Timothy Brighton	Received

401-PB	Utility of Thromboelastometry Analysis in Patients with Mild Bleedings Disorders	Anna Wieland	Received

402-PB	Increased Maximum Lysis of ROTEM in Pregnancy: It Is Not Hyperfibrinolysis	Jun Teruya	Received

403-PB	Significant von Willebrand Disease Can Be Missed if a von Willebrand Factor Activity Assay Is Not Performed	Sean Platton	Received

404-PB	Validation of Flow Cytometric Mepacrine Uptake and CD63 Expression in the Diagnosis of Storage Pool Disease	Ivar van Asten	Received

405-PB	Post-analytical External Quality Assessment - Interpretation of UK NEQAS (Blood Coagulation) Results	Ian Jennings	Received

406-PB	Performance of different D-dimer assays using the age-adjusted threshold for the exclusion of pulmonary embolism	Noémie Kraaijpoel	Received

407-PB	Safety of Multidetector Computed Tomography Pulmonary Angiography to Exclude Pulmonary Embolism in Patients with a Likely Pretest Clinical Probability	Helia Robert-Ebadi	Received

408-PB	Familial Multiple Coagulation Factor Deficiencies - Need for Deeper Clinical and Scientific Assessment	Barbara Preisler	Received

409-PB	Performance of Anti-factor Xa Heparin Assays in External Quality Control Surveys	Chantal BON	Received

410-PB	Ex-vivo Plasma Clot Formation and Lysis as a Universal Measure for Anticoagulation in Patients on Vitamin-K-antagonist, Dabigatran, Rivaroxaban, Apixaban, or Low-molecular-Weight Heparin	Oliver Knigsbrgge	Received

411-PB	Thrombin Generation Response of rFVIIa in Haemophilia A Patient Plasma when Using Different Triggers and Phospholipids	Lone Frost Larsen	Received

412-PB	Performances of the Hydragel 5 von Willebrand Multimers - A New within-Day von Willebrand Factor (VWF) Multimer Screening Method	ANNETTE BOWYER	Received

413-PB	The Selective Use of Computer-assisted Strain Gauge Plethysmography as an Additional Screening Test for Suspected DVT Can Decrease the Need for Compression Ultrasonography: A Validation Study	Andrew Hughes	Received

414-PB	Semi-automated Platelet Aggregometry Employing the Sysmex CS-2x00; Preliminary Findings in a Multi-centre Study	Aine McCormick	Received

415-PB	The Impact of Repeated Freeze-thaw Cycles on Antiphospholipid Antibody Titer	Karel Maelegheer	Received

416-PB	Suitability of a Liquid High-sensitivity Recombinant Human Prothrombin Time Reagent with Two Year Shelf Life on an Automated Coagulation Laboratory Platform	Kevin Cawthern	Received

417-PB	Discrepancy in Optical and Impedance Platelet Count in Platelet Rich Plasma Prepared for Light Transmission Aggregation as a Possible Sample Quality Indicator	Ana Mlinaric	Received

418-PB	Thrombophilia: Women-specific Reference Ranges May Prevent Overdiagnosis	C S B Veen	Received

420-PB	Comparison of Thrombin Generation Profiles among Patients Treated with Three Different Direct Oral Anticoagulants and Warfarin	Sophie Testa	Received

422-PB	Innovative Method for the Description of Human Platelets Population	Alena Litvinenko	Received

423-PB	Thromboelastometry to Detect Anticoagulant Effect of Apixaban in Patients with Non Valvular Atrial Fibrillation	Maria Giulia Mosconi	Received

424-PB	Assessment of Single-factor Deficiency Sensitivty of Three Thromboplastin Reagents	Vincent Juif	Received

425-PB	Genetic Analysis for Investigation of Heritable Bleeding Disorders - Update on the UK NEQAS (Blood Coagulation) Programme	Ian Jennings	Received

426-PB	Platelet Reactivity in Patients on Aspirin and Clopidogrel Therapy Measured by a New Bed-side Whole Blood Assay	Carolin Helten	Received

429-PB	Performance Evaluation of the microINR Point-of-Care INR-testing System	Jaco Joubert	Received

431-PB	Divergence of Normal Ranges Using Thromboelastography as Measured by Clot Viscosity versus Clot Harmonic Resonance	Geoffrey Wool	Received

432-PB	Identification of Triple Positivity Patients with Major Risk for Thromboses Is Dependent of Methodology Applied at the Lab Investigation	Silmara Montalvão	Received

433-PB	Performance Evaluation of the ZL 6000i Cone Plate Viscometer	Jayoung Lee	Received

435-PB	Accurate Recovery of N9-GP in a One-stage Ellagic Acid Based Clot Assay on the ACL Top Analyzer	Dr Anuja Khan	Received

436-PB	A Performance Evaluation of a New Lupus Sensitive APTT Reagent	Chris Gardiner	Received

438-PB	Establishment of Oral Anticoagulant Monitoring Facility at Tertiary Care Teaching Hospital in Western India: Four Years Experience	Anjali Kelkar	Received

439-PB	Do Chinese Patients with Heart Valve Replacement Benefit from Warfarin Pharmacogenetic Test: A Pilot Retrospective Study	Litao Zhang	Received

440-PB	Analytical Performance of an Anti Xa Assay with Rivaroxaban Specific Calibrators	CRISTINA DUBOSCQ	Received

441-PB	Multicenter Study on the Interference of Spontaneous Hemolysis at Blood Sampling on Five Main Hemostasis Tests	Chiara Novelli	Received

442-PB	Performance Evaluation of the Coag-Sense Point-of-Care INR-testing System	Jaco Joubert	Received

443-PB	Thrombin Generation in Patients with Coronary Complications during the First Year after Percutaneous Intervention	Tatiana Vavilova	Received

444-PB	Prediction of Partial Thromboplastin Time (PTT) and Prothrombin Time (PT) on the Basis of Factor Assay Activities Using Data from a Clinical Data Warehouse	Amrom Obstfeld	Received

445-PB	Use of a Synthetic Collagen to Monitor Platelet Function in Patients Receiving Dual Antiplatelet Therapy	Walter Jeske	Received

448-PB	Comparison of Activated Clotting Time Measured by I-STAT, Sonoclot and ACTPlus and Correlation with Anti-Xa during Cardiopulmonary Bypass Procedures	Stien Vandendriessche	Received

449-PB	Presence of Residual Venous Thrombus at Warfarin Withdrawal: A Predictor for Recurrence After a First Episode of Symptomatic Provoked Proximal Deep Venous Thrombosis in an Asian Population?	Nuttawut Sermsathanasawadi	Received

450-PB	Hemolyzed Samples: Should Be Accepted in Hemostasis Laboratories?	Dario Jacobsen	Received

451-PB	Coag S: A Professional INR Monitoring Device. Comparison with the Laboratory INR Testing	Zoltan Vajda dr.	Received

452-PB	Evaluation of the New Tcoag Pre-calibrated TriniLIATM D-Dimer II Assay	Jane Needham	Received

457-PB	Rivaroxaban for Initial Therapy in Patients with Pulmonary Embolism. A Real-life Study	Pierpaolo Di Micco	Received

459-PB	Prothrombin Complex Concentrate for Reversal of XA Inhibitors - Real Life Data	Galia Spectre	Received

461-PB	Rivaroxaban for Scheduled Work-up of Patients with Suspected Deep Venous Thrombosis: A Prospective Interventional Outcome Study - The Ri-Schedule study	Synne Fronas	Received

464-PB	Direct Anticoagulants and Vitamin K-antagonists Exert Differential Effects on Markers of Subclinical Cardiovascular Disease: Results from the MyoVasc Study	Lisa Eggebrecht	Received

465-PB	Lifelong Apixaban Treatment Is Cost-effective for Idiopathic Venous Thromboembolism	Lisa de Jong	Received

471-PB	Plasma Fibrin Clot Properties in the G20210A Prothrombin Mutation Carriers Following Venous Thromboembolism: The Effect of Rivaroxaban	Jakub Siudut	Received

472-PB	A Cross-Sectional, Multinational, Multidisciplinary Survey of Physicians Surrounding the Management of Bleeding Complications in the Setting of Direct Oral Anticoagulant Use	Joseph Shaw	Received

473-PB	Apixaban in Mechanical Circulatory Support - Evaluation in a Mock Circulatory Loop with Human Blood	David Connor	Received

474-PB	Management of Major Bleeding and Outcomes in Patients Treated with DOACs: Results from the START SSC Event Register	Emilia Antonucci	Received

475-PB	High Recanalization Rate in Patients with Proximal-vein Thrombosis Treated with the New Direct Oral Anticoagulants	Lucia Sarolo	Received

477-PB	Concentration Correlation of Direct Oral Anticoagulants as Measured by the TEG 6s Oral Anticoagulant Assay	Marc Doubleday	Received

478-PB	Self-poisoning with Direct Oral Anticoagulants: A Series of Five Cases Admitted to the Intensive Care Unit	Alain Stepanian	Received

479-PB	New Insights in Interindividual Variability of Pharmacodynamic (PD) Response to Rivaroxaban through Thrombin Generation in the Presence of an Active Protein C Pathway: DRIVING Study Results in Healthy Volunteers	Virginie SIGURET	Received

481-PB	No Additional Diagnostic Value of Chest X-ray Prior to the YEARS Algorithm in the Diagnostic Management of Suspected Pulmonary Embolism	Liselotte M. van der Pol	Received

482-PB	Rivaroxaban Levels in Patients Plasmas Are Comparable by Measuring through Two Different Calibrators in Two Different Systems	Marta Martinuzzo	Received

485-PB	Measurement of Apixaban and Rivaroxaban Levels in Real Life Clinical Practice: An Instrument to Improve Anticoagulation Management?	CHARALAMPOS KARTSIOS	Received

486-PB	Comparison of Bleeding and Thromboembolic Event Rates in Atrial Fibrillation Patients with Good and Poor Warfarin Control before and after Switching to Direct Oral Anticoagulants	Scott Kaatz	Received

487-PB	Measurement of Direct Oral Anticoagulant Drug Levels Following Bariatric Surgery	Eric Tseng	Received

488-PB	Use of a 4-factor Prothrombin Complex Concentrate for Management of Direct Xa Inhibitor-induced Major Bleeding	Paul Dobesh	Received

489-PB	Is Rivaroxaban Associated with Headache and Dizziness? A Retrospective Study	Siavash Piran	Received

492-PB	Length of Hospital Stays Following Acute Pulmonary Embolism in England: Observational Cohort Study Using the CPRD-HES Databases	Raza Alikhan	Received

495-PB	Adherence to Rivaroxaban for the Management of Acute Venous Thromboembolism (VTE) - Early Results from the Follow-up in Rivaroxaban Patients in Setting of Thromboembolism (FIRST) Registry	Victoria Speed	Received

496-PB	Level of Fatigue after Initiation of Rivaroxaban for Treatment of Venous Thromboembolism	Kristin Kornelia Utne	Received

497-PB	The Combination of Rivaroxaban and Dabigatran Is Superior to Either Agent Alone in Suppressing Mechanical Heart Valve-induced Thrombin Generation	Iqbal Jaffer	Received

500-PB	Influence of Anthropometric, Hematological and Biochemical Parameters on Plasma Levels of Direct Oral Anticoagulants	Monica Sacco	Received

501-PB	Non Vitamin-k Oral Anticoagulants (NOAC) Dose Reduction and Adverse Outcomes - A Single Center Experience	Aaron Lubetsky	Received

502-PB	Reversal of Rivaroxaban Using Prothromplex Total, a 4-Factor Prothrombin Complex	Hartirathpal Kaur	Received

503-PB	Similar Rivaroxaban Plasma Concentrations Induce Different Anticoagulant Effects in Individual Obese Patients	Debora Bertaggia Calderara	Received

504-PB	Reversal of Dabigatran in Emergency Situations	M ANGELES FERNANDEZ	Received

505-PB	Can we Successfully Reverse a Massive Overdose of Dabigatran?	Isabel Freire	Received

506-PB	Routine Coagulation Tests for Assess Anticoagulant Activity of Direct Oral Anticoagulants	Helena Cruz Gomes	Received

507-PB	Direct Oral Anticoagulants in the Treatment of Deep Vein Thrombosis: The Experience of a Hemostasis Unit	Emmanouil Papadakis	Received

508-PB	Reversal of Dabigatran with Idarucizumab in Five Patients Admitted to the Emergency Department of Centro Hospitalar São João, Porto	Luciana Gonalves	Received

510-PB	Measurement of Direct Factor Inhibitors Concentration in Practice Laboratory	Tatiana Vavilova	Received

514-PB	Long-term Outcome in Children on Anticoagulant Therapy after Extracardiac Conduit Fontan Operation (FO)	Mara Agazzoni	Received

516-PB	e-Health Usefulness in Oral Anticoagulation Therapy in Children: Point of Care Instruments and Mobile APPs	Rubén Berrueco	Received

518-PB	Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical Trials	Hugo Maas	Received

519-PB	Factor Levels in Heparinized Critically Ill Pediatric Patients	Jonathan Byrnes	Received

522-PB	Role of anticoagulation in management of neonatal portal vein thrombosis	Suzan Williams	Received

523-PB	The Incidence, Assessment and Management of Mental Health Issues in Young People on Anticoagulation Therapy Secondary to Idiopathic Venous Thromboembolism	Fiona Newall	Received

524-PB	Investigating the Experience of Parents who Have Given their Children Enoxaparin at Home	Fiona Newall	Received

526-PB	Secondary Antithrombotic Prophylaxis in Children with Right Atrium Thrombosis	Pavel Zharkov	Received

527-PB	Thrombotic Storm in an 11 Year Old Boy	Surjit Singh	Received

528-PB	Variation in Practice in Relation to Antithrombotic Therapy and Monitoring After Paediatric Cardiac Surgery: Results of a United Kingdom Survey	Tina Biss	Received

530-PB	Management of Henoch-Shnlein Purpura in Children with Heparin. Russian Long-term Experience	Nadezda Vaynyunskaya	Received

531-PB	Inherited Antithrombin Deficiency in Children: Treatment of Massive Cerebral Sinus Venous Thrombosis in a Neonate with a Mutation in Gene SERPINC1 (Exon 3 C481ct)	Antonio Moscardó	Received

532-PB	Venous Thromboembolism Prevention in Children	Attilia Maria Pizzini	Received

533-PB	Development of a Thrombus in Giant Coronary Aneurysm of a Child with Kawasaki Disease - An Unusual Clinical Manifestation	Surjit Singh	Received

534-PB	Management of Anticoagulation Therapy in Patients with Thromboembolism in The Context of Renal Diseases: Case Series and Practical Suggestions	Mihir Bhatt	Received

536-PB	Petechial Rash and Thrombocytopenia with Unfractionated Heparin (UFH) Use: Heparin Induced Thrombocytopenia (HIT) in a Child with Non-vegetative Infective Endocarditis	Joanna Chan	Received

538-PB	Selected Expression and Functional Importance of alpha4a-Tubulin in Platelet Biogenesis	catherine strassel	Received

540-PB	PDK1 is Crucial to Proplatelets Formation and Thrombopoiesis	Britta Walker-Allgaier	Received

541-PB	Inhibition of MAP Kinase-interacting Kinase-1 (Mnk1) Regulates Platelet Functional Responses and Protein Synthesis in Megakaryocytes	Manne Bhanu Kanth	Received

542-PB	On-track to Producing Commercially-Feasible cGMP-Compliant Human Platelets from induced Pluripotent Stem Cells at Clinical Scale	Whitney Berry	Received

546-PB	Calcium/calmodulin-dependent Protein Kinase II (CamKII) Regulates Platelet Formation	ROBERT CAMPBELL	Received

548-PB	Platelet Factor 4 (PF4) Levels Correlate with Platelet Count and Ability to Inhibit Megakaryopoiesis in Pediatric Patients with ITP	Michele Lambert	Received

549-PB	Role of NOD-like receptors (NLRs) in Megakaryo/thrombopoiesis	Lina Paola DAtri	Received

550-PB	In vitro Generation of Functional Megakaryocytes Derived from Induced Pluripotent Stem Cells of Parahaemophilia Patients	Claudia Radu	Received

553-PB	The Application of High throughput Sequencing to the Diagnosis of Thrombocytopenia	Ruth Wheeler	Received

556-PB	Uncovering GEnetic NEtworks Underlying Platelet Response to Thienopyridines by EXome Sequencing of Extreme Phenotype Patients: Discovery and Validation Results	Jean-Luc Reny	Received

557-PB	Poorly Controlled Diabetes Mellitus Is Associated with Decreased Aspirin-mediated Acetylation of Platelet Cyclooxygenase-1 (COX-1) at Serine 529	Francesco Finamore	Received

562-PB	Platelets in Severe Aortic Stenosis Have an Altered Protein Profile and Are More Vulnerable upon Activation Compared to Coronary Artery Disease	Christina Christersson	Received

564-PB	TREM-like transcript-1: a more sensitive marker of platelet activation than P-in	Christopher W. Smith	Received

566-PB	Mechanisms of Platelet Adhesive-receptor Shedding in Platelet Populations in Thrombus Formation	Constance Baaten	Received

568-PB	Gradient-dependent Modulation of Platelet Stimulatory G-protein Coupled Receptors (GPCR) Signaling	Ankit Macwan	Received

569-PB	Activation of aIIb3 Integrin Involves the Cys608-Cys655 Disulfide Bond and the Electrostatic Network of the -tail Domain	Ronit Mor-Cohen	Received

570-PB	Clathrin Mediated aIIb3 Endocytosis Plays an Important Role in Platelet Activation	Xuemei Fan	Received

571-PB	An Inhibitory Mutant of Snake Venom Rhodocytin Blocks CLEC-2/Podoplanin Interaction-dependent Platelet Aggregation and Experimental Lung Metastasis	Shimon Otake	Received

572-PB	Human and Murine Neonatal Platelets Display Reduced CLEC-2 and GPVI Expression and Function Profiles Compared with Adult Platelets	Verónica Palma-Barqueros	Received

573-PB	DCBLD2 but Not GARP Has A Minor Role in Thrombus Formation in Mice which is Not in Line with the Findings in Zebrafish	Elien Vermeersch	Received

575-PB	Engineering scFvs (Single Chain Variable Fragments) to Platelet Glycoprotein VI	Samir Hamaia	Received

577-PB	Decompensated Heart Failure Patients Demonstrate Shedding of Platelet Receptors Glycoprotein (GP) Iba and GPVI in Contrast to Stable Heart Failure Patients	Joshua Casan	Received

579-PB	C-Type Lectin-like Receptor 2 Promotes Hematogenous Tumor Metastasis and Prothrombotic State in Tumor-bearing Mice	Toshiaki Shirai	Received

582-PB	The Effect of Short Chained Polyphosphates on Complement Activation in Plasma and Human Whole Blood	Ina Hiland	Received

583-PB	Extracellular Histones Can Inhibit Complement Activation through C4 Binding	YASIR QADDOORI	Received

585-PB	C5B9 Deposits on Endothelial Cells for the Evaluation of Complement Function in Thrombotic Microangiopathies of Different Origin and Therapy Monitorization	Marta Palomo	Received

587-PB	The Effect of Platelets and Extracellular Vesicles on Complement Activation in Human Plasma	Robin Amanda Liang	Received

589-PB	Hemocompatibility Analysis of Silk Nanoparticles Leads to Different Results under Static and Flow Conditions	Manfred Maitz	Received

591-PB	Role of Protease-activated Receptor-1 in Poly I:C Induction of Tissue Factor Expression in Endothelial Cells and in the Activation of Coagulation in Mice	Saravanan Subramaniam	Received

592-PB	Role of Helicobacter Pylori Eradication Therapy in Platelet Recovery in Chronic Immune Thrombocytopenic Purpura	Arshi Naz	Received

593-PB	Intravascular Parasitic Worms and Hemostasis	Patrick Skelly	Received

594-PB	Comparative Functional Studies of Thrombin and Staphylocoagulase in Terms of Clotting Kinetics and Properties of the Resultant Fibrin	Craig Thelwell	Received

595-PB	Liver Fibrosis and Thrombophilia: Is There a Real Connection? Preliminary Results among HIV/HCV Co-infection	Silvia Perés	Received

597-PB	Comparison of Fibrin Generation Markers in Septic Shock	Jean-Christophe GRIS	Received

598-PB	Thoracic Manifestations in Behcets Disease	Leila Belhadj	Received

600-PB	A Systems Biology Approach to Elucidate the Post-translational Regulome of Coronary Artery Disease	Ankit Sharma	Received

602-PB	Electronic Alerts, Comparative Practitioner Metrics, and Education Effect on Thromboprophylaxis and Thrombosis in Community Hospitals	Scott Woller	Received

603-PB	Efficiency of Bayesian Logic in Reagent Batch Change Management: Application to aPTT	Frederic Sobas	Received

604-PB	aPTT as an Independent Risk Factor for 30-day Survival for Patients on Extracorporeal Membrane Oxygenation (ECMO): 8-year Experience at Albert Einstein College of Medicine, Montefiore Medical Center	Ivo Francischetti	Received

605-PB	Sensitivity of Spatial Thrombin Generation and Fibrin Clot Growth to Clotting Factors Deficiency	Anna Balandina	Received

606-PB	In-cardiome: A Knowledgebase Integrating Molecular and Clinical Worlds for Translational Research and Drug Development in Coronary Artery Disease	Ankit Sharma	Received

607-PB	Addressing Reproducibility Concerns for Mechanistic Models of Clot Formation	MOHAN ANAND	Received

608-PB	Epigenetic Regulation of PAR-4-mediated Platelet Activation Underlies Smoking-related Cardiovascular Disease	Christopher Williams	Received

609-PB	Polymorphic Variation in Glutathione-S-transferase Genes among Chronic Myeloid Leukemia Patients in Pakistan	Aneeta Shahni	Received

611-PB	Nanoscale Measurement of Force Generation during Platelet-driven Clot Formation in Platelet Rich Plasma	Timea Feller	Received

612-PB	Analysis of Platelet Activation by Stable Isotope-resolved Metabolomics (SIRM)	Qingjun Wang	Received

613-PB	Metabolites Associated with Massive versus Submassive Pulmonary Embolism - A Pilot Study	Christopher Kabrhel	Received

614-PB	Efficacy of Dabigatran Etexilate in a Cancer Associated Thrombosis Murine Model	Catherine Lemarie	Received

615-PB	Incidence of Venous Thromboembolism in Cancer Survivors: The Scandinavian Thrombosis and Cancer (STAC) Cohort	Inger Lise Gade	Received

618-PB	Impact of Tumor Grade on the Risk of Venous Thromboembolism in Cancer; the Scandinavian Thrombosis and Cancer (STAC) Cohort	Inger Lise Gade	Received

619-PB	Thromboembolic Events in Cancer Patients on Active Treatment with Cisplatin-based Chemotherapy; Another Look	Hikmat Abdel-Razeq	Received

620-PB	Low Discriminating Power of the Modified Ottawa VTE Risk Score in a Cohort of Patients with Cancer from The RIETE Registry	Adriano Alatri	Received

622-PB	Outcomes of Extended Anticoagulant Treatment of Venous Thromboembolism in Patients with Cancer	Monika Stalc	Received

623-PB	Joint Effects of Body Height and Cancer on the Risk of Incident Venous Thromboembolism: The Troms Study	Hanne Skille	Received

624-PB	Patients with Cancer-associated Thrombosis Benefit from Anticoagulant Treatment Beyond 6 Months	Ineke Wilts	Received

625-PB	Impact of Time Since Diagnosis and Mortality Rate on Cancer-associated Venous Thromboembolism in a General Population - The Scandinavian Thrombosis and Cancer (STAC) Cohort	Sigrid Braekkan	Received

626-PB	Quality of Life Related to Health in Cancer Associated Thrombosis. Pilot of Qca Study	Luis Jara-Palomares	Received

627-PB	Differential Impact of Triggers on the Risk of Venous Thromboembolism in Subjects with and without Cancer - Results from a Population-based Case-crossover Study	Olga Vikhammer Gran	Received

628-PB	Venous Thromboembolism in Patients with Lymphoma	Sithakom Phusanti	Received

629-PB	Cancer Associated Thrombosis in Cancer Patients Receiving Chemotherapy or Hormonal Therapy in an Ambulatory Setting	Sue Rhodes	Received

630-PB	Long-term Impact on Mortality of Isolated Superficial Vein Thrombosis in Patients with Active Cancer	Jean-Philippe Galanaud	Received

631-PB	Prediction of Venous Thromboembolism in Newly Diagnosed Patients Treated for Lymphoid Malignancies - Validation of the Khorana Risk Score among Patients with Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma	Joanna Rupa-Matysek	Received

634-PB	Joint Effect between Smoking Status and Cancer on the Risk of Venous Thromboembolism: The Scandinavian Thrombosis and Cancer Cohort	Benedikte Paulsen	Received

635-PB	The Impact of Traditional Triggers on the Risk of Venous Thromboembolism in Cancer - Results from a Population-based Case-crossover Study	Olga Vikhammer Gran	Received

636-PB	Impact of a Novel Version 2.0 of an Electronic Alert System for Venous Thromboembolism (VTE) Prevention in Hospitalised Cancer Patients	Rocío Figueroa	Received

637-PB	Platelet-related Thrombin Generation in Adult Survivors of Childhood Cancer	Marina Panova-Noeva	Received

639-PB	Clinical History of Thrombosis before Diagnosis of Overt Myeloproliferative Neoplasms in Triple Negative Patients	mariasanta napolitano	Received

641-PB	Variability of Khorana Score and its Validity after First Chemotherapy in Patients with Gastric Cancer	Harry Fuentes	Received

642-PB	Venous Thromboembolism in Patients Undergoing Allogeneic Stem Cell Transplantation with Umbilical Cord Blood	Genevieve Moyer	Received

643-PB	The Impact of FGG rs2066865 and Pre-cancer Plasma Fibrinogen Concentration on Cancer-related Venous Thromboembolism	Benedikte Paulsen	Received

644-PB	Performance of Current Risk Assessment Models for Prediction of Venous Thromboembolism in Patients with Gastric Cancer	Harry Fuentes	Received

645-PB	Clinical Course of Venous Thromboembolism in Patients with Pancreatic Cancer: Insights from the RIETE Registry	Corinne Frere	Received

646-PB	Mean Platelet Volume (MPV) and MPV/Platelet (plt) Identify Essential Thrombocythemia (ET) Patients at High Thrombotic Risk	Cristina Verzeroli	Received

647-PB	Interleukin Profile in Polycythemia Vera and its Correlation with the Risk of Thrombosis	DEO PRATEEK	Received

648-PB	Joint Modeling of Longitudinal Haemostatic and Inflammatory Biomarker Trajectories and Mortality in Patients with Cancer	Florian Posch	Received

649-PB	ClotAssist Program to treat Cancer-associated Thrombosis in an Outpatient Pharmacy Setting	Easaw Jacob	Received

650-PB	Biomarkers for Venous Thromboembolism (VTE) in Newly Diagnosed Multiple Myeloma (NDMM): Early Results from the Thromboprophylaxis in Multiple Myeloma (TiMM) Trial at Kings College Hospital	Zara Sayar	Received

651-PB	The CATs out of the Bag: Alternatives to Low Molecular Weight Heparin (LMWH) in Patients with Cancer Associated Thrombosis (CAT)	Maeve Crowley	Received

654-PB	Predictors of Prolonged Hospitalization Deep Vein Thrombosis Patients	Andree Kurniawan	Received

655-PB	Incidence of Central Venous Catheter-related Venous Thrombosis in Japanese Inpatients with Hematological Malignancies: Single Center Experience	KOJI MIYAZAKI	Received

656-PB	Inaugural Thrombotic Events in Myeloproliferative Neoplasms	Héla Baccouche	Received

657-PB	Biological Pro-coagulant and Pro-inflammatory Effect of Interferon Alpha in Myeloproliferative Neoplasms	Nadine Ajzenberg	Received

659-PB	Audit: Use of Khorana Score in Oncology Patients in Belfast Trust	Carrie Carson	Received

661-PB	Venous Thrombosis and Thromboembolic Risk Factors in Outpatients with Lymphoma on Chemotherapy	María Eva Mingot-Castellano	Received

664-PB	Effects of Low- and High-dose Doxorubicin and Paclitaxel on Tumorigenic, Thrombogenic and Angiogenic Properties of Extracellular Vesicles Derived from Breast Cancer Cell Lines	Anat Aharon	Received

665-PB	Functional Tissue Factor Activity on Endothelial Cells Conveyed by Blood-cell Microparticles	Anna Brandtner	Received

668-PB	P2Y1 and P2Y12 Receptors Mediate the Release and Composition of Platelet Extracellular Vesicles	Aleksandra Gasecka	Received

669-PB	Characterization of Plasma Microvesicles in Patients with Diabetic Nephropathy	Melissa Uil	Received

672-PB	Increase in Microparticles TF/TFPI Procoagulant Ratio in Carriers of Inherited Bleeding Disorders	Elena Campello	Received

673-PB	Factor Xa Inhibitors Apixaban and Rivaroxaban Suppress the Release of TF-bearing Microvesicles from Cancer Cell Lines	Sophie Featherby	Received

674-PB	Endothelial Nitric Oxide Synthase Gene Polymorphisms Influence on Endothelial Microparticles Levels in Renal Transplantation	SUELLEN RODRIGUES MARTINS	Received

676-PB	The Impact of Eculizumab on the Thrombogenicity Induced by Extracellular Vesicles in Paroxysmal Nocturnal Hemoglobinuria Patients	Adeline Wannez	Received

678-PB	Procoagulant Extracellular Vesicles in Amniotic Fluid	Johannes Thaler	Received

680-PB	Enumeration of Circulating Microparticles in Healthy Medical Workers Occupationally Exposed to Low Doses of Ionizing Radiation	Ghassan Al Massarani	Received

681-PB	A High Throughput Flow Cytometry Assay for the Detection of Platelet Microparticles	Caroline Reddel	Received

682-PB	Visualization of Tissue Factor-positive Microvesicles from Pancreatic Cancer Patients Using Laser Scanning Confocal Microscopy	Yohei Hisada	Received

684-PB	Circulating Microparticles in Women with Polycystic Ovary Syndrome: Preliminary Results	Elena Campello	Received

686-PB	Endothelial and Platelet Microparticles in Kidney Transplanted Recipients: Influence of Time Post Transplantation and Donor Type	SUELLEN RODRIGUES MARTINS	Received

687-PB	The Relation between Circulating Endothelial Microparticles and Asymetric Dimethylarginine in Vitamin B12 Deficient	Yasemin Altuner Torun	Received

688-PB	Circulating Microparticles as Predictive Biomarkers for Tumor Progression in Advanced Non-small Cell Lung Cancer	Fadi Najjar	Received

689-PB	Microparticles with Platelet Pro-aggregation Potential Are Present in Patients with Acute Coronary Syndrome and No Perfusion (TIMI-0)	Aurora de la Peña Díaz	Received

690-PB	Obesity and ADAMTS13 Deficiency as Risk Factors for TTP	Elien Roose	Received

691-PB	Acute Thrombotic Thrombocytopenic Purpura (TTP) - Diagnostic and Prognostic Implications of Highly Sensitive Troponin Assays, ECG and ECHO	Indrani Karpha	Received

692-PB	Plasmin Cleavage of ADAMTS-13 Enhances its Activity	Coen Maas	Received

694-PB	Unraveling Immunoprofiles of Acquired TTP Patients Using Anti-idiotypic Antibodies	An-Sofie Schelpe	Received

695-PB	The in vitro and in vivo Effects of Streptokinase in a Papio ursinus Baboon Model of Acquired Thrombotic Thrombocytopenic Purpura (TTP) - A Pilot Study	Jaco Joubert	Received

696-PB	mRNA Identification of a Novel Isoform (ISF) and ISF3 from ADAMTS13 in Different Types of Cells	Juvenal Paiva	Received

699-PB	The Incidence of Thrombotic Thrombocytopenic Purpura in Israel, as Determined by ADAMTS-13 Activity and Anti-ADAMTS-13 Antibody Levels	Galit Sarig	Received

700-PB	A Rapid and Simple Assay for the Determination of ADAMTS-13 Activity	Nikolaus Binder	Received

702-PB	Epidemiology of Thrombotic Microangiopathy in Malaysia	Yee Yee Yap	Received

703-PB	Highly Sensitive Fully Automated Chemiluminescent Immunoassay for Rapid Quantification of ADAMTS13 Activity	Maribel Mirabet	Received

704-PB	Clinical Characteristics and Outcome of Patients with Thrombotic Thrombocytopenic Purpura at Siriraj Hospital	Yingyong Chinthammitr	Received

707-PB	Complements are Activated to a Similar Level in both Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome	Doyeun Oh	Received

708-PB	Preliminary Report on the Genetic Background and Clinical Course of Upshaw-Schulman Syndrome in Polish Patients	Jerzy Windyga	Received

709-PB	A Murine Anti-ADAMTS13 Monoclonal Antibody against the Disintegrin-like Domain Inhibit the Enzyme Activity	Zhenni Ma	Received

710-PB	Relationship between ADAMTS13 antigen and free IgG anti-ADAMTS13 antibody, functional ADAMTS13 inhibitor and circulating immune complexes (CIC) using two ELISA techniques, in patients with acquired thrombotic thrombocytopenic purpura.	Juvenal Paiva	Received

711-PB	Predisposed Hemophagocytosis in a Patient with Thrombotic Thrombocytopenic Purpura	Takeshi Shimomura	Received

712-PB	Technozym ADAMTS-13 Activity Assay for Determination of Inhibitory Antibodies against ADAMTS-13	Nikolaus Binder	Received

713-PB	Evolution of ADAMTS13 Activity in Patients with Relapsing Acquired Thrombotic Thrombocytopenic Purpura	FAUSTINO GARCÍA-CANDEL	Received

714-PB	Evaluation of Sample Interferences on ADAMTS-13 Activity Measurement	Nikolaus Binder	Received

715-PB	Early Detection of Refractoriness and Silent Relapse in Acquired Thrombotic Thrombocytopenic Purpura	Pablo Manresa Manresa	Received

716-PB	Upshaw-Schulman Syndrome: The Importance of the Modulating Effect of the Different Genetic Variations	Pablo Manresa Manresa	Received

719-PB	Thrombotic Thrombocytopenic Purpura as an Initial Presentation of Systemic Lupus Erythematosus in a Thai Child: A Case Report	Rungrote Natesirinilkul	Received

720-PB	A Case of SLE developed different types of thrombotic microangiopathy during the course	EMIKO TATSUMI	Received

721-PB	Congenital Thrombotic Thrombocytopenic Purpura without Nephropathy and Neuropathy	Canan Albayrak	Received

722-PB	Thrombotic Microangiopathies (TMA): First Report of 250 Cases from a Single Institution Experience in Latin America	Célia Dos Santos	Received

723-PB	Successful International Standardisation of the ADAMTS13 Assays - Results from the APMAT (Asia Pacific Microangiopathic Thrombocytopenia) Network	Jim Tiao	Received

724-PB	Treatment of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in Pediatric Patients - A Single Center Experience	Olivera Serbic	Received

725-PB	Successful Treatment of Renal Infiltration Complicated by Atypical Hemolytic Uremic Syndrome in a Child with Acute Leukemia	ZHRE KAYA	Received

726-PB	Transplant/Imunosupressor Related Thrombotic Microangiopathy	Filipa Mousinho	Received

727-PB	A Heterozygous Mutation of G-protein-Coupled Receptor 25 in a Family with inherited Thrombocytopenia and Thrombosis	Jun Yamanouchi	Received

729-PB	Novel RUNX1 Mutations in Families with Inherited Thrombocytopenia	Patrizia Noris	Received

730-PB	A Novel Mutation in TBXA2R Impairs the Expression of the TP Isoform of the Platelet Thromboxane Receptor and Associates with Bleeding Diathesis	Loredana Bury	Received

732-PB	ACTN1 Macrothrombocytopenia: Deleterious Effects of Rod-domain ACTN1 Variants	Anne Vincenot	Received

734-PB	Identification of Two New P2RY12 Heterozygous Mutations Responsible for Hemorrhagic Diathesis in Two Unrelated Families	Arnaud Dupuis	Received

735-PB	Glanzmanns Thrombasthenia in China: New Insights into its Pathogenesis	lu zhou	Received

736-PB	A New Form of Inherited Thrombocytopenia (IT) Due to Monoallelic Loss-of-function Mutation in the Thrombopoietin (THPO) Gene	Patrizia Noris	Received

737-PB	MYH9 Variants Defined by Next-generation Sequencing: Predicting Variants Likely Causing MYH9-related Disorder	Loredana Bury	Received

739-PB	Pseudo-Glanzmann Thrombasthenia due to Mutation in RasGRP2 Gene Encoding for CalDAG-GEFI	Nurit Rosenberg	Received

741-PB	Detection and Analysis of Gene Mutations in Patients with Glanzmann Thrombasthenia by Next Generation Sequencing	Donglei Zhang	Received

743-PB	Refined Detection and Characterization of Delta Storage Pool Disorders: A Cohort Study on Pediatric Patients	Georgi Manukjan	Received

744-PB	Multiplex PCR and Cycle Sequencing for Detection of Mutations in ACTN1, TUBB1 and ANKRD 26	Letian Dai	Received

745-PB	Delta Storage Pool Deficiency in a Patient with a R216Q Mutation of GATA1	Maaike Blaauwgeers	Received

746-PB	Genetic Heterogeneity in Familiar Macrothrombocytopenia with Decreased Expression of GpIIbIIIa	catarina lau	Received

747-PB	Pseudodominance in a Family with Bernard-Soulier Syndrome due to a Homozygous Variant in the Platelet Glycoprotein IX (GP9) Gene	Catarina Lau	Received

748-PB	Highly Significant Bleeding Diathesis in Patients with Platelet Dysfunction due to a Novel Mutation in RASGRP2, Encoding CalDAG-GEFI (p.Gly305Asp)	Emilse Bermejo	Received

749-PB	Positive Impact of Social Media as a Support Group for Females with Glanzmann Thrombasthenia in Saudi Arabia - A Mothers Initiative	Mahasen Alsaleh	Received

750-PB	Five New Cases of Hermansky-Pudlak Syndrome: Identification of Novel Genetic Variants in HPS4 and HPS3 Associated to Relevant Clinical Complications	Jose M Bastida	Received

751-PB	Quality of Life Is Reduced in Patients with (Suspected) Congenital Platelet Function Disorders	Maaike Blaauwgeers	Received

752-PB	Screening for platelet function disorders with Multiplate and Platelet Function Analyzer	Floor Moenen	Received

753-PB	Evaluation of the Platelet Function in Different Inherited Thrombocytopenias. Correlation of Platelet Response Measured by Flow Cytometry with Bleeding Scores and Clinical Phenotypes	Maria Adele Alberelli	Received

754-PB	Management of a Patient with Glanzmann Thrombasthenia during a Coronary Artery Bypass Graft Surgery: A Case Study	Mohamad Kurdi	Received

756-PB	Quantitative Evaluation of Bleeding due to Platelet Disorders Associated with Dense Granule Deficiency and/or Impaired Aggregation Responses	Janaki Iyer	Received

757-PB	MYH9 Disorders Are the Most Common Cause of Macrothrombocytopenia in Australia: Importance of Mean Platelet Diameter Measurement and Dhle Body Detection for Improved Diagnosis	Marie-Christine Morel-Kopp	Received

758-PB	Hemorrhagic Diathesis in Four Patients with the Heterozygous Pro258Thr Mutation of the P2RY12 Gene	Maaike Blaauwgeers	Received

759-PB	Nine-year Effective Management of an LAD III Patient with Conventional Pro-hemostatic and Immunological Treatment	Paul Saultier	Received

762-PB	A Study of Comparison of Platelet Aggregation Response Obtained on Sysmex CS-2000i with Chrono-log Light Transmission Aggregometer	Ancy Abraham	Received

763-PB	Minor Dental Surgery in Patients with Glanzmann Thrombasthenia Patients	Anna Sikorska	Received

764-PB	Flow Cytometric Mepacrine Uptake Related to Platelet Size in Patients with Moderate Macrothrombocytopenia	Sory Jazmin Rodriguez Moreno	Received

765-PB	Circumcision in Children with Inherited Bleeding Disorders - A Tertiary Care Centre Experience in Saudi Arabia	Mahasen Alsaleh	Received

769-PB	Successful Management of Severe Bleeding with Combined Platelet Transfusion, rFVIIa and Tranexamic Acid Therapy in Glanzmann Thrombasthenia Patient	Bernadeta Ceglarek	Received

770-PB	Immature Platelets Fraction and its Application in the Differential Diagnosis of Congenital and Acquired Trombocytopenia	João Neves	Received

771-PB	A Case of Acquired, Transient Bleeding Diathesis Associated with Platelet Dysfunction	gian marco podda	Received

772-PB	Regular Physical Activity and Risk of Incident Venous Thromboembolism in the General Population	Line Holtet Evensen	Received

773-PB	Impact of Regular Physical Activity on the Risk of Recurrent Venous Thromboembolism and All-cause Mortality	Line Holtet Evensen	Received

775-PB	Associations between Serum Levels of Calcium, Parathyroid Hormone and Future Risk of Venous Thromboembolism - The Troms Study	Sigrid Braekkan	Received

776-PB	Repeated Measures of Fish Consumption, n-3 PUFA Intake and Future Risk of Incident VTE	Trond Isaksen	Received

777-PB	Residual Vein Thrombosis in Subjects with Proximal DVT: An Association with Subclinical Atherosclerosis. The VERITAS Study	Marta Milan	Received

778-PB	Elevated Circulating CD40-L in Atrial Fibrillation and its Modulation by Ablation	Amanda Walborn	Received

779-PB	Elevated Cellular Fibronectin is a Modifier of Clot Properties in Type 2 Diabetes: Association with Cardiovascular Disease	Agata Bryk	Received

781-PB	The CHA2DS2-VASc Score Predicts Bleeding Risk in a Cohort with Implantable Cardiac Monitoring Devices without Atrial Fibrillation	Fadi Shamoun	Received

784-PB	Effects of HAART on Fibrinogen, D-dimer and Protein C Levels in Patients with HIV at the University of Benin Teaching Hospital Benin City, Nigeria	Omolade Awodu	Received

787-PB	The Novel 2MACE Score Predicts Cardiovascular Events in Atrial Fibrillation Patients	José Miguel Rivera-Caravaca	Received

788-PB	Altered Platelet Lipidome Influences Thrombotic Disposition: Implications in Acute Coronary Syndrome and Modulation by the CXCL12-CXCR4-CXCR7 Axis	Madhumita Chatterjee	Received

791-PB	Up-Regulation of HO-1 by CORM-2 Attenuates Thrombin-Induced COX-2 Expression and Hypertrophy in Human Cardiomyocytes	Chuen-Mao Yang	Received

792-PB	Antithrombin levels are associated with the risk of first and recurrent arterial thromboembolism at a young age.	Frederik Nanne Croles	Received

795-PB	The Value of sPESI for Risk Stratification in Patients with Pulmonary Embolism	Elizabeth Benson-Cox	Received

796-PB	D-Dimer but Not Platelet Function Testing Improves Risk Stratification in Patients Treated with Elective PCI	Elena Novikova	Received

797-PB	Increased Extracellular Nucleosome Levels, Biomarkers of Cell Death, in Atrial Fibrillation Patients Compared to the Normal Population	Debra Hoppensteadt	Received

799-PB	The Incidence and Prognosis of Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE) Associated with Oral Contraceptives by Age Groups in Japan	Takao Kobayashi	Received

804-PB	Extracellular Nucleosomes, Markers of Cell Death, are Elevated in End-Stage Renal Disease Independent of Circulating Microparticle-associated Tissue Factor	Debra Hoppensteadt	Received

805-PB	Stroke Prevalence in Patients with Different Patterns of Atrial Fibrillation: Cross-sectional Study of Moscow Registry	Alexander Melekhov	Received

806-PB	Validation of a Patient-completed Caprini Risk Assessment Tool in a Spanish-speaking Population	Luis Paz	Received

808-PB	Patients with Multiple Cardiovascular Risk Factors Show a Characteristic Decrease in Circulating MAIT Cells	Satoshi Fujii	Received

809-PB	Protein Z Deficiency: A Reliable Risk Factor for Acute Coronary Syndrome	Deena Samir Eissa	Received

810-PB	Cardiac and Inflammatory Biomarkers and their Role in the Pathogenesis of Heart Failure in End-Stage Renal Disease	Jawed Fareed	Received

812-PB	Increased von Willebrand Factor Platelet Interactions in Patients with Chronic Pain	Maren Hoffmann	Received

813-PB	The effects of misclassification in routine care data on the accuracy of prognostic prediction models	Sander van Doorn	Received

814-PB	Markers of Plasma and Platelet Hemostasis Function as the Risk Factors for Leg Amputation in Patients with Critical Limbs Ischemia	Danuta Rosc	Received

815-PB	Validation of a Patient-completed Caprini Risk Assessment Tool	Harry Fuentes	Received

816-PB	Patients with Diabetes Mellitus 2 on Treatment, with or without Previous Cardiovascular Events, Have Delayed Clot Lysis, but Not Hyperactive Platelets Nor Increased Thrombin Generation	Diego Mezzano	Received

817-PB	Haemorrheologic and Fibrinolytic Activities in Diabetic Patient with Hypertension in Calabar, Nigeria	Margaret Solomon Edem	Received

821-PB	Administration of Dexamethasone during Initial Exposure to Factor VIII Reduces Inhibitor Development in Hemophilia A Mice Via Thymic Tolerance Induction Mechanisms	Maria Georgescu	Received

822-PB	Dual Mode of Interaction of Fibrinogen with the Staphylocoagulase-Prothrombin Complex	Ingrid Verhamme	Received

823-PB	Sensitive, Functional Assay for Detecting Polyphosphate in Plasma	Catherine Baker	Received

824-PB	Combined IV and SC administration of Long-acting FVIIa (MOD-5014) Significantly Improves the Pharmacokinetics (PK), Pharmacodynamics (PD) and Pharmacological Long-term Outcome in Preclinical and Toxicological Models	Malka Hoffmann	Received

828-PB	Selective Inhibition of Protein S Anti-coagulant Functions Restores in vitro Thrombin Generation in Haemophilia A and B Plasma	Jacob Lund	Received

830-PB	Differential Coagulotoxic Effects of Asian Pitviper Snake Venoms: Evolutionary, Pathophysiology and Biodiscovery Implications	Jordan Debono	Received

831-PB	The Effect of Histone H4 on Coagulation Enzymes and Complexes in Purified Systems	Shannon Prior	Received

832-PB	CP-5-001: A Phase 1/2a, Open-Label, Multicenter, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics Profile of a Long-acting Recombinant Factor VIIa (MOD-5014) in Adult Men with Hemophilia A or B	Malka Hoffmann	Received

833-PB	Age-related Variation in the Glycosylation of Alpha-2-Macroglobluin	Laura Calvert	Received

834-PB	First Evaluation of the Safety, Pharmacokinetics and Pharmacodynamics of BAY 1213790, a Full Human IgG1 Antibody Targeting Coagulation Factor XIa, in Healthy Young Men	Dirk Thomas	Received

835-PB	Case Study of Successful Transition to Fc Fusion Factor IX Replacement without Premedication in an Adolescent Male with Severe Hemophilia B, Anaphylactoid Reaction to FIX Replacement, and Previous History of Inhibitor and Nephrotic Syndrom	Amber Federizo	Received

836-PB	Estimates of Within-Subject Biological Variation of Prothrombin time-INR (PT-INR), Activated Partial Thromboplastin Time (APTT), Fibrinogen, Factor VIII clot (FVIII:C) and von Willebrand factor antigen (vWF:Ag) in Pregnant Women.	Ann Helen Kristoffersen	Received

837-PB	A Snake-venom Enzyme (Noscarin)-based Assay for APC-resistance Is Not Influenced by Non-vitamin K Antagonist Oral Anticoagulants (NOAC)	Anne Brisset	Received

838-PB	APC and TFPI Cofactor Activities of Thrombin-cleaved Protein S and C4BP-protein S Complex	Tilman Hackeng	Received

839-PB	Anticoagulants Differentially Affect Procoagulant Platelet Formation	Vivien CHEN	Received

840-PB	A Novel Hypoxia Response Element Regulates Oxygen-related Repression of Tissue Factor Pathway Inhibitor Expression	Xue Yan Cui	Received

841-PB	Impact of Thrombomodulin on Spatial Clot Growth and Fibrin Polymerization in Cirrhotic Patients	Aurélien Lebreton	Received

842-PB	Biomechanisms of a Severe Hypersensitivity Reaction Induced by Factor IX in Hemophilia B Complicated by Factor IX Inhibitor	Maria Elisa Mancuso	Received

843-PB	The Thrombomodulin Resistance in Prothrombin Belgrade Mutation Carriers	Valentina Djordjevic	Received

846-PB	ADP and ATP Inhibit Factor X Activation by Factor VIIa/Tissue Factor	Yan Wang	Received

847-PB	Intracranial Hemorrhage in Neonates and Infants with Congenital Bleeding Disorders: The Experience of ukurova University Hemophilia Center	Bulent Antmen	Received

848-PB	A Novel Mutation in the F7 Gene in a Tunisian Patient with Factor VII Deficiency	Gouider emna	Received

849-PB	A Rat-human Cross-species Compatibility Study: Catalytic Efficiency for Activation of Rat FX Is Decreased for Human FVIIa Compared to Rat FVIIa	Inga Tuneew	Received

852-PB	Correlation Analysis of Standard Bethesda Method versus Modified Nijmegen Assay in Detecting Factor VIII Inhibitors, and Impact of Marginal Titer Inhibitors on FVIII Pharmacodynamics and Pharmacokinetics in Patients with Hemophilia A	Angelika Batorova	Received

856-PB	Interim Safety of a Long-acting Recombinant Factor VIIa (MOD-5014): A Phase 1 Study in Adult Subjects Following Subcutaneous Administration	Malka Hoffmann	Received

858-PB	Hemarthrosis in Rare Factor Deficiencies	Zafer Salcioglu	Received

859-PB	Amyloidosis Induced Abnormal Coagulopathy Associated with Multiple Coagulation Factor Deficiencies	Nilgun Sayinalp	Received

863-PB	Signal through the Regulatory Subunits of PI3Kinase Endows Coagulation Protease Activated Protein C with Hormone Like Function	Madhusudhan Thati	Received

864-PB	Rivaroxaban Ameliorates Neuroinflammation	Monika Merker	Received

865-PB	Novel Role of Protein S in Clot Retraction: Induction of Apoptosis in Activated Platelets	Vijaya Pilli	Received

868-PB	Biochemical and Pharmacological Differentiation of APC and Recombinant Thrombomodulin with Reference to the Effect on the Hemostatic and Fibrinolytic Processes	Jawed Fareed	Received

869-PB	Plasminogen-deficient Patients	Hande KIZILOCAK	Received

870-PB	Direct Factor Xa Inhibitor Apixaban Prevents Endothelial Activation and Damage Associated with Chronic Kidney Disease	Sergi Torramade-Moix	Received

871-PB	A Factor X Activator from Caterpillar Triggers Cell Survival on Fibroblasts in Response to Serum Deprivation by Inhibition of Apoptosis	Miryam Paola Alvarez Flores	Received

873-PB	A Significant Change in Laboratory Markers of Thrombosis Very Early in the First Trimester of Pregnancy May be Linked to a Concurrent Increase in Estradiol	Catherine N Bagot	Received

874-PB	Analysis of potential microRNAs involved in regulation of TFPI-2 in breast cancer cells	Marianne S. Andresen	Received

875-PB	Comparative Studies on the Inhibition of Thrombin by Recombinant Thrombomodulin in Activated Protein C and Whole Blood Plasma	Jawed Fareed	Received

876-PB	Activation of the Hepatocyte Growth Factor/c-met Pathway during Experimental Envenomation of Rats with Bothrops Jararaca or Crotalus Durissus Terrificus Snake Venoms	Benedito Prezoto	Received

878-PB	Silencing of Anticoagulant Protein C Evokes Spontaneous Atherothrombosis in Apoe-/- Mice	Marco Heestermans	Received

882-PB	Positive Correlation of Plasma Protein S Levels to Apolipoprotein C-II in Middle-aged Obese Women and Non-obese Young Women	Hiroko Tsuda	Received

884-PB	Differential Modulation of Plasminogen Activator Mediated Thrombolysis by Recombinant Thrombomodulin and Activated Protein C	Jawed Fareed	Received

885-PB	G-quadruplex-Directed Aptamer Selection against Activated Protein C (APC)	Nasim Shahidi hamedani	Received

886-PB	The Protective Effect of Activated Protein C as the Baised Agonism in Activation of Protease-activated Receptor 1	Liubov Gorbacheva	Received

887-PB	Function and Prevalence of Host-derived Coagulation Factors on the Virus Surface	Bryan Huanjih Lin	Received

888-PB	Decryption of Hepatocyte Tissue Factor Procoagulant Activity by Bile Acids Requires Non-apoptotic Phosphatidylserine Externalization	Kevin Baker	Received

890-PB	A First-in-Human Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PF-06741086, an anti-TFPI Monoclonal Antibody, Following Administration of Single Subcutaneous or Intravenous Doses in Healthy Adult Male Volunteers	Matthew Cardinal	Received

893-PB	mTOR Inhibitors Reduce Expression of Tissue Factor Isoforms in Neuroendocrine Tumors of the Pancreas	Clayton Lewis	Received

895-PB	Renin-angiotensin System Blockade Downregulates Tissue Factor Expression Induced by ?-Glutamyltransferase in Human Peripheral Blood Mononuclear Cells Exposed to High Glucose	Valentina Scalise	Received

896-PB	Over-activation of Src1 Mediates Tissue Factor-induced Apoptosis in Endothelial Cells	Ali Ethaeb	Received

897-PB	Indoleamine 2,3-dioxygenase 1 Enhances Tissue Factor Expression in Coronary Atherosclerotic Plaque	Atsushi Yamashita	Received

901-PB	Rutin (quercetin-3-rutinoside) Modulates Hemostatic Disturbances and Reactive Species Levels in Experimental Bothrops jararaca Envenomation	Marcelo L. Santoro	Received

902-PB	Measurement of Tissue Factor Molecules and Factor Xa Generation on Vascular Cells	Marcela Rosas	Received

903-PB	Tissue Factor Pathway Inhibitor Polymorphism 399CT Predisposes to Idiopathic DVT in Young Indians	Renu Saxena	Received

907-PB	Transcriptional Regulation of the Tissue Factor Gene is Mediated by the Androgen Receptor	Bastian Hoesel	Received

908-PB	Factor V Expression in Aggressive Breast Cancer Modifies Patient Survival, Tumor Cell Growth and Response to Treatment	Mari Tinholt	Received

910-PB	Platelet-dependent von Willebrand Factor Activity in Acute Myeloid Leukemia Patients: Role in Haemostatic Alterations	Botheina Farweez	Received

912-PB	Altered Fibrin Clot Properties in Advanced Lung Cancer: Impact of Chemotherapy	Michal Zabczyk	Received

913-PB	The Effect of Neoadjuvant Chemotherapy on the Activated Protein C (aPC) Pathway in High Grade Serous Ovarian Cancer Patients	Mark Ward	Received

914-PB	Inhibition of Tumour Cell-induced Platelet Aggregation by a Novel Stat3 Inhibitor in Podoplanin Positive Cancer Cells	Kowit-Yu Chong	Received

916-PB	A Linkage between ERBB2 Expression and the Pro-coagulant Properties of Breast Cancer Cells is Mediated by the PI3k/Akt Signaling Pathways	Yunliang Chen	Received

917-PB	Exosomes from Heparin-treated Cancer Cells Exhibit Transferable Anti-tumorigenic Activity	Yunliang Chen	Received

918-PB	Sonic Estimation of Elasticity via Resonance (SEER) Sonorheometry to Identify Hypercoagulability in Patients with Cancer	Erin McLoughlin	Received

922-PB	The Role of asTF in Glioblastoma Multiforme	Maaike Kapteijn	Received

923-PB	Tumoral Factor VII Expression Changes TGF--mediated Intercellular Communication in Breast Cancer	Madelon Paauwe	Received

925-PB	Preoperative Panel Scores of CA 19-9, FVIII and D-dimer Predict Postoperative Survival in Pancreatic Ductal Adenocarcinoma	Nora Mattila	Received

926-PB	Expression of Coagulation Proteases from the Activated Protein C Pathway in Ovarian Cancers	Catherine Spourquet	Received

927-PB	Mucin1 Acts as a Potential Mediator of the Pro-coagulant Properties of Breast Cancer Cells by Altering the Activity of Key Phosphokinase Pathways	Yunlaing Chen	Received

930-PB	Dissolution of Platelet-rich Thrombus by Perfusion of N-acetyl Cysteine	Susan Hastings	Received

931-PB	Thrombolysis by rt-PA Combinated with Anticoagulant and Antiaggregant Molecules under Flow Conditions	Stéphane LOYAU	Received

932-PB	Systematic Review and Meta-analysis of Treatments for Massive and Submassive Pulmonary Embolism	Lana A. Castellucci	Received

933-PB	Structure and Function of Trypsin-loaded Fibrinolytic Liposomes	Anna Tanka-Salamon	Received

934-PB	Changes in Treatments and Outcomes after Creation of a Pulmonary Embolism Response Team (PERT)	Rachel Rosovsky	Received

935-PB	Comparing Emergency Department Patients to Inpatients Receiving a Pulmonary Embolism Response Team (PERT) Activation	Christopher Kabrhel	Received

936-PB	Indications and Results of Treatment with Ultrasound Assisted Cathether Thrombolysis in Patients with Pulmonary Embolism	Boris Dzudovic	Received

938-PB	A Case Series of Low Dose Alteplase for Submassive Pulmonary Embolism (PE)	Jay Lozier	Received

941-PB	Sub-massive PE - A Role for Low Dose Thrombolysis?	Maeve Crowley	Received

943-PB	Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A SIPPET Analysis	Roberta Palla	Received

945-PB	Bone Properties in Children with Hemophilia A: Influence of Target Joint and FVIII Inhibitor	Panagiota Xafaki	Received

947-PB	Obesity and Dosing of Replacement Therapy in Hemophilia; How to Optimize?	Marjon Cnossen	Received

948-PB	Safety of Nonacog Beta Pegol (N9-GP): Results from the paradigm? Clinical Trials	Peter Collins	Received

949-PB	Perioperative Replacement Therapy in Hemophilia B: Should We B More Precise?	Marjon Cnossen	Received

950-PB	Identification of Patient and Disease-related Characteristics Influencing the Risk of Bone Fracture in Individuals with Haemophilia	Predrag Miljic	Received

951-PB	Post-partum Bleeding in Women who Are Carriers of and Who Have Bleeding Disorders: A Case-Control Study	Sonia Wolf	Received

954-PB	Factor VIII (FVIII) Inhibitor Testing Using a Validated Chromogenic Bethesda Assay (CBA) in HAVEN 1 (BH29884), a Phase 3 Trial of Emicizumab in Persons with Hemophilia A (PwHA) with Inhibitors	Daniella Babu	Received

955-PB	Recombinant FVIII Product Type and the Risk of Inhibitor Development in Previously Treated Patients with Hemophilia A: Preliminary Results of a Systematic Review and Meta-analysis	antonino cannavo	Received

956-PB	Preliminary Observations from a Prospective, Dose Escalating, Prophylaxis Study in Young Boys with Severe Hemophilia A in China: The China Hemophilia Individualized Prophylaxis Study (CHIPS)	Wu Junde	Received

959-PB	Effects of Acute Moderate Physical Activity on Haemostatic Parameters in Severe Haemophilia A Subjects Using a Third Generation B-Domain Deleted Recombinant Factor VIII	CLEMENCE MERLEN	Received

962-PB	Pressure Pain Thresholds Hint at Structural Findings in Knees of Patients with Haemophilia	Steffen Krger	Received

963-PB	Once-weekly Prophylaxis with GlycoPEGylated Recombinant Factor VIII (N8-GP) in Severe Haemophilia A: Safety and Efficacy Results from a Randomised Phase 3 Trial (pathfinder?2)	Steven Lentz	Received

964-PB	End-of-trial Results from a Large Multinational Extension Trial (guardian?2) Using Turoctocog Alfa for Prophylaxis and Treatment of Bleeding in Patients with Severe Haemophilia A	Steven Lentz	Received

967-PB	Characterisation of the Inhibitor Status of Patients with Haemophilia A in Australia	Simon McRAE	Received

968-PB	Long-term Quality-of-Life Outcomes with rFIXFc in Adults with Hemophilia B: Results from B-LONG and B-YOND	Jun Su	Received

969-PB	Lower Risk of Factor VIII Inhibitors among Severe Hemophilia A Patients with Indigenous Background from Brazil	Margareth Ozelo	Received

970-PB	Surgery with Turoctocog Alfa: Efficacy and Safety in Bleeding Prevention During Surgery in Patients with Severe Haemophilia a - Results from the Guardian? Trials	Elena Santagostino	Received

974-PB	Association of Factor VIII and Factor IX Mutations, HLA Class II, Tumor Necrosis Factor-Alpha and Interleukin-10 on Inhibitor Development among Thai Hemophilia A and B	Ampaiwan Chuansumrit	Received

975-PB	Participation of Clinical Psychologist in a Non-hemophilia Treatment Center	Aya Nakao	Received

979-PB	Factor Utilization and Costs in Patients with Hemophilia B Using Standard and Extended Half-Life Recombinant Factor IX Replacement Products: Real-World Analysis in Japan	Ashley Daset	Received

980-PB	Long Term Hemostatic Efficacy of Once a Week Administration with a Combination Medicine of Plasma Derived Factor Viia and Factor X for a Hemophilia B Patient with Inhibitor	Takashi Suzuki	Received

984-PB	Improving the Survival for Life-threatening Hemorrhage with Hemophilia Patient in One Hemophilia Treatment Center for 34 Years	Kun Lee	Received

988-PB	Sports/Recreational Activity-specific Risks and Drivers of Risk in People with Hemophilia: Results of the Activity-intensity-Risk (AIR) Consensus Meeting of US Physical Therapists	David Cooper	Received

989-PB	Preferences of Hemophilic Patients and their Parents on the Characteristics of Replacement Treatment Used in Prophylaxis	Maria Elisa Mancuso	Received

992-PB	The Impact of a Comprehensive Hemophilia Management Programme in Vulnerable Population	Cesar Montaño	Received

996-PB	Prevalence of Adult-onset Medical Comorbidities and Active Intervention via Web-based Monitoring in Korean Hemophliacs	Hugh Kim	Received

998-PB	Pharmacokinetics and Annual Bleeding Rate (ABR) during Prophylaxis with a Full-length Recombinant FVIII: One Center Experience	Andrea Cocca	Received

999-PB	A Unique Case Involving Delivery of Bolus rFVIIa via an Innovative Syringe Pump to a Patient with Haemophilia and Inhibitors Undergoing a Kidney Transplant	Jenna Stanley	Received

1000-PB	The Prevalence of Concomitant Deep Vein Thrombosis, Symptomatic or Asymptomatic, in the Patients with Symptomatic Pulmonary Embolism	Jana Hirmerova	Received

1001-PB	Predicting Post-thrombotic Syndrome with Ultrasonographic Measurements after Proximal Deep Vein Thrombosis	Charlotte Dronkers	Received

1002-PB	Can Ultrasonographic and Laboratory Measurements One Year after Proximal Deep Vein Thrombosis Predict Post-thrombotic Syndrome?	Gerben C. Mol	Received

1003-PB	Patient-reported Reasons for and Predictors of Non-compliance with Elastic Compression Stockings in the SOX Trial	Susan Kahn	Received

1004-PB	External Validation of the Patient Reported Form of the Villalta Scale	Kristin Kornelia Utne	Received

1005-PB	High Accuracy and Reproducibility of CT Right-to-left Ventricular Diameter Measurement by Non-radiologists in Patients with Acute Pulmonary Embolism	Yvonne Ende-Verhaar	Received

1006-PB	Nationwide Study on the Management and Outcomes of Patients with Superficial Vein Thrombosis under Real-life Conditions (INSIGHTS-SVT)	Rupert Bauersachs	Received

1007-PB	Post-Thrombotic Syndrome in Patients Treated with Rivaroxaban or Warfarin for Venous Thromboembolism	Kathleen Leonard-Bedwell	Received

1009-PB	Possible Predictors of Long-term Dyspnea in Patients with Pulmonary Embolism - A Cross Sectional Study	Mazdak Tavoly	Received

1010-PB	Reliability Testing of the CAPTSureTM Pediatric Post-thrombotic Syndrome Tool	Maria Laura Avila	Received

1011-PB	Measuring Limb Edema in Children at Risk of Post Thrombotic Syndrome: Do I See what You Feel?	Maria Laura Avila	Received

1012-PB	Laboratory and Clinical Parameters at Diagnosis of Venous Thromboembolism (VTE) Are Not Associated to the Presence of Residual Vein Thrombosis (RVT)	Sandra Martins Silva Soares	Received

1013-PB	An Innovative Approach to an Age-old Problem: Piloting a Smart Compression Garment Device	Maria Laura Avila	Received

1014-PB	Post-Pulmonary Embolism Syndrome Development among Patients who Needed Pulmonary Embolism Response Team Assessment	Alya Ahsan	Received

1015-PB	Patients Treated with Rivaroxaban Presented Low Prevalence of Post-thrombotic Syndrome	Joyce M. Annichino-Bizzachi	Received

1016-PB	Non-invasive Detection of Fresh Deep Vein Thrombosis with Diffusion Weighted Magnetic Resonance Imaging	Yasuyoshi Kuroiwa	Received

1017-PB	Patients Experience of Post-thrombotic Syndrome: A Qualitative Study with Focus Groups Aiming at a More Accurate Diagnosis	Marit Engeseth	Received

1018-PB	Optimizing Treatment for Post-thrombotic Syndrome (PTS): A Systematic Review	Samuel Abegunde	Received

1020-PB	Comparison of Trans-popliteal Reflux in the Limb with Deep Vein Thrombosis and the Limb without Thrombosis	Lucia Sarolo	Received

1022-PB	Inferior Vena Cava Filters: Experience of 133 Patients in a Tertiary Referral Center	Antoni Riera-Mestre	Received

1025-PB	Comparison of Pulmonary Embolism Severity Index Score and Hestia Criteria to Identify Pulmonary Embolism Patients for Outpatient Treatment	Syed Ahsan	Received

1026-PB	Clinical Courses of Portal Vein Thrombosis (PVT) in Children	Patcharee Komvilaisak	Received

1027-PB	The Incidence of Catheter-related-Thrombosis during Induction Chemotherapy and Follow-up in Chinese Acute Lymphocytic Leukemia Children	Yunyun Yunyun	Received

1030-PB	Pulmonary Thromboembolism in Children: Tuberculosis May Be the Underlying Problem	Mualla etin	Received

1031-PB	Inherited Prothrombotic Risk Factors in Turkish Children with Hereditary Anjioedema. Single Center Experience	ALPER OZCAN	Received

1033-PB	Preoperative Assessment of Bleeding Risk - Implementing Strategies in the Pursuit of Effective Patient Blood Management	Joanne Joseph	Received

1034-PB	Indications for the Use of Fresh Frozen Plasma in Neonatal Intensive Care Unit in a Tertiary Care Hospital	Romana Akbar	Received

1035-PB	Intermittent Intravenous Deferoxamine for the Treatment of Transfusional Iron Overload	Mala Varma	Received

1036-PB	Reasons for Blood Donor Deferral among Voluntary Blood Donors in a Tertiary Care Hospital in Kathmandu, Nepal	Bipin Nepal	Received

1037-PB	Haemovigilance Reports of Adverse Blood Donor Reaction among Voluntary Blood Donors in Tertiary Care Hospital in Kathmandu, Nepal	Bipin Nepal	Received

1038-PB	Re-infusion of Heparinized Shed Blood in Aortic Surgery to Maintain Hemostatic Levels of Fibrinogen	Meredith Reyes	Received

1041-PB	Pseudomyxoma Peritonei Surgery: Potential for Predicting Fibrinogen Use using Thromboelastometry	Jane Needham	Received

1044-PB	Five Years of Hemovigilance Reports of Complications of the Blood Donation Reported at a Tertiary Care Centre in Karachi	Bipin Nepal	Received

1048-PB	Is the Thrombin Generation Test, a Useful Research Tool, Suitable to Characterize Therapeutic Plasmas?	Catherine RAVANAT	Received

1049-PB	Viral Inactivation and Enrichment of Factor VIII, Factor XIII, Fibrinogen and von Willebrand Factor (VWF) Multimers from Fresh Frozen Plasma (FFP)using, VIPS Plasma, Virus Inactivation Treatment System	Bipin Nepal	Received

1050-PB	Prolonged Platelet Storage Associated with Increased Incidence of Platelet Transfusion Adverse Events	Jian Chen	Received

1051-PB	Remote Bridging Clinics Maximise Efficiency and Patient Satisfaction in the Perioperative Management of Anticoagulation	Sinead Brookman	Received

1052-PB	Expanding the Role of the Anticoagulation Nurse	Stephanie Rivera	Received

1053-PB	Nurse-led Clinic Initiative for Patients Commencing Direct Oral Anticoagulants (DOACs) in the National Coagulation Centre, Dublin, Ireland	Lidhy Solomon	Received

1054-PB	Haemorrheologic and Fibrinolytic Activities of Sickle Cell Subjects in Steady and Crisis States in Abuja Metropolis, Nigeria	Dorathy Chioma Okpokam	Received

1055-PB	Social Work Research and Funding Opportunities: The Canadian Experience Claude Bartholomew, St. Pauls Hospital, Vancouver, Canada Neale Smith, University of British Columbia	Claude Bartholomew	Received

1057-PB	Empowering a Link Practitioner Network to Enhance Venous Thromboembolism (VTE) Prevention and Anti-coagulation Care	Richard Greenall	Received

1059-PB	Has the Introduction of the Direct Oral Anticoagulants (DOACs) Made Any Difference to Telephone Calls to A Secondary Care Led Anticoagulant Clinic?	Sarah Bond	Received

1061-PB	When the Absence of Prophylaxis in Patients with Hemophilia, Surgery is Inevitable	Ljiljana Rakic	Received

1064-PB	Abrogating Fibrinolysis Does Not Markedly Affect the Bleeding Phenotype or Response to rFVIII Therapy in Mice with Haemophilia A	Rikke Stagaard	Received

1065-PB	Vascular Remodeling in Hemophilic Joint Bleeding is Associated with Vascular Leak: A Possible Mechanism for Re-Bleeding	Esther Cooke	Received

1068-PB	Identification of Regulatory B Cells in Severe Hemophilia A Patients	Davide Matino	Received

1069-PB	Prophylactic Treatment with Turoctocog Alfa Pegol (N8-GP), a GlycoPEGylated Recombinant Factor VIII, Completely Prevents Development of Arthropathy in a F8 - Knockout Mouse Model of Induced Knee Bleeding	Josephine B Hebsgaard	Received

1070-PB	Two Large F8 Deletions Possibly Related to the Mechanism of Microhomology-mediated Break-induced Replication (MMBIR) as a Cause of Severe Haemophilia a and Inhibitors	Miguel Martin Abelleyro	Received

1071-PB	Measurement of Basal Levels of TF, FVII, FVIIa, Free and Total TFPI and FVIIa.AT Complex Levels in Patients with Haemophilia A and B	Emma Fosbury	Received

1072-PB	F8-deficiency in Mice is Associated with Increased von Willebrand Factor (VWF) Content in the Hepatic Endothelium and with Increased VWF Plasma Levels	Klytaimnistra Kiouptsi	Received

1074-PB	The Bone Disease in Haemophilia: A Possible Role of Coagulation Factors?	Stefano Lancellotti	Received

1075-PB	Determinants of Thrombin Generation in Haemophilia A and B	Michelle Piot	Received

1076-PB	Unusual Genomic Rearrangement Combined with Inv22 and Wild-type X-chromosome in Severe Hemophilia A Patients	Shogo Tamura	Received

1082-PB	Turoctocog AlfaPegol (N8-GP) Is Cleared from Subcutaneous Injection Sites without Local Degradation	Maj Petersen	Received

1083-PB	Thrombin Generation Profiling in Amish Factor IX Carriers and Controls: Plasma Composition and Bleeding Phenotype	Maria Cristina Bravo	Received

1087-PB	Rapid and Cost-effective FVIII Intron Inversion 22 Screening of the Central South African Haemophilia A Population	Walter Janse van Rensburg	Received

1088-PB	Patient Satisfaction of Home Delivery Program in Haemophilia through an Association of Patients	Martín Cerezuela	Received

1089-PB	Contribution to the Molecular Study of Hemophilia B in an Algerian Population	yamina ouarhlent	Received

1091-PB	Induction of FVIII Tolerance by Gene Transfer of IL2 and Factor VIII Plasmids in Hemophilia A Mice	Meghan J. Lyle	Received

1092-PB	Therapeutic Expression of Factor VIII Following Ultrasound-mediated Gene Delivery of High-expressing FVIII Variant Plasmids and Immunomodulation in Hemophilia A Mice	Carol H. Miao	Received

1095-PB	A Novel Strategy for Liver Cell-based Therapy in a Hemophilia B Model	Ching-Tzu Yen	Received

1100-PB	Preliminary Results of SPK-9001 Gene Transfer Demonstrate Statistical Improvements on the Health-related Quality-of-Life in Adults with Haemophilia B	Sylvia von Mackensen	Received

1106-PB	Hyperfibrinolysis in Children. Prevalence of Hyperfibrinolysis in Mucocutaneous Bleeders of Unknown Cause in a Pediatric Cohort	Pamela Zuñiga	Received

1109-PB	Dysprothrombinemia Caused by the Homozygote Mutation Ala563Val in the F2 Gene Was Associated with Reduced Thrombin Generation in a Patient with Bleeding Disorder	Heidi Glosli	Received

1111-PB	A Novel Thrombin-activable Factor X Corrects Acquired Hemophilia A in Rabbit	Jean-Luc Plantier	Received

1113-PB	Treatment of Hemophilia A by Injection of FVIII-encoding mRNA	Jules Russick	Received

1115-PB	Rescue of Multiple Hemophilia B-causing Mutations in F9 Exon 3 by a Unique ExSpeU1	Dario Balestra	Received

1116-PB	Dose-response and Duration of Effect of a Half-life Extended Recombinant Factor VIIa in the Tail Vein Transection Bleeding Model in Haemophilia A Rats	Torben Elm	Received

1117-PB	Defining extended half-life rFVIII: a critical review of the evidence	Johnny Mahlangu	Received

1119-PB	Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered Marzeptacog Alfa (Activated) in Hemophilia B Mice	Howard Levy	Received

1120-PB	Underestimation of N-glycoPEGylated Factor IX (N9-GP) Activity in One-stage Clotting Assay Owing to Contact Activator Impairment of N9-GP Activation	Egon Persson	Received

1123-PB	Administration of rFVIIa to Concizumab-dosed Monkeys Is Safe and Concizumab Does Not Affect the Potency of rFVIIa in Haemophilic Rabbits	Brian Lauritzen	Received

1124-PB	A Monoclonal Antibody with TFPI Neutralizing Activity, Improves the Coagulation Parameters of Hemostatic Assays Performed with Hemophilic Whole Blood	Sunita Hett	Received

1125-PB	Protein Engineering of Factor X to Restore Coagulation: Building an Alternate Amplification Loop	Grant E Blouse	Received

1132-PB	The Safety and Efficacy of IB1001 in Previously Treated Children 12 Years of Age or Younger with Hemophilia	David Schaaf	Received

1133-PB	A Single Analysis for Simultaneous Measurement of All 4 DOACs	Jan Emmerechts	Received

1134-PB	Interest of PERC Rule (Pulmonary Embolism Rule-out Criteria) to Exclude Pulmonary Embolism in European Patients with Low Implicit Clinical Probability: PERCEPIC Study	andrea penaloza	Received

1135-PB	Validation of STA-Liatest D-Di Assay for Exclusion of Deep Vein Thrombosis According to the Latest Clinical and Laboratory Standard Institute/Food and Drug Administration Guideline. Results of a Multicenter Management Study	Francois Depasse	Received

1136-PB	Variation in Practice for FVIII and FIX Inhibitor Investigations - Results from a UK NEQAS (Blood Coagulation) and UK HCDO Multicentre Exercise	Ian Jennings	Received

1137-PB	Improving aPTT Test and Resource Utilisation in Manitoba, Canada - A Successful Provincial Experience	Charles Musuka	Received

1138-PB	Prediction of Coagulation Testing in Underfilled Patient Samples	Jonathan Miller	Received

1139-PB	Thrombin Generation Based Factor VIII Assay is Sensitive to Low FVIII Levels in Hemophilia	Cuicui Bai	Received

1140-PB	Novel Biochip Detects Drug Effects in Patients with Cardiovascular Disease in a Near Patient Setting	Amy Hall	Received

1141-PB	Microfluidic Systems with Vascular Biomimetic Surfaces for Assessment of Platelets and Fibrin Components of Hemostasis: Comparison with a Classic Annular Device in the Evaluation of the Antithrombotic Effects of Apixaban	Irene Lopez-Vilchez	Received

1143-PB	Prenatal diagnosis for Inherited Bleeding Disorders in India	Eunice Edison	Received

1145-PB	The Use of the ADJUST (Age Adjusted) D-dimer Cut-off in Screening Patients Aged over 50 Years Presenting with Suspected DVTs Can Decrease the Need for Compression Ultrasonography	Andrew Hughes	Received

1146-PB	Is the Application of a Single Conversion Factor Suitable for the Laboratory Monitoring of Single Chain rFVIII by One-stage FVIII:C Assay?	ANNETTE BOWYER	Received

1147-PB	Impact of Pneumatic Tube System Transportation for the Monitoring of Heparin Therapy	Aurélien Lebreton	Received

1148-PB	Comparison of von Willebrand Factor Collagen Binding Activity (VWF:CB) Determined by a Chemiluminescent Assay on AcustarTM to an ELISA Kit	Emilie Jousselme	Received

1149-PB	Validation of a Flow Cytometric Platelet Function Test in a Cohort of Patients with a Suspected Platelet Function Disorder	Ivar van Asten	Received

1150-PB	Comparison of light transmission aggregometry and multiple electrode aggregometry for the evaluation of platelet aggregation in patients with mucocutaneous bleeding	Sara Israels	Received

1151-PB	Clot Waveform Analysis Has the Potential to Detect Fibrinogen Abnormalities	Atsuo Suzuki	Received

1152-PB	Effect of Anticoagulant Adjustment on Prothrombin Time Test Using 2 Different Thromboplastins in Patients with Elevated Hematocrit	DENISE CARVALHO REZENDE	Received

1154-PB	LC-MS/MS Nonradioactive Serotonin Release Assay for Platelet Function Analysis in Whole Blood	Jonathan Miller	Received

1155-PB	Thromboelastometry can Generate Significant Disagreement in the Management of Patients after Cardiopulmonary Bypass due to Analytical Variability	Felipe Guerrero	Received

1156-PB	Establishing of Therapeutic Range for Unfractionated Heparin Therapy: Activated Partial Thromboplastin Time vs. Anti-Xa Measurement	Litao Zhang	Received

1157-PB	Impact of Rivaroxaban and Dabigatran on Clotting Screens as Performed Using the Roche Cobas t 711 Analyser	Anna Lowe	Received

1158-PB	Genotypic Characteristics of Polish Patients with Antithrombin, Protein C and Protein S Deficiency	Edyta Odnoczko	Received

1159-PB	Assessment of Overall Coagulation and Fibrinolytic Activity in Hemophilia A Patients by Using Global Hemostatic Laboratory Methods: Overall Hemostasis Potential, aPTT-waveform Analysis and Endogenous Thrombin Potential	Marija Milos	Received

1160-PB	Thrombin Generation in Patients with Systemic Lupus Erythematosus (SLE)	Zsuzsa Bagoly	Received

1161-PB	Comparison of Three Different Anti-Xa Assays in Major Orthopedic Surgery Patients Treated with Edoxaban	Hideo Wada	Received

1162-PB	Assessment of Two Chromogenic FVIII Assays In Haemophilia A Patients Infused with B-domain Truncated or Deleted Products: Results from a French Multicentric Study	Emmanuel De Maistre	Received

1163-PB	Effects of Interfering Substances on Factor Assays Performed Using Q Smart Analyser and DG-PT RecombiLIQ or DG-APTT Synth Reagents	Anita Woolley	Received

1164-PB	Comparison of Point-of-Care Instruments I-STAT, ACTPlus and Hemochron Signature Plus for Measurement of Activated Clotting Time (ACT)	Stien Vandendriessche	Received

1166-PB	Laboratory Expert System in the Field of Hemostasis and Thrombosis: A Pilot Project for the Diagnosis of von Willebrand Disease	Holger Seidel	Received

1167-PB	A New and Improved Euglobulin Clot Lysis Time Assay (iECLT)	Anton Ilich	Received

1168-PB	Platelet Estimation from Peripheral Blood Smear: Does it Really Works?	Ikram Bachiri	Received

1169-PB	Comparison of Rotational Thromboelastometry Reference Ranges with Normative Ranges across Trimesters in Pregnancy	Amir Shamshirsaz	Received

1170-PB	Enhanced Coagulation Decreases Probability of Positive Outcome during in vitro Fertilization	Anna Balandina	Received

1171-PB	Development and Implementation of a Coagulation Factor Testing Method Utilizing Autoverification in a High Volume Clinical Reference Laboratory Environment	Paul Riley	Received

1172-PB	Factors VII and VIII Assays: Analytical Performance and Reference Ranges for Argentinian Population	Maria De Lourdes Herrera	Received

1174-PB	Standardization of a Cytometry Test to Measure the von Willebrand Factor Collagen Binding Activity	Daniel Chaves	Received

1177-PB	Results of Implemented Postanalytical Quality Indicator - Turnaround Time (TAT) Monitoring for Urgent Coagulation Tests	Sandra Margetic	Received

1178-PB	Is it Helpful for Physicians the Laboratory Post Analytical Comments on a Prolonged APTT?	Mirta Del Valle Arias	Received

1179-PB	Sensitive Method for Determination of Blood Hypercoagulation	Olga Petrova	Received

1180-PB	Variants of FVII Deficiency at an Elderly Care Hospital	Rodolfo Emanuel Sueldo	Received

1181-PB	Towards Harmonization of Critical International Normalized Ratio Values Reporting: The Croatian Survey	Ana Bronic	Received

1182-PB	Improving Laboratory Operational Efficiency with the Implementation of a Specialized Hemostasis Lab Automation	Vicente Cortina	Received

1183-PB	In Search of a Sensitive and Reliable Laboratory Tool to Assess Hypercoagulability	Debora Bertaggia Calderara	Received

1184-PB	HIL Interferences in Coagulation Testing: Evaluation of Automatic Check with the New ACL TOP 550 CTS Analyzer	Anna Skibowska-Bielinska	Received

1185-PB	Comparison of Clot Waveform Analysis from Sepsis Patients and Healthy Control Group	Nadjwa Zamalek	Received

1186-PB	Impact of New Oral Anticoagulants on Routine Coagulation Assays	Ana Bronic	Received

1189-PB	Clinical Outcomes in Fragile Patient with Venous Thromboembolism	Farès MOUSTAFA	Received

1190-PB	Comprehensive Characteristics of the Anticoagulant Activity in Relationship to the Plasma Concentration of Dabigatran	Willemijn Comuth	Received

1191-PB	Menstrual Bleeding Patterns in Women Treated with Rivaroxaban: Data from the EINSTEIN CHOICE Trial	Kochawan Boonyawat	Received

1193-PB	Impact of Evolving ACCP Guidelines on Estimates of Venous Thromboembolism Risk in US Hospitals	Frederick Anderson	Received

1195-PB	Oral Anticoagulation with Direct Thrombin Inhibitors Prevents the Early Events of Atrial Remodeling and the Thrombin-activated ErbB Signaling in a Rat Model of Atrial Dilation	Monique David-Dufilho	Received

1197-PB	Outcomes, Interventions and DOAC Plasma Concentration Assay Utility in DOAC-treated Patients Presenting with Major Haemorrhage or Thrombosis - Results from the Anticoagulant Reversal and Events Study Collaborative (ARES1)	DAulerio Giuliana	Received

1198-PB	Direct Oral Anticoagulants in Patients with Venous Thromboembolism Usually Excluded for Clinical Trials	Manuel Monreal	Received

1199-PB	A New Method for Determining Concentrations of Direct Oral Anticoagulants	Saartje Bloemen	Received

1200-PB	Patients with Dabigatran Circulating Concentration above 200 ng/ml Have a Rebound after Neutralization by a Single Dose of Idarucizumab	Nicolas Gendron	Received

1202-PB	Comparison of Applying TTR Proportion of Tests and TTR Rosendaal to a Sample Population Attending a Warfarin Clinic	Thomas O Halloran	Received

1205-PB	Pulmonary Embolism Rule-out Criteria (PERC) Has No Added Value to the YEARS Algorithm to Rule out Pulmonary Embolism	Liselotte M. van der Pol	Received

1206-PB	Evaluation of Different Coagulation Laboratory Methods to Monitor Apixaban, Rivaroxaban and Dabigatran Treatment	Jovan P Antovic	Received

1207-PB	Effect of Rivaroxaban on Expression of Monocyte Platelet Aggregates and P Selectin in Patients with Atrial Fibrillation	Rita Duarte	Received

1208-PB	Gastrointestinal Bleeding in Patients on Warfarin and Direct Oral Anticoagulant Therapy: An Observational Study in a District General Hospital	Andrew Mcsorley	Received

1209-PB	Select-d Trial Qualitative Sub-study: Patient and Carer Experience of Anticoagulation for Cancer-Associated Thrombosis	Sophie Rees	Received

1210-PB	TRAP-induced Platelet Aggregation is Reduced in Patients Receiving Dabigatran	Juraj Sokol	Received

1211-PB	An Oral Factor Xa Inhibitor Edoxaban Ameliorates Neointima Formation Following Vascular Injury in ApoE KO Mice	Yoshiyuki Morishima	Received

1213-PB	Lower Prevalence of Isolated Subsegmental Pulmonary Embolism in the YEARS Diagnostic Algorithm Compared with the Conventional Algorithm for Suspected Pulmonary Embolism	Liselotte M. van der Pol	Received

1214-PB	Renal Clearance is Able to Predict Drug Discontinuation in Patients with Atrial Fibrilation Treated with Direct Oral Anticogulants	Begoña Navarro Almenzar	Received

1217-PB	Treatment Effect Estimates for Extended Treatment of VTE Using Network Meta-analysis from Clinical Trials with Rivaroxaban, Aspirin or Placebo	Kathleen Leonard-Bedwell	Received

1218-PB	Is LMWH-calibrated Anti-Xa Assay Useful to Estimate Apixaban Concentration in Patients Undergoing Apixaban Treatment?	Maria De Lourdes Herrera	Received

1219-PB	Calibrated Automated Thrombogram II: A New Thrombin Generation Test Able to Measure in the Presence of a Direct Thrombin Inhibitor	Anouk Gulpen	Received

1222-PB	Management of Pulmonary Embolism in a Short Stay Medical Unit: A Cohort Study	Marco Donadini	Received

1224-PB	Performance of a Chromogenic Assay for the Measurement of Edoxaban Concentration in Plasma	Aurore Barthod-Malat	Received

1227-PB	Evaluation of Prescribing Practices and Medication Persistence in Patients Initiated on Direct Oral Anticoagulant Therapy at a Tertiary Care Academic Medical Center	Patrick Klem	Received

1228-PB	Selection of Long-term Anticoagulation Therapy after Acute Pulmonary Embolism in Real Life	Valdis Gibietis	Received

1229-PB	Impact Analysis of Prognostic Stratification for Pulmonary Embolism: The iAPP Study	marco donadini	Received

1230-PB	Do the Direct Oral Anticoagulants (Doacs) Make Managing Anticoagulant Therapy during the Peri-operative Period Easier?	Kwesi Kittoe	Received

1231-PB	Limits of Sensitized Rotational Thromboelastometry for Rivaroxaban and Apixaban Detection	Claire PAILLERET RINGUIER	Received

1232-PB	Choice of Anticoagulation in the Obese	Georgia McCaughan	Received

1233-PB	Antithrombotic Effects of Edoxaban, a Direct Factor Xa Inhibitor, and Antiplatelet Agents and their Combination Effects on Stent Thrombosis in Rats	Yoshiyuki Morishima	Received

1234-PB	Dental Extractions on NOACs withouT Stopping Therapy (DENTST) Study: Interim Analysis	Yvonne Brennan	Received

1235-PB	Patients on a Fixed Dose of DOAC: What Percentage is in the Therapeutic Window?	H. Coenraad Hemker	Received

1236-PB	Comparing the Performance of Different Assays for Monitoring Dabigatran Plasma Concentrations in Real-practice	Luciana Gonalves	Received

1237-PB	Total Thrombus-formation Analysis System (T-TAS) as a Potential Tool for Assessing Comprehensive Hemostatic Function in Patients Taking Dabigatran	Takashi Ito	Received

1240-PB	Measurement of Direct Oral Anticoagulants Levels in Patients Admitted for Bleeding Events: A Prospective Study	Anne-Laure Sennesael	Received

1242-PB	Oral Anticoagulant Associated Bleeding Events - A Single Centre Experience	McNeill Susan	Received

1243-PB	Influence of Direct Oral Anticoagulants in Fibrinolysis Testing	Monica Pereira	Received

1244-PB	The Incidence and Assessment of Post-thrombotic Syndrome in Critically Ill Children Two Years Post-central Venous Catheter Placement	Sophie Jones	Received

1246-PB	Chronic Blood Transfusion Therapy Corrects Abnormalities of Coagulation and Fibrinolysis in Children with Sickle Cell Disease	Suzan Williams	Received

1247-PB	Evaluating the Relationship between von Willebrand Factor, ABO Blood Group and Circulating Lymphoblasts in the Development of ALL-associated Thromboembolism in Children	Terry Mizrahi	Received

1248-PB	Central Venous Catheter Associated Thrombosis in Congenital Heart Disease Patients: A Preliminary Analysis of the Childrens Hospital Acquired Thrombosis (CHAT) Registry	Michael Silvey	Received

1249-PB	Neutrophil Extracelular Traps (NETs) and Inflammatory Biomarkers in Patients with Hereditary Spherocytosis. Influence of Splenectomy	Antonio Moscardó	Received

1251-PB	The Association between Central Venous Catheter Placement and Central Venous Catheter Related Thrombus	Sophie Jones	Received

1254-PB	Venous Thromboembolism in Children with Hodgkins Lymphoma	Pavel Zharkov	Received

1255-PB	Thrombin Generation in Venous Thromboembolism, Arterial Ischaemic Stroke and Bleeding Events in Children	Vera Ignjatovic	Received

1256-PB	Paroxysmal Nocturnal Hemoglobinuria Spectrum among Pediatric Age Group of Patients: Single Center Experience without Any Thrombotic Events	Neslihan Kalkan	Received

1257-PB	Incidence and Risk Factors for Childhood Thrombosis: Ten Years Experience of a Paedatric Hematology Center from Turkey	Adalet Meral Gne&351;	Received

1258-PB	A Default in Acetyl-CoA Carboxylase Phosphorylation Increases Thrombus Growth in vitro and in vivo, and in a Collagen-dependent Manner	Sophie Lepropre	Received

1260-PB	Fibrin Activation and Not GPCR Ligand Activation Induces Shedding of Platelet GPVI: Soluble GPVI is Elevated in Thermal Injury and ICU Patients	Samantha Montague	Received

1262-PB	Patient Derived HLA Monoclonal Antibodies Induce Fc&947;RIIa Dependent Platelet Activation	Maaike Rijkers	Received

1263-PB	Platelet PN-1 Regulates Clot Structure and Retraction	stéphane LOYAU	Received

1265-PB	Cyclophilin D Restricts the Lytic Susceptibility of Fibrin via Modulation of Platelet Functions	Veronika Judit Farkas	Received

1270-PB	Controlled Adhesion of Endothelial Cells and Platelets onto Patterned CoCr Alloy Surfaces by Direct Laser Interference Patterning Technique for Cardiovascular Applications	Marc Pino	Received

1271-PB	Authophagy of Microparticles by Platelets is Partially Mediated through TLR-4 and Enhances Thrombogenicity	Irene Lopez-Vilchez	Received

1272-PB	Analysis of Venous and Arterial Hemostatic Plugs Reveals Strikingly Similar Composition and a Gradient of Platelet Activation	Chelsea Matzko	Received

1273-PB	Platelet Reactivity and Receptor Density in Platelets with Different MPV	Anna Sdergren	Received

1276-PB	A Novel Role for the Membrane Protein G6f in Platelet Activation Induced by Weak Stimulation	Ali Amirkhosravi	Received

1278-PB	Heparin Decreases Thrombin Induced Procoagulant Platelet Formation via a Direct Platelet Effect	Vivien CHEN	Received

1280-PB	Autophagy Inhibitors Reduce Platelet Function by Preventing Granule Exocytosis	Dafna Groeneveld	Received

1281-PB	Kinetics of Prothrombin Interaction with Subpopulations of Activated Platelets	Nadezhda Podoplelova	Received

1282-PB	Inhibition of MRP4 Mediated Transport Reduces Platelet Function in a cAMP-cGMP Independent Manner	Laura Alemanno	Received

1284-PB	Systemic Alteration of Platelet Activity during Each Trimester of Normal Pregnancy	Steven Cullen	Received

1290-PB	Exploration of additional parameters of multiple electrode aggregometry is encouraged	Mette Tiedemann Skipper	Received

1295-PB	Synergistic Inhibitory Effect of Capsaicin and Dihydrocapsaicin on the Arachidonic Acid Pathway of Platelet Aggregation	Murray Adams	Received

1296-PB	The PI3K pathway master kinase PDK1 controls platelet activation by regulating the MAPK pathway via the Raf-1 proto-oncogene, serine/threonine kinase	Patrick Mnzer	Received

1299-PB	ELMO1 Negatively Regulates Glycoprotein VI-mediated Signaling by RhoG in Platelets	Akruti Patel	Received

1301-PB	Kindlin-3 identified as a key negative regulator of the small Rho GTPase, Cdc42 during platelet spreading	Dorsaf Ghalloussi	Received

1303-PB	Arp2/3 is Critical for Platelet Homeostasis but Dispensable for Hemostatic Plug Formation	David S. Paul	Received

1305-PB	RGS Proteins Shape the Hemostatic Response by Regulating the Platelet Signaling Networks	Shuchi Gupta	Received

1307-PB	RhoGAP6 and RhoGEF2 are Novel Regulators of RhoA in Platelets	Shane Comer	Received

1309-PB	Annexin A7 (ANX7) regulates GPVI-dependent platelet activation and Ca2 signaling	Sascha Geue	Received

1311-PB	Disabled-2 Controls Platelet Activation Through a Regulatory Circuit Involving Multiple Interacting Proteins	Hui-Ju Tsai	Received

1312-PB	Sustained Inhibition of Acetyl-CoA Carboxylase Decreases Platelet Dense Granules Secretion and Aggregation	Sophie Lepropre	Received

1314-PB	Changes in Gene Expression Levels in Immune Thrombocytopenia Patients Treated with Eltrombopag	Jose M Bastida	Received

1315-PB	Calcium Homeostasis in Platelets in Pregnancy Women with Preeclampsia	Volha Bichan	Received

1316-PB	PDK1 Regulates Platelet Activation through Phosphorylating of S6K on Thr229	Xue Chen	Received

1318-PB	Integration of Platelet Agonist Signaling during the Hemostatic Response in vivo	Timothy Stalker	Received

1320-PB	Platelet Proteomic Profiling in a Patient with Severe Platelet Dysfunction Associated to an Anti-aIIb3 Autoantibody Triggering Outside-in Signaling	Mathieu FIORE	Received

1321-PB	STAT3 Phosphorylation Is Regulated by Thromboxane A2 Receptor in Platelets	Antonio Moscardó	Received

1324-PB	Involvement of aIIb3 Integrin on Release of Extracellular Vesicles and Chemokines CXCL4 and CCL5 by Platelets	Rory Koenen	Received

1329-PB	Btk Kinase Activity is Not Critical for Platelet Activation by GPVI	Phillip Nicolson	Received

1330-PB	Extracellular Signal-regulated Kinase 5 Associates with Casein Kinase II to Regulate GPIb-IX-mediated Platelet Activation via PTEN/PI3K/Akt Pathway	Yu Hu	Received

1331-PB	Agonist-induced Protein Disulfide Isomerase Activity in Platelets: Different Effect of Different Agonists	Ronit Mor-Cohen	Received

1332-PB	Dose-dependent Inhibitory and Stimulatory Effects of Sphingosine-1-phosphate on Platelet Adhesion to Endothelium	Carolin Helten	Received

1334-PB	Reelin Modulates PLC?2 Phosphorylation upon Platelet Activation and Integrin Outside-in Signaling	Irena Krger	Received

1335-PB	Calcium Monitoring in Platelets: Tool for Diagnosing Platelet Function Defects	Alessandro Aliotta	Received

1337-PB	Role of Heterotrimeric G Proteins in Platelet Activation and Clot Formation in Platelets Treated with Integrin aIIb3 Inhibitor	Naphtali Savion	Received

1338-PB	In vitro Assessment of Catecholamines to Restore Platelet Aggregation in the Presence of Ticagrelor and Aspirin	Anne-Céline Martin	Received

1339-PB	Emerging Role for TLT-1 at the Interception of Inflammation and Hemostasis	Jessica Morales	Received

1341-PB	Platelets Express and Release Immune-modulatory CXCL14 upon Activation	Alexander Witte	Received

1342-PB	CD8 T Cells Are Important Mediators of Platelet Refractoriness	Cheryl Maier	Received

1345-PB	Renal Denervation Decreases the Platelet Activation Status in Hypertensive Patients	Maria Teresa Kristina Zaldivia	Received

1346-PB	Upregulation of Inflammatory Transcripts in Platelets of Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Role of Platelets in the Inflammatory Network of NAFLD	Maria Adele Alberelli	Received

1347-PB	Characterization of PF4-heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential	Jawed Fareed	Received

1348-PB	Acetylsalicylic Acid Differentially Limits The Activation and Expression of Death Markers in Human Platelets Exposed to Staphylococcus aureus Strains	Adrien Chabert	Received

1349-PB	Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in vitro and in Renal Cell Carcinoma Patients	Bibian Tullemans	Received

1350-PB	Tunable Activation of Therapeutic Platelet-Rich Plasma by Pulse Electric Fields: Differential Effects on Clot Formation, Growth Factor Release and Platelet Morphology	Andrew Frelinger	Received

1352-PB	Ascorbic Acid on Platelet Activation. New Functions for an Old Drug	Roberto Pozner	Received

1354-PB	Intercellular Signalling between Platelets and a Myeloid Leukemic Cell Line	Tayyaba Iftikhar	Received

1355-PB	An Optimized Protocol for Platelet Rich Plasma Preparation to Improve its Angiogenic and Regenerative Properties	Julia Etulain	Received

1357-PB	Treatment of Patients with Autologous Platelet Rich Fibrin is Dependent on the Composition of Peripheral Blood Cells: Dental Implant Stability is Associated with Red Blood Cells and Not with Platelets	Jasper Remijn	Received

1358-PB	Identification of a Novel Regulator Platelet P2Y12 Receptor Function: Tetherin, a Lipid-raft Organizing Protein Negatively Regulates Receptor Activity	Xiaojuan Zhao	Received

1359-PB	Platelet Endocytosis in Immune Responses to Viral Infection	Sidney Whiteheart	Received

1360-PB	Pharmacologic Blockade of Platelets Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis	Susann Eichler	Received

1362-PB	Platelets Enhance Distinct Dynamics of Effector Cell Responses of Nave, Effector, and Central Memory CD4 T Cells	Shuai Tan	Received

1364-PB	Platelets Play a Protective Role in the Host Defense against Burkholderia pseudomallei (Melioidosis)	Theodora Claushuis	Received

1366-PB	Platelets Promote Immunosuppression and Colorectal Tumor Formation: Inhibition by Clopidogrel	Laurence Servais	Received

1367-PB	Interplay between Platelets, Neutrophils and Coagulation in Bleeding in a Mouse Model of Inflammatory Bowel Disease	Odile Wéra	Received

1369-PB	Complete Attenuation of PrP(106-126)-mediated Pathological Responses by Flufenamic Acid in Platelets	Ram Lala Mallick	Received

1371-PB	Contributions of von Willebrand Factor to the Development of Angiotensin II-induced Vascular Inflammation	Jérémy Lagrange	Received

1372-PB	Platelets Are Effectors of Articular Degradation in Rheumatoid Arthritis	Eleonora Petito	Received

1374-PB	Procoagulant Platelets as a Biomarker in Suspected Sepsis - A Pilot Study	Leonardo Pasalic	Received

1378-PB	Anticoagulant and Anti-inflammatory Properties of the Novel Antimicrobial Peptide Centrocin 1 from Green Sea Urchin	Bjarne sterud	Received

1379-PB	Deficiency of Sirtuin 3 Elevates Mitochondrial ROS in Neutrophils and Platelets but Does not Exacerbate NETosis or Venous Thrombosis	Hideki Hayashi	Received

1380-PB	Nucleosomes and Neutrophil Extracellular Traps in Septic and Burn Patients	Mirta Schattner	Received

1382-PB	Platelets Release Pathogenic Serotonin in Response to Immune Complexes	Nathalie Cloutier	Received

1383-PB	Influence of Intravenous Immunoglobulin and Methylprednisolone on Cytokines Secreted by T Lymphocyte in Children ITP	Ma Jingyao	Received

1386-PB	GDF-15 Alters the expression of Actin Associated Protein, Increases Migration and the Phosphorylation of Smad2 is Mediated via TGFRII	Lena Kask	Received

1387-PB	Validation of Plasma Marker Candidates for VTE Using Affinity and Mass Spectrometry-based Proteomics Indicate a Link to Alternative Complement Pathway	Laura Sanchez-Rivera	Received

1389-PB	Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets - Results from the Gutenberg Health Study	Marina Panova-Noeva	Received

1390-PB	Metabolomic Study in Plasma Samples to Identify a Metabolite Profile Associated to Venous Thromboembolism	Álvaro Fernández-Pardo	Received

1391-PB	Prevalence of Deep Vein Thrombosis and Wells Score Accuracy for Inpatient with Suspected Deep Vein Thrombosis	Michelangelo Sartori	Received

1392-PB	Impact of Chronic Inflammation, Assessed by C-reactive Protein, on the Association between Red Cell Distribution Width and Risk of Incident Venous Thromboembolism	Trygve Slberg Ellingsen	Received

1394-PB	Plasma Leptin is Not a Mediator of the Association between Obesity and Risk of Venous Thromboembolism	Lars Daae Horvei	Received

1395-PB	Identifying a Common Biochemical Background for Thrombotic Events in Patients with Deep Vein Thrombosis (DVT) and Peripheral Artery Disease (PAD)	Arina ten Cate-Hoek	Received

1396-PB	Plasma Levels of miRNAs Are Associated with Risk of Cancer-related Venous Thromboembolism	Irina Starikova	Received

1397-PB	A Global Metabolomic Analysis Comparing Low-risk and High-Risk Pulmonary Embolism	Christopher Kabrhel	Received

1398-PB	Changes in the Fibrinolytic Status and Cardiovascular Profile in Obese Patients Undergoing Bariatric Surgery	Ana Marco	Received

1399-PB	Evaluation of Risk Factors for Postpartum Hemorrhage after Vaginal Delivery in Uncomplicated Pregnancy	Kazuhiro Nishioka	Received

1400-PB	Analysis of the Substrate Specificity of Factor VII Activating Protease (FSAP) and Design of a Specific and Sensitive Peptide Substrate	sandipk kanse	Received

1401-PB	Von Willebrand Factor Propeptide May Identify the Patients Susceptible for Renal Dysfunction in Collagen Disease	Noritaka Yada	Received

1402-PB	Age-related Diagnostic Value of D-dimer Testing and the Role of Inflammation in Patients with Suspected Deep Vein Thrombosis - Results from the VTEval Study	Jrgen Prochaska	Received

1404-PB	Characterization of a Transient Procoagulant Phenotype Induced by Recombinant Activated Factor VII (rFVIIa)	Heiko Rhl	Received

1405-PB	The Effects of Shear Stress on Platelet Activation and Incipient Clot Characteristics: Exploring the Mechanisms of Shear Induced Clot Formation	Karl Hawkins	Received

1407-PB	Changes in Thrombin Generation in Obese Patients Undergoing Bariatric Surgery: Improvement in the Hypercoagulable Status	Ana Marco	Received

1408-PB	Combined Detection of Factor XIII and D-Dimer Is Helpful for Differential Diagnosis in Patients with Suspected Pulmonary Embolism	Ning Tang	Received

1409-PB	Clinical Significance of Circulating Endothelial-derived Microparticles and Coagulation Profiles in Patients with Advanced Solid Tumors	DER SHENG SUN	Received

1411-PB	A Quantitative Clot-based Assay for Antithrombin Activity	Walter Calhoon	Received

1413-PB	Platelet Counts and Plateletcrit are Associated with an Increased Risk of Venous Thrombosis in Females. Results from the RETROVE Study	Miquel Vázquez-Santiago	Received

1414-PB	Plasma Levels of miRNAs Are Associated with Future Risk of Incident Venous Thromboembolism	Irina Starikova	Received

1416-PB	D-dimer in Acute Medically Ill Adults: A Multicenter Observational Study Evaluating the Prevalence of Elevated D-dimer in Acute Medically Ill, Hospitalized Adults: The DAMIACT Study, Initial Results	Iwona Bucior	Received

1417-PB	Down-regulation of Protein C Pathway Associated with Increased Inflammation in Patients with Implanted Ventricular Assist Devices as a Potential Cause of Pump Thrombosis	Walter Jeske	Received

1418-PB	The effect of iron status on the relationship between red cell distribution width (RDW) and venous thromboembolism (VTE)	Jostein Lappegrd	Received

1419-PB	Utility of novel biomarkers (TAT, PIC, tPAIc and TM) in evaluating worsening of coagulopathy and mortality in APL and Sepsis induced DIC patients: A Prospective Observational study	Anupama Janaki Krishnamoorthi	Received

1422-PB	Assessment of Endothelial and Inflammatory Markers in Brazilian Renal Transplant Recipients	SUELLEN RODRIGUES MARTINS	Received

1423-PB	Remote Platelet Function Testing Using Platelet-Bound P-in as a Marker of Platelet Activation	Stanley Heptinstall	Received

1424-PB	Endothelial Microparticles, Thrombomodulin and D dimer in Women with Systemic Lupus Erythematosus under treatment	Fernanda Freire	Received

1425-PB	Chronic Lymphocytic Leukemia: Is there a Role for Circulating Microparticles or Trombin Generation in Clinical Heterogeneity?	Fernanda Freire	Received

1426-PB	Determinants of Clot Strength in Polycythemia Vera and Primary Myelofibrosis using Rotational Thromboelastometry	Nikolaj Nytofte	Received

1427-PB	Identification & Characterization of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients with Continuous Flow Left Ventricular Assist Device Implants	Walter Jeske	Received

1428-PB	Haemostasis in Children with Acute Lymphoblastic Leukemia	Elena Seregina	Received

1429-PB	Association between FTO rs9939609 Polymorphism and Risk of Recurrent Venous Thromboembolism	Abrar Ahmad	Received

1430-PB	The protein Z system dynamic in patients undergoing offpump coronary artery bypass surgery	Zekanowska Ewa	Received

1431-PB	Relevance of Co Morbidities, D-Dimer, Red Cell Distribution Width and Factor VIII Levels in Thrombosis	Annamma Kurien	Received

1432-PB	Longitudinal Assessment of Coagulation and Fibrinolysis in Pregnant Women with Risk Factors for Preeclampsia	Luci Dusse	Received

1433-PB	Role of Oxidized High-density Lipoprotein (oxHDL) on Coagulation and Platelet Adhesion Modulation	Lorena Perez	Received

1434-PB	Inter-individual Variability and Normal Ranges of Whole Blood and Plasma Thrombin Generation and Correlation with Clotting Factor Levels in a Large Healthy Control Population	Hilde Kelchtermans	Received

1435-PB	Venous Thromboembolism Events over Five Years Presenting with a Normal D-Dimer	Huw Rowswell	Received

1436-PB	Biomarkers for the Diagnosis of Venous Thromboembolism: D-dimers, Thrombin Generation, and Phospholipid-dependent Clotting Time	Alexander Gatt	Received

1437-PB	Risk Factors and Clinical Characteristics Favoring Pulmonary Embolism Vs DVT in Hormonal Therapy (HT) Associated Thromboembolism. Retrospective Analysis of 73 Cases from a Single Hemostasis Unit	Emmanouil Papadakis	Received

1439-PB	Is Platelets - Bound C4d a Marker for Active Disease and Correlates with Hypercoagulability in Patients with Systemic Eritematosus Lupus?	Fernanda Freire	Received

1440-PB	Profiling of Thrombotic and Inflammatory Mediators in Synovial Fluid from Patients Undergoing Primary Total Joint Arthroplasty	Jawed Fareed	Received

1442-PB	Anti-2-Glycoprotein I Antibodies Cause Lupus Anticoagulant and Activated Protein C Resistance via Coagulation Factor V	Rolf T. Urbanus	Received

1443-PB	Plasma Clot Properties, Disease Phenotype, and Thrombotic Risk in Patients with a Lupus Anticoagulant: Results from the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)	Florian Posch	Received

1444-PB	Biophysical Characterization of Clot Retraction in Platelet Rich Plasma of Patients with Anti-phospholipid Syndrome	Jolan Harsfalvi	Received

1446-PB	Longitudinal Anti-phospholipid-Antibody Trajectories for Dynamic Thrombotic Risk Prediction in Patients with the Lupus Anticoagulant: A Joint Model	Florian Posch	Received

1447-PB	Impact of Adding Antiphosphatidylserine/Prothrombin Antibodies in the Thrombotic Risk of Patients with APS Laboratory Criteria: A Prospective Study	Marta Martinuzzo	Received

1449-PB	The Effect of Treatment with Hydroxychloroquine on Soluble Tissue Factor Levels in Patients with Antiphospholipid Antibodies and Antiphospholipid Syndrome	Karen Schreiber	Received

1450-PB	Increased Plasma Cell-free DNA (cfDNA) and Myeloperoxidase (MPO) and Impaired Fibrinolysis in High-risk Patients with Antiphospholipid Antibodies (aPL)	FABRIZIO SEMERARO	Received

1453-PB	Clinical Impact of Triple Positivity of Antiphospholipid Antibodies in Primary Thrombotic Antiphospholipid Syndrome	Sabrina Saraiva	Received

1454-PB	2GpI Binds to Fibrinogen and Alters Fibrin Generation and Degradation	Daniele Peterle	Received

1455-PB	Circulating Microparticles in Pregnant Patients with Primary Antiphospholipid Antibody Syndrome: An Explorative Study	Elena Campello	Received

1456-PB	Outcomes of Anticoagulant Therapy in Patients with Antiphospholipid Syndrome Managed in an Anticoagulation Clinic	Monika Stalc	Received

1457-PB	Elevated Oxidized Low Density Lipoprotein Levels in Antiphospholipid Syndrome is Related to the Autoantibodies against High Density Lipoprotein and its Associated Proteins	Kenji Oku	Received

1458-PB	Platelet Activation by Antiphospholipid Antibodies through the IgG Receptor Fc?RIIa: Possible Role in Thrombosis Associated with Antiphospholipid Syndrome?	Enriqueta Coll	Received

1459-PB	Prognostic Impact of Antiphospholipid Antibodies on the Clinical Course of Primary Immune Thrombocytopenia or Autoimmune Hemolytic Anemia	Ana Clara Ladeira Cruz	Received

1462-PB	Are Anti2-glycoprotein I IgG Domain I a Useful Tool to Predict Thrombosis?	Ana Marco	Received

1463-PB	Oral Anticoagulation Cost in Primary Antiphospholipid Syndrome: Comparison between Warfarin and Hypothetical Rivaroxaban	Paul Ames	Received

1464-PB	Comprehensive Characterization of Platelet Parameters for Thrombosis Risk Prediction in Patients with the Lupus Anticoagulant	Johanna Gebhart	Received

1465-PB	Severe Vitamin D Deficiency a Potentially Risk Factor for Recurrent Miscarriages in Women with Positive Antiphospholipid Antibodies	STAMATIOS PETOUSIS	Received

1466-PB	Antibodies against Domain I of Beta2-glycoprotein I Have No Added Value for Prediction of Antiphospholipid Syndrome Compared to Classical Antiphospholipid Antibodies	Nathalie Pequeriaux	Received

1469-PB	Thrombocytopenia is Uncommon in High-risk Patients with Antiphospholipid Syndrome (APS)	Alessandra Banzato	Received

1470-PB	Circulating Neutrophil-Extracellular Traps (NETs) in Patients with the Antiphospholipid Syndrome	Joan Carles Reverter	Received

1471-PB	Catastrophic Antiphospholipid Syndrome: Onset and Outcome	Tatiana Reshetnyak	Received

1472-PB	Effect of Hydroxychloroquine on Circulating Levels of Inflammatory Cytokines in Patients with Primary Antiphospholipid Syndrome	Bruna Mazetto	Received

1473-PB	A High Molecular Weigh Protein Is Responsible of Anticoagulant Activity in Isolated Lupus Anticoagulant	Alessandra Banzato	Received

1475-PB	What Is the Risk of The First Thrombosis in Asymptomatic Antiphospholipid Antibodies Carriers?	Lidia Costa	Received

1476-PB	Clinical Relevance of Anti Phospholipid Antibodies in Deep Venous Thrombosis	Doaa Eissa	Received

1477-PB	Results of Lupus Anticoagulant Investigation in Unive Population of Patients Referred for Testing	Sandra Margetic	Received

1479-PB	Detection of Thrombogenicity Positive Antiphospholipid Antibodies in Antiphospholipid Syndrome Diagnosis	Jana Ulehlova	Received

1482-PB	Plasma Thrombogenic Potential in Patients with Granulomatosis with Polyangiitis in Comparison to Antiphospholipid Syndrome	Magdalena Celi&324;ska-Lowenhoff	Received

1485-PB	Predictors of Thrombotic Events in Patients with Antiphospholipid Antibodies	Ghaith Abu Zeinah	Received

1486-PB	Recurrent Arteriovenous Fistula Thrombosis in Female Patient with Antiphospholipid Syndrome (APS), Factor V Leiden Mutation and MTHFR C677 T Mutation	Bernadeta Ceglarek	Received

1487-PB	Comparison of Genetic Risk Score Models to Predict First Venous Thromboembolism in a Population-based Case-cohort. The Troms Study	Sigrid Braekkan	Received

1488-PB	Next-Generation DNA Sequencing Approach to Study Burden of Rare Variants in Loci Susceptible to Cerebral Vein Thrombosis	Paolo Bucciarelli	Received

1489-PB	Impact of Age and Prothrombotic Genotypes on the Risk of Incident Venous Thromboembolism	Birgit Smbrekke	Received

1490-PB	Joint Effects of Ischemic Stroke and Prothrombotic Genotypes on the Risk of Venous Thromboembolism. The Troms Study	Ludvig Balteskard Rinde	Received

1491-PB	Joint Effects of Myocardial Infarction and Prothrombotic Genotypes on the Risk of Venous Thromboembolism. The Troms Study	Ludvig Balteskard Rinde	Received

1492-PB	Population-based Incidence of Venous Thromboembolism in Oklahoma County, OK April 1, 2012-March 31, 2014	Aaron Wendelboe	Received

1493-PB	Differential Impact of Surgery as a Trigger Factor for Venous Thromboembolism in Patients with and without Prothrombotic Genotypes	Esben Bjri	Received

1494-PB	Hospitalization as a Trigger for Venous Thromboembolism - Results from a Large Population-based Case-crossover Study	Esben Bjri	Received

1495-PB	The Rare Allele of the K858R Variant of Factor V Protects from the Risk of Venous Thrombosis but Only in Non Carriers of the FV Leiden Mutation	Pierre Suchon	Received

1496-PB	Joint Effects of Prothrombotic Genotypes and Body Height on Risk of Venous Thromboembolism: The Troms Study	Lars Horvei	Received

1498-PB	The effect of prothrombotic genotypes on the relationship between red cell distribution width (RDW) and venous thromboembolism (VTE)	Jostein Lappegrd	Received

1499-PB	Homozygous and Heterozygous Factor V Leiden Mutation (FVL) Is Associated with an Increased Risk for Recurrent Venous Thromboembolism (VTE) after First VTE	Rainer B. Zotz	Received

1502-PB	Genetic Characterization of Antithrombin, Protein C and Protein S Deficiencies in Slavic Thromboembolic Patients	Ewa Wypasek	Received

1504-PB	Molecular Genetic Diagnostics of Protein S and Protein C Deficiency	Ole Halfdan Larsen	Received

1505-PB	GPX1 Pro198LEU Polymorphism as a Risk Factor for Venous Thromboembolism in Young Men from North-Western Russia	Zhanna Sidorova	Received

1506-PB	Genetic Association Study between Candidate SNPs and Brazilian Patients with Venous Thromboembolism (VTE)	Anna Virgínia Calazans Romano	Received

1507-PB	Absolute Quantification of Jak2 V617F in Patients with Splanchnic Venous Thrombosis by Droplet Digital PCR	Donatella Colaizzo	Received

1508-PB	Screening of Deletions in Protein S Deficient Families	Tereza Fenclova	Received

1511-PB	A Novel Splice Site Mutation Leading to AT Deficiency	Dana Provaznikova	Received

1512-PB	Gender Differences in the Incidence of Venous Thromboembolism Among Chronic Lung Diseases and Rheumatoid Arthritis in Korea	Won-Il Choi	Received

1513-PB	Application of Massive Parallel Sequencing Searching for Rare Genetic Variants of Protein C and S Associated with Thrombophilia - Implementation to Clinical Practice	Ludek Slavik	Received

1514-PB	Combined Protein C / Protein S Deficiency: Genotype-Phenotype Relationship in an Italian Family Carrying Two Novel Mutations	GIOVANNI FAVUZZI	Received

1515-PB	Impact of Factor V-Leiden, Prothrombin G20210A and MTHFR C677T Mutations on Egyptian Patients with Sickle Cell Disease	Abeer Saad	Received

1516-PB	Heightened Hypercoagulability in Sickle Cell Anemia Patients with Chronic Leg Ulcers	Edeghonghon Olayemi	Received

1518-PB	Apolipoprotein E Gene Polymorphisms: An Indian Study Showing Lateral Association with Thrombophilic Risk Factors in Patients with Deep Vein Thrombosis	PULKIT RASTOGI	Received

1521-PB	Risk Factors of Cerebral Venous Sinus Thrombosis - Single Center Experience	Adela Gwozdowska	Received

1523-PB	Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thromboembolism	Andrea Artoni	Received

1524-PB	Quantification of the Effect of NET-derived Cell-free DNA on Thrombosis and Haemostasis Phenotypes	Sonia Lopez	Received

1525-PB	Iron Deficiency Alters Red Blood Cell Adhesion and Arterial Thrombosis	Lalitha Nayak	Received

1526-PB	Complete Protein S Deficiency and Pregnancy Outcome in Murine Model	Raja Prince	Received

1527-PB	Thrombophilic Phenotype in a Neonate and Five Young Siblings of a Family with Homozygous Antithrombin Type 2 (Budapest III) Deficiency	Hans-Joerg Hertfelder	Received

1528-PB	Venous Thromboembolism in Women Using Hormonal Contraception and the Risk of Recurrence. Findings from a Single Center	ALEJANDRA LATORRE	Received

1529-PB	Thrombophilia Screening Practices in a Tertiary Care Hospital: An Assessment of Appropriateness and Financial Impact	Ninada Ganta	Received

1530-PB	Retrospective Analysis of the Size of Recurrent Pulmonary Embolus: Single Centre Study	Will Thomas	Received

1531-PB	Hyperaggregability of Platelets with Low Dose of ADP and Epinephrin in Patients with Venous Thrombosis: Preliminary Results from the RETROVE Project (Risk of Enfermedad TROmboembólica VEnosa)	Dolors Llobet	Received

1532-PB	The Association of D-dimer Level with Common Inherited and Acquired Risk Factors of Thrombosis	Anatoly Dobrovolsky	Received

1533-PB	Antithrombin p.Thr147Ala: Not Just Another SNP?	Kristin Jochmans	Received

1535-PB	Risk Factor Stratification for Venous Thromboembolim in Patients with Below Knee Injuries Treated with Immobilisation and the Future Role of Thromboprophylaxis	Daniel Mulligan	Received

1536-PB	Paroxysmal Nocturnal Hemoglobinuria (PNH) in Patients Presenting with Cerebral Vein and Sinus Thrombosis (CVST) - Results of Flow Cytometry Based Screening in Indian Patients	Jasmina Ahluwalia	Received

1537-PB	High Levels of VAMP 8 and Serotonin Transporter Suggest a Tendency of Thrombosis in Spanish Population. Preliminary Results from the RETROVE Project (Risk of Enfermedad TROmboembólica VEnosa)	Dolors llobet	Received

1538-PB	Genetic Heterogeneity of Protein C Deficiency in Hungary; Genotype-phenotype Correlations	Marianna Speker	Received

1539-PB	Elevated Plasma Factor IXa Activity in Women Using Hormonal Contraception	Pansakorn Tanratana	Received

1540-PB	Analysis of Factor V Leiden Paradox from a Large Monocentric Cohort Study: A Role for Distal Thrombosis?	Elena Campello	Received

1542-PB	Results of Thrombophilia Testing in Infertile Women and Women Experienced a Miscarriage	Sandra Margetic	Received

1544-PB	Screening of Thrombophilia in Latin America	Cecilia Guillermo	Received

1545-PB	First Do Not Harm: Questioning Ethics Aspects of Thrombophilia Law in Argentina	Beatriz Grand	Received

1546-PB	Extensive molecular characterization of a family with thrombophilia: implication of multiple genetic alterations of low thrombotic risk profile	Marina Carrasco Exposito	Received

1549-PB	Impact of the Molecular Study of the PROC, PROS1 and SERPINC1 Genes in Patients with Venous Thrombosis	Patricia Martinho	Received

1551-PB	Venous Thromboembolism (VTE) in Homozygous Carriers of Factor V Leiden Mutation Patients (FVL)	Bernadeta Ceglarek	Received

1552-PB	Characteristics and Outcomes of Patients with Cerebral Venous Sinus Thrombosis in Oman	khalid Alhashmi	Received

1553-PB	Anticoagulant Therapy in Disorders in the Fibrinolysis System among Patients with Primary Infertility	Igor Kurtov	Received

1554-PB	Pattern of Thrombophilia Testing in Patients with Venous Thromboembolism at a Tertiary Care Hospital	MANILA GADDH	Received

1556-PB	Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Patient with Decompensated/Uncontrolled Hypertension, Hyperhomocysteinemia, Hypercholesterolemia and Hyperlipidemia	Bernadeta Ceglarek	Received

1557-PB	Twice-daily Low-dose Aspirin Provides a More Consistent Platelet Inhibition in Patients with Essential Thrombocytosis	Mads Lamm Larsen	Received

1558-PB	Long-term Aspirin (ASA) Use Significantly Attenuates Platelet Interactions with von Willebrand Factor (VWF) in Acute Coronary Syndromes (ACS)	Dermot Kenny	Received

1559-PB	Patients with Coronary Artery Disease Have a Pathological P2Y12 Platelet Response with Heightened Procoagulant Platelet Potential	Leonardo Pasalic	Received

1560-PB	Platelet Inhibition with Ticagrelor Versus Clopidogrel in Patients with Peripheral Artery Disease: The EUCLID Platelet Substudy	Jeffrey Berger	Received

1561-PB	Antiplatelet Agents are the Key Drugs for the Prevention of Recurrent Arterial Thrombosis in Patients with Antiphospholipid Syndrome	Naoki Ohnishi	Received

1562-PB	Cyclic Nucleotide Modulators and P2Y12 Antagonists as Novel Anti-platelet Combination Therapy	Paul Armstrong	Received

1563-PB	Prasugrel vs. Ticagrelor after STEMI: Results from the Dsseldorf STEMI Registry	Carolin Helten	Received

1565-PB	Effect of Aspirin Therapy on Abacavir-associated Platelet Hyperreactivity in HIV-infected Patients: A Randomized, Double-blind, Placebo-controlled, Cross-over Study	Giuseppe Guglielmini	Received

1566-PB	Investigation of the Physiological Mechanisms Leading to the Release of BDNF by Platelets and their Susceptibility to Antiplatelet Agents	Marie Lordkipanidze	Received

1567-PB	Clopidogrel Efficiency in Cerebral Aneurysm Stenting: Are Biological Tests Useful?	nadine ajzenberg	Received

1568-PB	Comparison of Platelet Function Tests in a Trial of Different Aspirin Dose Regimens in Type 2 Diabetes	Paul Harrison	Received

1569-PB	The Offset of Ticagrelor Prior to Coronary Artery Bypass Graft (CABG) Surgery	Kok Weng Ow	Received

1570-PB	Nanoparticle Inhibition of Shear Induced Platelet Aggregation	David Ku	Received

1571-PB	Plasma Fibrinogen Level is an Important Determinant of Platelet Reactivity in the VerifyNow Assay	Dobrovolsky Anatoly	Received

1573-PB	Assessment of Low Platelet Reactivity (LPR) with Multiple Electrode Impedance Aggregometry (MEA) and Risk of Bleeding in Patients Receiving P2Y12 Receptor Inhibitors	DOBRINKA DINEVA	Received

1574-PB	Concomitant Use of Antiplatelet and Direct Oral Anticogulants Increase but Not Significantly the Bleeding Risk in Patients with Atrial Fibrilation	Juan Jose Cerezo	Received

1576-PB	Combined Effect of CYP2C19 G681A Polymorphism and Plateletcrit on Clopidogrel Low-responsiveness in Thai Patients with Acute Coronary Syndrome	Sornsith Jirungda	Received

1578-PB	Platelet (plt) reactivity in patients with essential thrombocythemia (ET) receiving antiplatelets therapy with aspirin (ASA)	Sara Gamba	Received

1579-PB	The Influence of Prostaglandin E1 on the Correlation between the Multiple Electrode Aggregometry ADP and the VerifyNow P2Y12 Test in Patients Using P2Y12 Inhibitors	Paul Verhezen	Received

1580-PB	Could Aspirin Play a Role in Diminishing ADP Induced Platelet Aggregation in Clopidogrel Nave Patients?	Theodora Kostelidou	Received

1581-PB	Obesity Is Associated with Reduced Platelets SERCA3 Isoform Expression and Subsequent Platelet Inhibition, Reversible after Weight Loss	Alain STEPANIAN	Received

1582-PB	Patterns and Levels of Platelet Glycosylation in Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus	Chenxue Qu	Received

1583-PB	Hemostatic Abnormalities in Patients with Ehlers-Danlos Syndrome	Maria Abbattista	Received

1586-PB	Chronic Immune Thrombocytopenic Purpura (ITP) in Egyptian Children: A 10 Year Single Center Retrospective Study	Magy Abdelwahab	Received

1587-PB	Acute Episodes of Atrial Fibrillation Cause Altered Platelet Function and Procoagulant Microparticle Consumption	Line Pourtau	Received

1588-PB	Impaired Platelet Responsiveness in Thrombocytopenic Cancer Patients after Chemotherapy as a Consequence of Mitochondrial Dysfunction	Constance Baaten	Received

1590-PB	Thrombocytopenia and Altered Coagulation as Independent Predictors of the Etiology of Tropical Jaundice in Adults Presenting to Emergency in a Tertiary Care Hospital in North India	ashish bhalla	Received

1591-PB	Plasma microRNAs Characterizing patients with Immune Thrombocytopenia	Bin Zuo	Received

1592-PB	Evaluation of in vitro Effects of Tyrosine-kinase Inhibitors on Primary Haemostasis	Falk Eckart	Received

1594-PB	Further Characterization of Platelets Bearing Mutations in Calreticulin or JAK2 Genes in Essential Thrombocythemia Patients	Hagit Hauschner	Received

1595-PB	Clinical Evaluation of the Revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-Thrombosis) in a Cohort of 746 Chinese Adult Patients	Rongfeng Fu	Received

1596-PB	Variations of Mean Platelet Volume with Time Since Blood Sampling in Different Anticoagulants	gian marco podda	Received

1597-PB	Cytosolic Calcium Concentrations in Platelets from Patients with Pulmonary Embolism and Implications for Therapy	Jonathan Pike	Received

1598-PB	Probable Risks and Benefits of Second Line Therapy Splenctomy versus TPO Mimetics in Chronic Idiopathic Thrombocytopenic Purpura an Experience of a Third World Country, Pakistan	Tanzeel Imran	Received

1599-PB	Sonoclot Signature Analysis In Thrombocytopenic Patients	kundan mishra	Received

1600-PB	High Incidence of Platelet Dysfunction is unmasked in Newly-diagnosed Multiple Myeloma	Theera Ruchutrakool	Received

1601-PB	Effects of Time and Different Anticoagulants on Platelet Count in Blood Donors and in Thrombocytopenic Patients	gian marco podda	Received

1602-PB	In vitro Ibrutinib Effect on Platelets Function. A Single Centre Study	Sofia Gkotsi	Received

1603-PB	The Platelet Function Analyzed by Flow Cytometry in Psoriatic Patients on Reference Therapy	Tatiana Vavilova	Received

1607-PB	Protein Disulfide Isomerase Is Regulated by S-nitrosylation: Implications for Vascular Quiescence and Thrombus Formation	Roelof Bekendam	Received

1608-PB	Ultra-sensitive Molecular Magnetic Resonance Imaging of Blood Cells - Endothelium Interactions In vivo	Maxime Gauberti	Received

1609-PB	Contribution of the P2X1 Receptor Expressed by Lung Macrophages to Experimental TRALI	Marie-Belle EL MDAWAR	Received

1610-PB	The Role of von Willebrand Factor in Experimental Malaria-associated Acute Respiratory Distress Syndrome	Sirima Kraisin	Received

1611-PB	Blood platelets bind A&946; peptides vie Integrin &945;IIb&946;3 and induce amyloid-&946; aggregation in cerebral vessels	Lili Donner	Received

1612-PB	Platelet Extracellular Vesicles Induce a Proinflammatory Smooth Muscle Cell Phenotype	Tanja Vajen	Received

1613-PB	Conditional Knockout of Heme Oxygenase-1 in Lysozyme M Positive Cells Attenuates Angiotensin II Induced Vascular Inflammation	Jérémy Lagrange	Received

1614-PB	Defective Fibrin Accumulation and Thrombus Stability in Endothelial Cell-specific BAMBI Knockout-mice	Isabelle I. Salles-Crawley	Received

1615-PB	FXI Inhibition Protects from Vascular Inflammation and Endothelial Dysfunction in Arterial Hypertension	Sabine Kossmann	Received

1616-PB	Function of an Endothelial-specific GPCR in Thrombosis	Leonardo Gottlob	Received

1617-PB	Factor VII Activating Protease (FSAP) Regulates the Expression of Inflammatory Genes through Protease Activated Receptor (PAR1) in Vascular Smooth Muscle and Endothelial Cells	Kristina Byskov	Received

1618-PB	Regulation of Platelet String Formation on Endothelial Cells in the Presence of Coagulation under Shear	Toshiaki Shirai	Received

1620-PB	A2 Domain of von Willebrand Factor (VWF) Mediates Human Vascular Smooth Muscle Cells (VSMCs) Proliferation and Migration	Morel E. Worou	Received

1621-PB	Dietary Alpha-linolenic Acid Reduces Platelet Activation and ex vivo Thrombus Formation in Sickle Cell Disease Mice	Simona Stivala	Received

1622-PB	Podoplanin Overexpression on Endothelial Cells Promotes Superficial Erosive Injury and Thrombus Formation in Rat Carotid Artery	Eiji Furukoji	Received

1623-PB	Evaluation a Novel Mouse Model of Abdominal Aortic Aneurysm to Study Platelet Mechanisms of the Proinflammatory Thrombus	YACINE BOULAFTALI	Received

1624-PB	Increased Inflammatory Properties of Neutrophils and Endothelial Cells (ECs) in Patients with Venous Thromboembolism (VTE), Long after the Acute Disease	Kiara Cristina Senger Zapponi	Received

1626-PB	Effects of Aspirin and Rivaroxaban on Murine Arterial Vessel Wall Remodelling after Vascular Injury	Tom Mastenbroek	Received

1627-PB	Plasminogen Activator Inhibitor Type 1 in Platelets Evokes Thrombogenicity and Increases Thrombus Size by Elevating Thrombolysis Resistance under Shear Stress	Tetsumei Urano	Received

1628-PB	Tissue Engineered Small Vessel Conduits - The Anti-thrombotic Effect of Re-endothelialisation of Decellularised Baboon Arteries	Leana Laker	Received

1630-PB	Protein Kinase C-Dependent Loss of Tissue Factor by Human Pericytes Results from Altered Synthesis, Trafficking and Degradation	Maureane Hoffman	Received

1633-PB	Endothelial Dysfunction in Idiopathic Thromboembolism Investigated through Gene Expression Profiling of Endothelial Colony Forming Cells	Corrado Lodigiani	Received

1634-PB	Role of Lysozyme M Cells in the Development of Angiotensin II-induced Vascular Inflammation	Jeremy Lagrange	Received

1638-PB	Platelet a-granule Deficiency Protects Local and Distal Organs in Intestinal Ischemia Reperfusion Injury	Katrina Ashworth	Received

1640-PB	Development of a Novel Strategy to Target CD39 Antithrombotic Activity to the Endothelial-platelet Microenvironment in Kidney Ischemia-reperfusion Injury	Harshal Nandurkar	Received

1642-PB	Inhibition of Coagulation Factor Xa Attenuates Myocardial Ischemia Reperfusion Injury in Mice	Jens Posma	Received

1644-PB	Contribution of Neutrophil Extracellular Trap (NET) Components to the Structure of Thrombi from Therapeutic Intervention in Ischemic Coronary, Peripheral and Cerebral Artery Disease	Ádám Zoltán Farkas	Received

1645-PB	A Novel Easy-to-Perform Thromboembolic Stroke Model in Mice: Application to the Study of the Thrombolytic Effect of N-acetylcysteine	Maxime Gauberti	Received

1646-PB	Human Platelet Alloantigens and P-Selectin Gene Polymorphisms in Pediatric Arterial Ischemic Stroke	Renata Zadro	Received

1648-PB	Incidence Rates and Case Fatality Rates of Cerebral Vein Thrombosis: A Population-based Study	Dentali Francesco	Received

1649-PB	Biomarkers for the Symptomatic Carotid Atheroma	Maria Jesus Iglesias Mareque	Received

1650-PB	Neutrophil Extracellular Traps (NETs) in Patients with Acute Stroke Are Associated with Stroke Severity and Progression	Antonio Moscardó	Received

1651-PB	Case-fatality after Venous Thromboembolism and Ischemic Stroke in Subjects without and with Atrial Fibrillation. The Troms Study	Erin Mathiesen Hald	Received

1654-PB	Thrombi Retrieved from Patients Suffering Acute Ischemic Stroke Show both Active and Mechanical Interaction between Stent Retrievers and Thrombus, and is Associated with Specific Thrombus Surface Characteristics	Heleen van Beusekom	Received

1655-PB	The Effect of Recanalization on Long-term Neurologic Outcome after Cerebral Vein Thrombosis	Francesco Dentali	Received

1656-PB	Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation	Benot Ho-Tin-Noé	Received

1658-PB	Effects of Phosphodiesterase 3A Modulation on Murine Cerebral Microhemorrhages	Mark Fisher	Received

1660-PB	Long-term Stroke Risk Prediction in Real World Atrial Fibrillation Patients: A Comparison of the ABC-stroke and CHA2DS2-VASc Scores	José Miguel Rivera-Caravaca	Received

1661-PB	Time-restricted Feeding Disturbs Circadian Expression of Thrombomodulin in the Mouse through Peripheral Clock Molecules	Shuichi horie	Received

1662-PB	Reduced ADAMTS13 Levels in Patients with Acute and Chronic Cerebrovascular Disease	Frederik Denorme	Received

1664-PB	Evaluation of the Thrombolytic Potential of N-Acetyl Cysteine in a Mouse Model of Thrombotic Stroke	Frederik Denorme	Received

1665-PB	Is There a Difference in Inherited Prothrombotic Polymorphisms between Arterial Ischemic Stroke and Cerebral Sinus Venous Thrombosis in Children?	Renata Zadro	Received

1666-PB	Alpha-2-antiplasmin Arg407Lys Polymorphism and Cryptogenic Ischemic Cerebrovascular Events: Association with Neurological Deficit	Ewa Wypasek	Received

1669-PB	Early Plasma Fibrinogen Level after Thrombolytic Therapy in Acute Ischemic Stroke Patients Cannot Predict Intracranial Hemorrhage	Theera Ruchutrakool	Received

1670-PB	Prediction of Venous Thromboembolism and Ischemic Stroke by Modified CHA2DS2-VASc Score in Patients with Atrial Fibrillation. The Troms Study	Erin Mathiesen Hald	Received

1671-PB	Safety of Aspirin for Secondary Stroke Prevention: POoled Data Reanalysis of Aspirin for CErebraL InfArction PreventIoN : PORCELAIN Study	Takehiko Nagao	Received

1672-PB	Abnormal Red Cell Indices and the Risk of Arterial Ischemic Stroke in Children	Nongnuch Sirachainan	Received

1673-PB	Remote Platelet Function Testing Using Platelet-bound P-in as a Marker of Platelet Activation. Findings in Patients with Stroke or TIA Treated with Clopidogrel	Stan Heptinstall	Received

1674-PB	Mechanical Endovascular Therapy Plus Intravenous Tissue Plasminogen Activator versus Intravenous Tissue Plasminogen Activator Alone for the Management of Acute Ischemic Stroke: An Adjusted Indirect Treatment Comparison Meta-analysis	Jonathan Caranfa	Received

1676-PB	Unhelpful Use of Hereditary Thrombophilia Tests in Young Patients with Ischemic Stroke. Final Results of the AISYFs Trial	José Manuel Ceresetto	Received

1679-PB	Incidence and Outcome of Childhood Stroke in Thailand	Patcharee Komvilaisak	Received

1681-PB	Another Indication to DOACs	Attilia Maria Pizzini	Received

1682-PB	Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI	Ingrid Stroo	Received

1683-PB	Acute Lowering of Factor XII Induces Accelerated Spontaneous Venous Thrombosis in Mice: New Evidence for the Contact System that Idles?	Marco Heestermans	Received

1684-PB	A Two-step Mechanism for Factor XII Activation in Solution	Steven de Maat	Received

1686-PB	Endothelial Cell Serpins, Including PAI-1, Form a Complex with Fxia Blocking its Activity and Inducing the Clearance, Internalization and Degradation of FXIa	Cristina Puy	Received

1687-PB	Characterization of Polyphosphate in Endothelial Cells under Cellular Stress	Rachel Rigg	Received

1688-PB	Identification of F11 Gene Variations Involved in the Interindividual Variability of Factor XI in Subjects with Congenital Deficiency Caused by Recurrent Mutations	Salam Salloum-Asfar	Received

1692-PB	Activation of The Contact Pathway by Red Blood Cell and Platelet Microvesicles	Denis Noubouossie	Received

1693-PB	Contaminating Silica Particles Contribute Substantially to the Procoagulant Activity of DNA Isolated Using Commercial Kits	Stephanie Smith	Received

1696-PB	Contribution of Intrinsic Coagulation Factors in ex vivo Thrombus Formation and Lysis	José Govers-Riemslag	Received

1698-PB	Haemocompatibility Properties of Polyethersulfone Based Haemodialysis Membrane with Different Amounts of Polyurethane	Fatmawati Kamal	Received

1699-PB	Comparison of Nine Different Blood Collection Tubes for Contact Activation of Coagulation	Cornelis Kluft	Received

1701-PB	Short-term Increase in Factor (F)XIa-dependent Procoagulant Activity in Citrate Blood	Shannon Prior	Received

1704-PB	Mechanism of Growth and Inhibition of Plasma Clots Growing from a Surface with Immobilised Tissue Factor	Cornelis Kluft	Received

1705-PB	Co-operative Binding of VWF to the TSP8 and CUB Domains of ADAMTS13 is Required for its Conformational Activation	kieron south	Received

1706-PB	a-Synuclein Binds to Human a-Thrombin and Inhibits Thrombin-mediated Platelet Aggregation: Possible Implications in Parkinsons Disease	Daniele Peterle	Received

1707-PB	The Effect of Short Chained Polyphosphates on Coagulation Activation in a Whole Blood Model	Ina Hiland	Received

1709-PB	Evidence for Direct and Indirect Modulation of Haemostatic Factors by miR-494	Jasmine Tay	Received

1710-PB	Situation-adjusted Anticoagulant Release System with Response to Different Coagulation Factors	Manfred Maitz	Received

1711-PB	Liver Hypoxia Regulates Protein S Levels in Obese Patients	Vijaya Pilli	Received

1712-PB	Thrombin is a Selective Inducer of Heparanase Release from Platelets and Granulocytes via Protease-activated Receptor-1	Yona Nadir	Received

1714-PB	Fibrinogen Polymorphisms Predict Fibrinogen and Clot-related Phenotypes Independently and through Interactions with IL-6	Héléne Toinét Cronjé	Received

1717-PB	Characterization of GGCX Mutations Identified in the First Clinical Case of a VKCFD Patient	Da-Yun Jin	Received

1718-PB	Comprehensive Identification of miRNA-gene Interactions Reveals Extensive Regulation of the Plasmatic Coagulation Network	Jamie Nourse	Received

1719-PB	Resolving the Roles of Platelets and (Anti)Coagulation Pathways in Whole-blood Fibrin Formation under Flow to Phenotype Hemostatic Disorders	Johanna van Geffen	Received

1721-PB	Thrombin Generation in Schizophrenia Patients Treated with Antipsychotic Medications	Karl Egan	Received

1723-PB	Tissue Factor-dependent Heme-induced Whole Blood Coagulation Activation: A Thromboelastometry Study	Bidossessi Wilfried Hounkpe	Received

1724-PB	Salivary EV: A New Link between Primary and Secondary Hemostasis	Yuanjie Yu	Received

1726-PB	Heparan Sulfate Chains Contribute to an Anticoagulant Milieu in Malignant Pleural Effusion	Yona Nadir	Received

1728-PB	Procoagulant Properties of Microparticles Produced by Monocytes, Granulocytes, Platelets and Endothelial Cells	Alexey Mazurov	Received

1729-PB	Ventricular Assist Devices without Anticoagulation: An Impossible Dream?	Phillip Coghill	Received

1731-PB	The Modification of Thrombin Generation Assay Parameters in Patients with Recurrent Pregnancy Loss	Héla Baccouche	Received

1736-PB	A Polydeoxynucleotide Derived Drug Defibrotide Inhibits Nucleosome Generation in Whole Blood. Implications in the Management of VOD	Jawed Fareed	Received

1742-PB	FXIII and EACA Increase Thrombus Stability and Decrease Pulmonary Embolism in an in vivo Mouse Model of Venous Thromboembolism, but EACA Increases Thrombus Size	Shana Shaya	Received

1744-PB	Fibrin-derived B15-42 Peptide Is a Gatekeeper of Thrombus Resolution	Stela Chausheva	Received

1745-PB	Theoretical Model for Thrombin-FXIII-A2 Complex and the Effect of Ca2 Ions on the Dynamic Behavior of FXIII-A2	Gábor Balogh	Received

1747-PB	Platelet and Plasma Factor XIII Levels after Replacement Therapy in Severe Congenital Factor XIII Deficiency: Is there a Role for Factor XIII Uptake by Megakaryocytes?	Claudia Radu	Received

1749-PB	Genetic and Clinical Epidemiology of Congenital Fibrinogen Disorders	Alessandro Casini	Received

1752-PB	Congenital FXIII Deficiency in Pakistan: An Update	Munira Borhany	Received

1754-PB	Factor XIII in Tears and its Possible Role in Corneal Wound Healing	Zsuzsanna Z. Orosz	Received

1755-PB	A Role for Factor XIII in Clot Formation and Clot Contraction of Whole Blood	Tom Plug	Received

1756-PB	Structural and Phylogenetic Analysis of Coagulation Factor XIII Explains its Uniqueness in the Transglutaminase Family	Arijit Biswas	Received

1757-PB	In silico Analysis of Extended Promoter Regions of F13A1 and F13B Genes Indicates Putative Sites Might Underlie Regulatory Variation in Factor XIII Levels	Muhammad Ahmer Jamil	Received

1758-PB	Fibrinogen Caracas IX a Novel Fibrinogen Mutation: FGA g. 3057 CT (p. 104 ArgCys) Impair Fibrinogen Secretion	Rita Marchi	Received

1760-PB	Evidence for the Presence of Cross-beta Structures in Fibrin Clots	Dick C. Rijken	Received

1763-PB	Cellular Factor XIII in Human Cornea	László Muszbek	Received

1764-PB	Fibrin-associated ROTEM variables and thrombin generation in patients with congenital fibrinogen defects	Timea Szanto	Received

1765-PB	Studies to Determine Novel Interacting Partners and Functional Roles for Factor XIII B Subunit	Sneha Singh	Received

1766-PB	The Effect of Factor XIII Levels and Factor XIII B Subunit Polymorphisms on the Risk of Venous Thromboembolism	Zoltán A Mezei	Received

1768-PB	Galactosemia Presenting with Afibrinogenemia	Inci Yaman Bajin	Received

1769-PB	Plasma Tromboelastometry (ROTEM) Could be a Complement in Study Fibrinogen Disorders	Alicia Beatriz Vilaseca	Received

1770-PB	A Fibrinogen Activity Method on Photo-optical Coagulation Analyzers without Interference from Hydroxyethyl Starch	Zhenghua Cao	Received

1771-PB	Construct and Known Group Validity of Patient-reported Outcome (PRO) Instruments in US Adults and Caregivers of Children with Hemophilia B: Results from the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) Study	Tyler Buckner	Received

1775-PB	Comparing the One-stage and Chromogenic Assay: Factor VIII Activity Assay Discrepancy at Baseline Does Not Reflect Assay Discrepancy after DDAVP in Non-severe Hemophilia A	Lisette M Schtte	Received

1776-PB	Risk Differential in Inhibitor Development in the First Days of Treatment by Product Class: A SIPPET Analysis	Roberta Palla	Received

1777-PB	Pocket Handheld Ultrasound Has High Accuracy in Identification of Effusions and Major Landmarks in Normal and Hemophilic Joints: Expanding Point of Care for Patients with Hemophilia with Joint Disease	Lena Volland	Received

1778-PB	Influence of Family History on Mode of Delivery in Severe Haemophilia in the UK	elizabeth chalmers	Received

1781-PB	Individualizing Hemophilia Prophylaxis using Thromboelastography (TEG)	Guy Young	Received

1782-PB	Impact of a Product-Specific Reference Standard for the Measurement of a PEGylated rFVIII Activity: The Swiss Multicentre Field Study	Pierre Fontana	Received

1783-PB	Long-term Quality-of-Life Outcomes with rFVIIIFc Prophylaxis in Adult Subjects with Severe Hemophilia A	Jun Su	Received

1784-PB	Bleeding Events and Safety Outcomes in Persons with Hemophilia A (PwHA) with Inhibitors: The First Large, Prospective, Multicenter, Non-interventional Study (NIS) from a Real World Setting	Daniella Babu	Received

1785-PB	Disparities in Age at Diagnosis and Initial Treatment between People with Moderate and Severe Haemophilia A: Evidence from the KAPPA Register	Mehdi Osooli	Received

1788-PB	Intracranial Hemorrhage in Hemophilia Patients: The Status of Ongoing Retrospective-Prospective Italian Registry (2009-2016)	Ezio Zanon	Received

1790-PB	Comparison of the Relationship between Factor IX Activity and Bleeding Risk during Prophylaxis with Nonacog Beta Pegol (N9-GP)	Guy Young	Received

1792-PB	Chronic Liver Disease in People with Hemophilia Aged 40 Years and Older	Christian Qvigstad	Received

1793-PB	Once Weekly rfIX Prophylaxis for Severe-Phenotype Haemophilia B in Normal Clinical Practice: Data from UKHCDO and Finland	Martin Scott	Received

1795-PB	Application of Pharmacokinetic-tailored Approach to Prophylaxis in Routine Hemophilia Care	Stacy E Croteau	Received

1796-PB	Prevalence of Cerebral Microbleeds and Macrobleeds in Neurologically Asymptomatic Patients of Congenital Hemophilia	Pankaj Malhotra	Received

1798-PB	Evaluation of the Impact of Polymorphism/Mutations in Genes Associated to Hemostasis in Clinical Diversity in Patients with Severe Hemophilia	Daniel Chaves	Received

1799-PB	The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort	Antonino Cannavò	Received

1801-PB	Evaluate the Situation Diagnosis and Treatment of Hemophilia in Vietnam in 2015	Mai Nguyen Thi	Received

1803-PB	Development of the Education Interventions to Enhance Adherence to Prophylactic Treatment in Korean Hemophilia Patients	Eun Jin Choi	Received

1804-PB	Immune Tolerance Induction in Patients with Haemophilia using Fc Fusion Recombinant Factor VIII	Azusa Nagao	Received

1805-PB	Spectrum and Origin of Mutations in Sporadic Cases of Haemophilia A in China	yeling lu	Received

1806-PB	The Utility of Activated Partial Thromboplastin Time Clot Wave Form Analysis in the Investigation of Hemophilia A Patients Using Destiny Max TM Analyzer	Ancy Abraham	Received

1807-PB	Pharmacokinetics of Octocog a in Severe Hemophilia A Boys Aged Less than Six Years on Routine Prophylaxis	Tomasz Urasinski	Received

1808-PB	The World Bleeding Disorders Registry: The Pilot Study	Christine Herr	Received

1809-PB	Data from the Austrian Haemophilia Registry: An Update	Judit Rejt	Received

1810-PB	Application of the Pattern and Parameters of the aPTT Clot Reaction Curve in Patients with Hemophilia A and Acquired HA	Rodolfo Emanuel Sueldo	Received

1812-PB	Personalized Treatment in Hemophilic Patients in Argentina	Rodolfo Emanuel Sueldo	Received

1813-PB	Global Hemostatic Assay at Different Target Procoagulant Activity of Factor VIII and Factor IX	Ki-young Yoo	Received

1814-PB	The Impact of Secondary and Tertiary Prophylaxis in the Reduction of Bleeding Events in Moderate or Severe Hemophilia A or B	Karla Bayer Mendonca	Received

1815-PB	New Methods of Physiotherapy in Patients with Advanced Haemophilic Arthropathy	Krystyna Zawilska	Received

1819-PB	Is Intermediar Intensity Prophylaxis with Factor VIII Sufficient for Improvement of Overall Hemostasis Potential in Hemophilia A Patients?	Irena Djunic	Received

1820-PB	Can Tertiary Prophylaxis Bring about Zero Bleed in Adult Persons with Hemophilia? A Single Center Observation Study in Japan	Teruhisa Fujii	Received

1823-PB	Two Effective Cases of Immune Tolerance Induction Using Turoctocog Alfa Combined with Immunosuppressive Therapy in Non-severe Hemophilia A	Chikasawa Yushi	Received

1824-PB	Tailored Prophylaxis: A Bridge between QoL and Retrenchment. Our Experience with Simoctocog Alfa	Jacopo Agnelli Giacchello	Received

1825-PB	Therapeutic Efficacy of Low-dose Immune Tolerance Inductionin 5 Chinese Severe Hemophilia A Children with Inhibitor in Good Risk	Zhenping Chen	Received

1826-PB	Efficiency of Prophylaxis in an Adult with Hemophilia after Dose Adjustment Using a Bayesian Model FVIII Pharmacokinetics Estimation	MARIANA CANARO HIRNYK	Received

1828-PB	Personalized Approach to Treatment due to Pharmacokinetic Study: Description of One Case of Moderate Haemophilia A with Severe Bleeding Phenotype after Switch to Simoctocog Alfa	Chiara Ambaglio	Received

1829-PB	Haemophilia and Acute Coronary Syndrome (ACS)	Attilia Maria Pizzini	Received

1830-PB	The Diagnostic Value of Rotational Thromboelastometry in Patients with Non-severe Hemophilia A	Minoo Ahmadinejad	Received

1832-PB	Hemophilia Care in Pakistan	Munira Borhany	Received

1833-PB	Risk Management of Pelvic Pseudotumor in a Patient with Inhibitors and Severe Hemophilia	Ricardo Silva	Received

1834-PB	A Study of Home Therapy in Hemophilia Patients	Kim Mikyung	Received

1835-PB	Are we Close to International Standards for Hemophilia Care in Tunisia?	Gouider emna	Received

1837-PB	Screening for heart failure with natriuretic peptides in patients with atrial fibrillation	Sander van Doorn	Received

1838-PB	Direct Oral Anticoagulants (DOAC) vs Low Molecular Weight Heparin (LMWH) as Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation (NVAF) and Concomitant Active Cancer	Anna Varela-Magallon	Received

1839-PB	Thrombin Generation and International Normalized Ratio in Patients with Atrial Fibrillation Using Rivaroxaban or Warfarin	Fernanda Freire	Received

1840-PB	Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation	Michela Giustozzi	Received

1841-PB	Global Public Awareness about Atrial Fibrillation	Aaron Wendelboe	Received

1842-PB	VKA Treatment and Bleeding Rate of Patients Aged Older than 90 Years: Results from a Prospective Multicentre START Register Study	Emilia Antonucci	Received

1843-PB	Predictive performance of the CHA2DS2-VASc rule in atrial fibrillation: A systematic review and meta-analysis	Sander van Doorn	Received

1845-PB	Optimisation of Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation Using a Virtual Clinic Model	Alison Brown	Received

1846-PB	Evaluation of Antithrombotic Management in Patients with Atrial Fibrillation at a Tertiary Care Academic Medical Center	Snehal Bhatt	Received

1847-PB	Recent Years Trends in Real-life Antithrombotic Therapy for In- and Out-patients with Atrial Fibrillation in Moscow	Alexander Melekhov	Received

1848-PB	Should we Abandon the APTT for Monitoring the Anticoagulant Effect of Unfractionated Heparin?	Deepa Jayakody Arachchillage	Received

1849-PB	Evaluation of the 4T Score and Rapid Anti PF4/Heparin Antibodies Detection for Heparin Induced Trombocytopenia (HIT) Diagnosis in Clinical Practice. A Multicenter Study	Maximiliano Villagra Iturre	Received

1850-PB	Risk of Thromboembolic Disease in Renal Transplant Patients	Veronica Privitera	Received

1852-PB	In ECMO Patients Anticoagulated with Heparin the Dose-response Relationship Disappears when the Dose is Adjusted by ACT but it is Preserved with Anti-Xa Activity	Felipe Guerrero	Received

1854-PB	A Post Hoc Analysis of Dalteparin versus Vitamin K Antagonist for the Treatment of Cancer-associated Venous Thromboembolism in High-risk Patients with Metastatic Disease and Recent Antineoplastic Treatment	Seth Woodruff	Received

1855-PB	Tinzaparin for the Treatment of Superficial Vein Thrombosis of the Lower Limbs	KONSTANTINOS NIKOLAKOPOULOS	Received

1856-PB	Structural and Haemostatic Features of Pharmaceutical Heparins from Different Animal Sources: Challenges to Define Thresholds Separating Distinct Drugs	Mariana Sá Pereira	Received

1857-PB	The Effect of Prolongation of Initial Enoxaparin Therapy to One Month on the Risk of VTE Recurrences and the Recanalization of Deep Veins	Natalya Vorobyeva	Received

1858-PB	Validation of the Pulmonary Embolism Severity Index (PESI) and Simplified PESI in Asian Patients with Acute Pulmonary Embolism	Wei Ying Jen	Received

1859-PB	Help the Aged? Are we Failing to Protect Patients with Dementia from the Risks of Developing Hospital Associated Venous Thrombo-Embolism?	Andrew McSorley	Received

1860-PB	The Efficacy and Safety of Anticoagulations in Cerebral Vein Thrombosis: A Systematic Review and Meta-analysis	Bader Al Rawahi	Received

1861-PB	Study of Bioaccumulation of Tinzaparin in Renally Impaired Patients when Given at Prophylactic Dose: The STRIP Study	denis projean	Received

1862-PB	Thromboembolic Events Following Splenectomy: Risk Factors, Prevention, Management and Outcomes	Yosef Kalish	Received

1863-PB	Inhibition of thrombin generation distinguishes low and high responders to unfractionated heparin	Lisa van der Vorm	Received

1864-PB	Should Anticoagulation Therapy for Cancer Associated Pulmonary Embolism (PE) Be Modified in Individuals with Brain Metastasis or Thrombocytopenia?	Kate Musgrave	Received

1865-PB	Comparison of the Injection Site Reactions Elicited by Two Subcutaneously Injected Heparins, Nadroparin Calcium and Enoxaparin Sodium	Jacob van Tonder	Received

1866-PB	The Incidence of Adverse Events in Patients Treated with Therapeutic Dose Enoxaparin in Relation to Body Mass Index	Riyadh Mustafa Murtadha Al-Shehristani	Received

1867-PB	Management of Venous Thromboembolism in Patients with Glioma	Mosaad Almegren	Received

1868-PB	Resistance of Liquid Anti-Xa Assay (IL) to Platelet Factor 4 Interference	Jagadeesh Gabbeta	Received

1869-PB	A Matched Case-control Study to Determine Early Post-operative Haematological Complications after Renal Transplantation in Chronic Renal Failure Patients Receiving Therapeutic Anticoagulation	EMILY MEEKS	Received

1870-PB	Factors Associated with Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy	Yosef Kalish	Received

1871-PB	Clinical Course of Patients Presenting with Acute Superficial Vein Thrombosis: A Post-hoc Analysis of the ICARO Study on 488 Patients	Dentali Francesco	Received

1872-PB	The Assessment of Safe Prescribing and Cost-effectiveness of Low Molecular Weight Heparin Treatment	Jagjot Kaur Chahal	Received

1875-PB	Efficacy and Safety of Pharmacological Thromboprophylactic Agents for the Prevention of Venous Thromboembolism after Major Abdominal Surgery: A Systematic Review and Meta-Analysis	Bader Al Rawahi	Received

1876-PB	Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications	Debra Hoppensteadt	Received

1877-PB	Nuts and Bolts of Running a Pulmonary Embolism Response Team: Results from an Organizational Survey of the National PERT? Consortium Members	Geoffrey Barnes	Received

1878-PB	Long Term Anticoagulant Treatment Management in Patients with Portal Vein Thrombosis at High Bleeding Risk	mariasanta napolitano	Received

1880-PB	Establishing the Heparin Therapeutic Range Using aPTT and Anti-Xa Measurements for Monitoring Unfractionated Heparin Therapy	Anila Rashid	Received

1881-PB	Patients Are More Adherent to Treatment with LMWH Nadroparin than Enoxaparin for Cancer Related Venous Thromboembolism	Sake van der Wall	Received

1882-PB	Prevalence of FOXD1 Mutations in Primigravidae with Pregnancy Loss	Jean-Christophe GRIS	Received

1883-PB	Prothrombin Fragment F12 (F1F2) in Pregnancy Is Associated with a History of Venous Thromboembolism (VTE) and Thrombophilia	Rainer B. Zotz	Received

1885-PB	Incidence and Risk Factors of Pregnancy-associated Venous Thromboembolism in Singhealth, a Major Healthcare Cluster in Singapore	Sandra Lynn Jaya-Bodestyne	Received

1886-PB	The Features of Pregnancy Management in Paroxysmal Nocturnal Hemoglobinuria	Maria Vinogradova	Received

1887-PB	High Levels of Complement C3 Increases the Risk for Postnatal Venous Thrombosis	Anders Erik Astrup Dahm	Received

1888-PB	Risk of Venous Thromboembolism in Unsuccessful ART Cycles: An Italian Cohort Study	Michela Villani	Received

1889-PB	M2 Haplotype in Annexin A5 Gene and Antiphospholipid Antibodies: Possible Relationship and Clinical Impact in a General Obstetric Population	Michela Villani	Received

1891-PB	Effect of Blood Loss during Caesarean Section on Coagulation	Svetlana Tchaikovski	Received

1892-PB	Assessment of Peripartum Management in a Population at High Risk for Venous Thromboembolism	Heiko Ruehl	Received

1893-PB	Role of ADAMTS-13 Activity and Inhibitor Monitoring during Pregnancy in Women with History of Severe Preeclampsia	Alexander Makatsariya	Received

1894-PB	Assessment of Annexin A5 and Annexin A2 Levels as Biomarkers for Pre-eclampsia: A Pilot Study	Maha Othman	Received

1895-PB	Attenuated Thrombin Generation and Enhanced Fibrinolytic Activity in Early Onset Preeclampsia	Karl Egan	Received

1896-PB	Management of Venous Thromboembolism in Women during Pregnancy and Puerperium (SAVE): A cross-sectional registry in Africa, Eurasia, Middle East and South Asia	Jean-Christophe GRIS	Received

1897-PB	Genetic Variants Associated with Thrombophilia and Gestational Complications in an Argentinian Cohort	Gabriela de Larrañaga	Received

1898-PB	Risk Factors for Venous Thromboembolism and Pregnancy Outcomes in Women with Pelvic Vein Thrombosis during Pregnancy - A Retrospective Study from a Stockholm Cohort, Ranging from 2000 to 2014	Roza Chaireti	Received

1899-PB	Maternal Carriage of the Annexin A5 M2 Haplotype is Associated with a Higher Risk of Suffering from Gestational Vascular Complications	Federico Aranda	Received

1900-PB	Pregnancy-associated Hemolytic Uremic Syndrome as a Cause of Maternal Mortality	Maria Vinogradova	Received

1903-PB	Women with Homozygous AT Deficiency Type II Heparin Binding Site (HBS) Are at High Risk of Pregnancy Loss and Pregnancy Complications	Julia Kraft	Received

1906-PB	Venous Thromboembolism in Women Undergoing Assisted Reproduction: Data from RIETE	Elvira Grandone	Received

1907-PB	Outcomes of Threatened Abortions Following Anticoagulation Treatment to Prevent Recurrent Pregnancy Loss	Yosef Kalish	Received

1908-PB	OTTILIA and FIRST: Preliminary Data from Two Ongoing International Registries on Foeto-maternal Prognosis in Women with Recurrent Reproductive Failures after Spontaneous or Assisted Conception	Michela Villani	Received

1909-PB	Efficacy and Safety of Treatment with High Dose Thromboprophylaxis in Pregnant Women - A Retrospective Study from a Stockholm Cohort, Ranging from 2004 to 2014	Roza Chaireti	Received

1910-PB	Thromboelastography Analysis of Haemostasis in Pre-eclamptic, Hypertensive and Normotensive Pregnant and Non-Pregnant Women	Maha Othman	Received

1912-PB	Obesity and Thromboembolic Risk during Hospitalization in Pregnancy: Preliminary Results	VENINA BARROS	Received

1913-PB	Management of a Pregnant Patient with Antithrombin Deficiency and Acute Venous Thromboembolism	Julia Hews-Girard	Received

1914-PB	Prevalence of FOXD1 Mutations in the Obstetric Antiphospholipid Syndrome	Jean-Christophe GRIS	Received

1915-PB	Management of Pregnancy in Cobalamin C Defect Causing Homocystinuria and Methylmalonic Aciduria	Elvira Grandone	Received

1919-PB	Different Approaches of Thromboprophylaxis during Pregnancy in the Routine Clinical Practice. Results from the TEAM Project	Santamaria Amparo	Received

1920-PB	In the TEAM PROJECT, the Management of Placental-mediated Pregnancy Complication (PMC) Reflects a Real Gap between Evidence-based Guidelines and Routine Clinical Practice	Amparo Santamaria	Received

1921-PB	Risk Assessment of Venous Thromboembolism in Women Furing Pregnancy and Puerperium (SAVE): A Cross-Sectional Registry in Africa, Eurasia, Middle East and South Asia	Jean-Christophe GRIS	Received

1922-PB	Evaluation of Venous Thrombo-embolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in Saudi Arabia (The Saudi Arabian Pregnancy Venous Thromboembolism Registry)	Saud Abu-Harbesh	Received

1923-PB	Ischemic-stroke due to an Embolic Thrombus in Carotid Artery in Recent Postpartum: Case Report and Review of the Literature	VENINA BARROS	Received

1924-PB	Hypodysfibrinogenemia: AChallenge in Maternity Ward - Course of Pregnancy and a Literature Review	Justyna Magdalena Teliga-Czajkowska	Received

1927-PB	Pregnancy Complications in Women with Thrombophilia and their Future Pregnancy Outcome after Anti-coagulant Treatment	najib dally	Received

1928-PB	What is the Actual Role of Antiphospholipid Antibodies in Obstetric Morbidity?	Lidia Costa	Received

1929-PB	Low Molecular Weight Heparin for Women with Pathologic Evidence of Placental Malperfusion	Alexandra Gomez-Arteaga	Received

1931-PB	Intracranial Haemorrhage Associated with during the Course of Extracorporeal Membrane Oxygenation for Severe Respiratory Failure	Dee Jayakody Arachchillage	Received

1933-PB	Soluble Fibrin Causes an Acquired Platelet GPVI-deficiency in Response to Convulxin, Collagen-related Peptide and Collagen: Implications for Trauma Induced Coagulopathy	Scott Diamond	Received

1934-PB	Acquired Hemophilia A and Concomitant Factor XIII Consumption: A Case Series	Jameel Abdulrehman	Received

1935-PB	Von Willebrand Factor and ADAMTS13 in Bothrops jararaca Envenomation: Involvement of Snake Venom Metalloproteinases and Botrocetin	Camila Thomazini	Received

1936-PB	Efficacy and Safety of Combined Use of aPCC and Antifibrinolytics in Acquired Hemophilia A: Results from the FAIR Registry	Ezio Zanon	Received

1937-PB	Prediction of Outcome in Acquired Hemophilia A	Elizabeth Donnachie	Received

1938-PB	Severe Bleeding Diatheses in an Elderly Patient due to Autoantibody against Factor XIII A Subunit; Novel Approach to the Diagnosis and Classification of Anti-FXIII Antibodies	Mária Kun	Received

1939-PB	Usefulness of Anti-factor VIII IgG Antibody Detection by ELISA in the Management of Patient with Acquired Hemophilia A	Laetitia Mauge	Received

1940-PB	Pulsatility as a Modulator of Circulatory Support-related Acquired VWF Defect	Antoine Rauch	Received

1943-PB	Successful Inhibitor Eradication with Ofatumumab in a Patient with Acquired Hemophilia A	Ronald Fischer	Received

1947-PB	Acquired von Willebrand Syndrome (AVWS): Diagnostic and Treatment, a Single Centre Experience	Maria Joana Costa Pinto Prego de Faria	Received

1948-PB	Heparin-Like Substance in Patients with Dengue Infection and Prolonged Activated Partial Thromboplastin Time	Yingyong Chinthammitr	Received

1950-PB	Two Patient Cases of Acquired Hemophilia Treated with Recombinant Porcine Sequence FVIII (rpFVIII, OBIZUR)	Elina Armstrong	Received

1951-PB	Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy: Importance of Hemostasis Screening in the Preoperative Management of Three Case Studies	Mohamad Kurdi	Received

1952-PB	Study of Clinical Characteristics, Laboratory Findings and Response to the Treatment of Patient with Acquired Hemophilia in National Institute of Hematology and Blood Transfusion of Vietnam	Mai Nguyen Thi	Received

1953-PB	Acquired Hemophilia A in China: A Result of a Multicenter, Prosepective Study in China	Boyang Sun	Received

1958-PB	Acquired Haemophilia Patients Journey from the Exhaustive French Nationwide Database Collecting the Activity in Hospital (Programme of Medicalisation of the Systems of Information - PMSI)	Jean-Franois Schved	Received

1959-PB	A Report of Clinicians Attitude Survey of Acquired Hemophilia A for Improving its Prognosis in Japan	Yoshinobu Seki	Received

1961-PB	Acquired Haemophilia: Overcoming Practical Challenges to Deliver Optimal Nursing Care	Debra Pollard	Received

1964-PB	Acquired Factor XIII Deficiency in the Inpatient Setting: Retrospective Case Series	Fernando Chuliber	Received

1965-PB	Bleeding Manifestations as First Clinical Presentation of Systemic Lupus Erithematosus: A Case of Acquired von Willebrand Syndrome (AVWS)	Oriana Paoletti	Received

1966-PB	IPS Derived Vascular Endothelial Cells (vECs) from HA-patients with Nonsense Mutations Are a Potential Cell-model to Study the MHC-driven Risk for Inhibitor Development	Heike Singer	Received

1967-PB	Investigation of an F8 Exon 25 Deletion Suggests an Unusual Mutation Mechanism	Bimal Theophilus	Received

1968-PB	Stoichiometry of Immunodominant Factor VIII Immune Complexes	Pete Lollar	Received

1969-PB	Analysis of VWF-FVIII Interaction in Natural pdFVIII/VWF Complex Compared with rFVIIIVWF Complex through a Novel Flow Cytometry Technique	María Isabel Bravo	Received

1970-PB	FVIII-vWF Complex Displays Greater Efficiency than Vwf-Free Preparations in Restoring Thrombin Generation in Hemophilic Plasma with Inhibitor under Conditions of Physiological Relevance	FABRIZIO SEMERARO	Received

1971-PB	40 kDa PEG of N9-GP is Eliminated from Tissues and Will Reach Steady State after Chronic Dosing	Inga Bjoernsdottir	Received

1973-PB	Identification of High-molecular Weight Species in Commercial Recombinant Factor VIII Products	Pete Lollar	Received

1974-PB	Pharmacokinetics (PK) of N8-GP (Turoctocog Alfa Pegol) Dosed Subcutaneously (SC) to Non-human Primates (NHPs) and Prediction of Human PK Profile	Frederik Rode	Received

1975-PB	Molecular Characterisation of Variants on Non-coding RNA Genes in the X-inactivation Centre from Three Symptomatic Carriers with Severe Haemophilia A (HA) and Extremely Skewed X-chromosome Inactivation	Claudia Pamela Radic	Received

1976-PB	Clinical Trials and Registries in Haemophilia A: Opponents or Collaborators?	Christine Keipert	Received

1977-PB	In Haemophilic Patients, Individual Factor VIII or IX Level for the Correction of Thrombin Generation Is Predictable	Michelle Piot	Received

1978-PB	Factor 8 Assay Discrepancy in a United States Non-severe Hemophilia A Cohort	HELEN OKOYE	Received

1979-PB	Aberrant Inflammatory Cytokines, Skew T Helper Cells and Decreased Regulatory T Cell Numbers in Hemophilia A Patients with FVIII Inhibitor	Donglei Zhang	Received

1980-PB	Hemophilia A and the Role of Factor VIII in Balancing Pro- and Anticoagulant Processes	Viola Strijbis	Received

1983-PB	Plasma Steady State PEG Concentrations Are Reached in Patients after Once Weekly Prophylactic Treatment with N9-GP	Ola Sternebring	Received

1984-PB	Thrombin Generation Assay as Additional Tool in Diagnosis of Mild/Moderate Haemophilia A Patients with Discrepancies in FVIII Activity Assays	Beata Baran	Received

1985-PB	Burden of Comorbidities in Persons Living with Haemophilia: Insight from the PROBE Phase 2b Study Database	Mark Skinner	Received

1986-PB	Cost-Effective Algorithm for Molecular Diagnosis of Families with Severe Haemophilia A in Argentina	Vanina Daniela Marchione	Received

1987-PB	Tissue Factor and Phospholipid-activated Thrombin Generation Assays for Detection of Factor VIIa Activity, Dose and Duration of Effect in Mice	Stepan S. Surov	Received

1988-PB	Assessment of F9 Mutation Associated with Inhibitor Development in Japanese Hemophilia B Patients	Hiroto Sakane	Received

1989-PB	Homogenous Reactivity of Recombinant FVIII against Inhibitors in the Presence of VWF Regardless Origin of Cell Line or Sequence Integrity	María Isabel Bravo	Received

1990-PB	Validation of the Factor IX One-stage aPTT Clot Assay Calibrated with Pooled Normal Plasma for the Measurement of N9-GP in Patient Plasma	Stefan Tiefenbacher	Received

1991-PB	Haemophilia A and B in Costa Rica - An Update of the National Register	Lizbeth Salazar-Sanchez	Received

1992-PB	Understanding Hemophilia A and B Factor Replacement Administration Patterns: A Feasibility Study	Ashley Daset	Received

1993-PB	Prevalence and Possible Risk Factors of Hyperhomocysteinemia in Patients with Severe Hemophilia from North-Western Russia	Ludmila Papayan	Received

1994-PB	A Thrombomodulin Gene Variant Leading to Hyperthrombomodulinaemia and an Inherited Bleeding Disorder	Campbell Tait	Received

1996-PB	Association of Homozygous PAI-1 Deficiency with Cardiac Fibrosis in Humans	AMY SHAPIRO	Received

1997-PB	Molecular, Diagnostic and Clinical Features of 216 Patients from 46 Unrelated Families with FXI Deficiency Caused by Different Recurrent and Sporadic Mutations. Data from A 60,000 Inhabitants Spanish Town	María Eugenia de la Morena-Barrio	Received

1998-PB	The International Society on Thrombosis and Haemostasis - Bleeding Assessment Tool (ISTH-BAT) and the Risk of Future Bleeding	Eugenia Biguzzi	Received

2000-PB	In Vitro Study of a New Plasma-derived Factor V (FV) Concentrate: Dose-response Evaluation in Plasma from Patients with Congenital FV Deficiency	Cristiana Bulato	Received

2001-PB	Multi-platform Characterization and Application of a Bleeding Assessment Tool in a Cohort of Patients with Factor XIII Deficiency	Ancy Abraham	Received

2002-PB	New Bleeding Disorder with Enhanced Fibrinolysis due to Lysinuric Protein Intolerance and Renal Failure	Hanna Pitknen	Received

2003-PB	Mutation Profile of Factor X Deficiency	Anna Pavlova	Received

2004-PB	Retrospective Evaluation of Phenotype and Management of Dysfibrinogenemia and Hypodysfibrinogenemia in a Cohort of Italian Patients	Cristina Santoro	Received

2006-PB	Safety and Efficacy of Recombinant Factor XIII (rFXIII-A2) in Patients with Congenital FXIII-A Subunit Deficiency Undergoing Minor Surgical Procedures: Results from the Mentor?2 Trial	Katarina Cepo	Received

2008-PB	Clinical and Molecular Data in 15 Italian Subjects with Congenital FXI Deficiency	GIOVANNI FAVUZZI	Received

2009-PB	Are Heterozygotes of Factor XIII Deficiency Prone to Bleeding, A New Finding in Area of Rare Bleeding Disorders	Majid Naderi	Received

2010-PB	FVII Deficiency: Characterization of Three Different Mutations in the FVII Catalytic Domain	Maria Eugenia Chollet Dugarte	Received

2011-PB	Correction of Coagulopathy Related to Severe Factor V Defects with a New Plasma-derived FV Concentrate: An In vitro Study with ROTEM	Cristiana Bulato	Received

2012-PB	Molecular Analysis and Clinical Description of an Italian Cohort of Patients with FXI Deficiency	Gabriele Quintavalle	Received

2014-PB	Genotypic Abnormalities in Phenotypic Confirmed Patients with Rare Bleeding Disorders	Waander L. van Heerde	Received

2016-PB	Clinical Presentation and Management of Glanzmanns Thrombasthenia: A Case Study	Ilgen Sasmaz	Received

2017-PB	Prevalence of Menorrhagia in Women Diagnosed with Congenital Bleeding Disorders	Munira Borhany	Received

2020-PB	Identification of Novel and Recurrent Mutations in F13B Gene leading to FXIII Deficiency	Vytautas Ivaskevicius	Received

2023-PB	Acute Coronary Syndrome in a Patient with Factor V Deficiency: A Case Report	Sasa Anzej Doma	Received

2024-PB	Congenital Hypoprothrombinemia Presenting in the Neonatal Period: Report of 2 Cases in South of Iran	Mohammadreza Bordbar	Received

2025-PB	Rare Bleeding Disorders in the Netherlands (RBIN)	Joline Saes	Received

2026-PB	Identification of Two Novel F5 Compound Heterozygous Mutations in Two Norwegian Patients with Severe Factor V Deficiency N	Nina Iversen	Received

2027-PB	Retrospective Evaluation of Phenotype and Management of A-hypo-Fibrinogenemia in a Cohort of Italian Patients	Cristina Santoro	Received

2028-PB	Factor X Deficiency Followed by a Tertiary Pediatric Hematology Center	Gonul Aydogan	Received

2029-PB	Correlation of Hemorrhagic Complications with Novel Mutations in FGA And FGG: In Punjabi Congenital Afibrinogenemia Patients	Tehmina Nafees Sonia Khan	Received

2032-PB	Rare Bleeding Disorders: Snapshot from a Tertiary Care Hospital of Pakistan	Anila Rashid	Received

2033-PB	Severe Congenital Factor VII Deficiency in Northern Region of Turkey	Davut Albayrak	Received

2034-PB	Evaluation of Rare Factor Deficiencies in Presurgical Plasma Samples	ZHRE KAYA	Received

2035-PB	Spotting of Two Novel Mutations in FGG Gene: In Unrelated Patients of Congenital Afibrinogenemia in Pakistan	Tehmina Nafees Sonia Khan	Received

2036-PB	Factor VII Deficiency: One Novel Mutation and Genotype-phenotype Correlation in Patients from Southern Italy	Elvira Grandone	Received

2037-PB	Successful Delivery in an Afibrinogenemia Patient after Three Abortions: A Case Report and Review of Literature	Mehran Karimi	Received

2039-PB	Congenital Afibrinogenemia Case Presenting with Surrenal Bleeding and Cervical Hematoma	Nihal Ozdemir	Received

2040-PB	Severe Congenital Factor X Deficiency in the Northern Region of Turkey: Successful Prophylaxis with Activated Prothrombin Complex Concentrates	Canan Albayrak	Received

2041-PB	Pseudoxanthoma Elasticum-like Disease with Deficiency of Vitamin K-dependent Clotting Factors, Hypofibrinogenemia and Cutis Laxa Features: A Case Report	katia taouli-allal	Received

2042-PB	Rare Inherited Coagulation Disorder (RICD) in Females - Data from a Developing Country	Shabneez Hussain	Received

2043-PB	Congenital Factor V Deficiency	Elena Yakovleva	Received

2044-PB	Von Willebrand Factor Deficiency Reduces Experimental Liver Fibrosis in Mice	Anna Kopec	Received

2045-PB	Genotypical Classification of Patients with von Willebrand Disease	Waander L. van Heerde	Received

2046-PB	Common VWF Sequence Variants Associated with Higher VWF and FVIII Are Less Frequent in Subjects Diagnosed with Type 1 VWD	Veronica Flood	Received

2048-PB	Structural Thermodynamics of a Clinically Elusive High-affinity von Willebrand Factor Binding to Platelet GPIba	Matthew Auton	Received

2049-PB	Pro-angiogenic Signal in Plasma of Left Ventricular Assist Device Patients	Joseph Blackshear	Received

2053-PB	Perioperative Management of von Willebrand Patients with Desmopressin; Towards a Predictive Population PK Model	Jessica Heijdra	Received

2054-PB	In-Frame Heterozygous Large Deletion in von Willebrand Factor (VWF) Gene in a Patient with Severe Bleeding Manifestations Might Accelerate VWF Clearance	Hamideh Yadegari	Received

2055-PB	Acquired von Willebrand Disease in Patients with Extracorporal Membrane Oxygenation: The VWF:GPIbM/VWF:Ag Ratio is a Sensitive Diagnostic Tool	Sabine Flommersfeld	Received

2056-PB	Different Modes of Association between Protein Disulfide Isomerase PDIA1 and VWF in von Willebrand Disease	Maria Alexandra Brehm	Received

2059-PB	Wound Healing is Not Delayed in Mice with Reduced von Willebrand Factor in Spite of the Presence of a Severe Bleeding Tendency	Maureane Hoffman	Received

2061-PB	A Cell-based Assay to Quantify aIIb3 Integrin Binding of von Willebrand Factor Mutants	Gesa Knig	Received

2063-PB	Single Centre Audit of Laboratory Testing in Sub-classification of Type 2 von Willebrand Disease	Ruchika Kohli	Received

2064-PB	Von Willebrand Factor Testing through the Ages: A Review of Recent Results from the Royal College of Pathologists of Australasia Quality Assurance Program	Roslyn Bonar	Received

2065-PB	Comparing Platelet-dependent von Willebrand Factor Activity Assays in 661 Patients with von Willebrand Disease - from the WiN Study	Johan Boender	Received

2068-PB	The Prevalence of Bleeding Disorders in Women with Histologically Proven Endometriosis	sonia Grover	Received

2070-PB	Comparison of Three Different Factor VIII Assays in 154 Patients with Type 3 von Willebrand Disease: Results from the 3WINTERS-IPS Cohort	Jenny Goudemand	Received

2072-PB	Type of Renal Replacement Therapy, Access and von Willebrand Factor (VWF) Function	Joseph Blackshear	Received

2073-PB	Retrospective Single Centre Study of On-demand and Treatment Prophylaxis in 24 Patients with Type 3 von Willebrand Disease	Martin Hendelmeier	Received

2074-PB	Trends in Severity of Acquired von Willebrand Syndrome with Lower Rotational Speed Left Ventricular Assist Device	Dong Chen	Received

2075-PB	Prevalence of von Willebrand Disease among Saudi Students: from Saudi Screening Program for Bleeding Disorders (SSBD)	Tarek Owaidah	Received

2076-PB	Molecular Caracterization of Type 2 von Willebrand Disease	Chaves Daniel	Received

2077-PB	Validation of a Rapid Diagnostic Approach with Automatic Tests in a Cohort of Chinese Patients with von Willebrand Disease: Results from the Chinese-Italian CReWilAct Study	Augusto B Federici	Received

2078-PB	The Self-association of Ristocetin	Pete Lollar	Received

2079-PB	VWD2M Genotype Carrying Double Heterozygous Mutations with More Severe Phenotype than Classic VWD2M	Juvenal Paiva	Received

2080-PB	The Occurrence of Prothrombotic Mutations in a Patient with von Willebrand Disease and Symptomatic Bleeding Disorder	Anna Sikorska	Received

2081-PB	Von Willebrand Factor (VWF) Propeptide (VWFpp) and VWFpp to VWF Antigen (VWF:Ag) Ratio in Assessment of Inherited (VWD) and Acquired (AVWS) von Willebrand Disease	Bernadeta Ceglarek	Received

2082-PB	Extensive Bilateral Mandibular Pseudotumor in a Boy with Type 3 von Willebrand Disease (VWD) Treated with Plasma Derived VW/Factor VIII Concentrate (FC): Diagnosis, Treatment and Outcome	Juan Pablo Frontroth	Received

2083-PB	Laboratory Identification of von Willebrand Disease: A Contemporary Approach	Emmanuel Favaloro	Received

2085-PB	Molecular Genetic Investigations in Hereditary Hemorrhagic Telangiectasia in Hungary; Identification of a Founder Mutation	Réka Gindele	Received

2086-PB	How Well can Laboratories Make a Diagnosis of Type 3 VWD? Results from a UK NEQAS (Blood Coagulation) Diagnostic Challenge Exercise	Ian Jennings	Received

2087-PB	Rivaroxaban but Not Apixaban Causes False-positive Results in Lupus Anticoagulant Testing that Can Be Overcome with Andexanet Alfa	Grace Gilmore	Received

2089-PB	One Stage and Chromogenic FVIII Assays in Spiked and Post Infusion Samples Containing rFVIIIFc or Recombinant FVIII: Data from a UK NEQAS for Blood Coagulation Survey	steve kitchen	Received

2090-PB	Epitope Mapping of Anti-FVIII Antibodies in Hemophilia A Patients Using LumiTope, a FVIII Domain-specific Multiplex Microsphere Based Immunoassay	Behnaz p	Received

2091-PB	Investigation of an Incidental Finding of Factor 8 Gene Duplication Detected by Chromosomal Microarray Analysis	Rima Dardik	Received

2092-PB	Thromboxane Formation Assay to Identify High on-treatment Platelet Reactivity to Aspirin	Carolin Helten	Received

2093-PB	Prospective Multicenter Validation of Standard and Age-adjusted D-Dimer Testing in Patients with Suspected Pulmonary Embolism (PE) and Deep Venous Thrombosis (DVT)	Blair Alden Parry	Received

2095-PB	The Detection of Cross-reactive Antibodies to Recombinant Porcine FVIII	Annette Bowyer	Received

2096-PB	Mixing Test to Discriminate between Lupus Anticoagulant and Direct Oral Anticoagulant in Diluted Russells Viper Venom Time Test	Osamu Kumano	Received

2097-PB	Assessment of Three Contact Activation Reagents for the Diagnosis of Factor XI Deficiency	Salam Salloum-Asfar	Received

2098-PB	Platelet Reactivity in a Large Population with the Bruneck Cohort	Melissa Chan	Received

2099-PB	Evaluation of IgG4 Anti-FVIII as Strategy to Improve the Diagnosis of Factor VIII Inhibitor in Association with Modified-Bethesda Assay	Silmara Montalvão	Received

2100-PB	Comparison of Age-adjusted D-dimer and Clinical Probability-adjusted D-dimer for Diagnosing Pulmonary Embolism	Sameer Sharif	Received

2101-PB	The Screening aPTT Mixing Test Is Not Sufficient to Rule Out the Presence of Inhibitor	Silmara Montalvao	Received

2102-PB	Quantitation of Dabigatran by Global and Specific Coagulation Assays	Jay Lozier	Received

2105-PB	Reference Interval Mean Clotting Times Should Not Be Used to Calculate Lupus Anticoagulant Mixing Test Ratios Unless They Match the Normal Pooled Plasma Clotting Time	Gary Moore	Received

2106-PB	Lupus Anticoagulant-hypoprothrombinemia Syndrome (LAHPS): Report of 4 Cases	LUCIA REMOTTI	Received

2107-PB	Fibrinogen Prothrombin Time Derived Method Is Not Useful in Anticoagulated Patients by LMWH or Rivaroxaban	CRISTINA DUBOSCQ	Received

2109-PB	Evaluations of Automated Chromogenic Assays for the Diagnosis and Monitoring of Haemophilic Patients	Cristina Novembrino	Received

2110-PB	Evaluation of Utility of ISTH Scoring System and its Modifications in Diagnosis of Disseminated Intravascular Coagulation in a Tertiary Care Centre in Southern India	Pooja Sai Muddana	Received

2112-PB	Evaluation of an Automated Chemiluminescent Assay and two ELISAs for Detection of Heparin Induced IgG Antibodies in the Diagnosis of Heparin Induced Thrombocytopenia (HIT)	Liesbeth De Cooman	Received

2113-PB	The Influence of a High Fat Meal, Smoking, Coffee, Exercise and Sample Storage on Light Transmission and Impedance Aggregometry in Healthy Volunteers	Yvonne Henskens	Received

2115-PB	The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery	Ekaterina Koltsova	Received

2116-PB	Forty Years of Riddle Solving to Decipher Puzzling Test Results in the Coagulation Laboratory	Ariella Zivelin	Received

2118-PB	Point-of-care INR with CoaguChek XS Pro is comparable to laboratory INR in a hospital setting	An Stroobants	Received

2120-PB	Evaluation of Platelet Response by Whole Blood Multiple Electrode Aggregometry Method in Patients Using Antiplatelet Therapy	Marinez Matos	Received

2122-PB	Rotational Thromboelastometry Parameters Have Variable Correlation with Plasma-based Assays of Coagulation across Trimesters of Pregnancy: A Cross-sectional Study	Karin Fox	Received

2123-PB	Thrombin Generation Assay CANNOT Identify Antithrombin Resistance During Anticoagulant Therapy	Yuki Takagi	Received

2124-PB	Clot Wave Form Parameters of Prolonged APTT in Different Situations: Is There Any Difference between Them?	Marta Martinuzzo	Received

2126-PB	Alterations in the Parameters of Classic, Global and Innovative Assays of Hemostasis Caused by Sample Transport via a Pneumatic Tube System	Alexander Poletaev	Received

2128-PB	Mutation Screening for the C677T Variant in the MTHFR Gene by Melting Point Analysis with the Real Time PCR: Detection of a Rare Variant Val225Ile	Isabel Tirado Garcia	Received

2129-PB	Evaluation of Potential Sources of Variation in 1-stage Factor IX Assays	Jane Needham	Received

2130-PB	The Calibrated Automated Thrombography in Normal Pregnancy	Natalya Silina	Received

2131-PB	Impact of Sample Preparation on the Results of Thrombin Generation - Lessons Learned from the Generation of Normal Reference Ranges	Emma Fosbury	Received

2133-PB	Current Practice Related to D-dimer Testing in Croatia	Sandra Margetic	Received

2134-PB	Usefulness of APTT Reagents for LA Detection and Frequency of LA Positive Patients in APTT Prolonged Patients	Suthatip Anun	Received

2135-PB	An Evaluation of the Activated Partial Thromboplastin Time Waveform in Various Diseases	Takeshi Matsumoto	Received

2136-PB	Identification of Rare Inherited Diseases by Next Generation Sequencing	SHAHID SABA	Received

2138-PB	Evaluation of a Novel Short-acting Direct Dual FXa/FIIa Inhibitor for its Use in Acute Anticoagulation	Stefan Heitmeier	Received

2139-PB	Discovery of ONO-5450598, a Highly Orally Bioavailable Small Molecule Factor XIa Inhibitor: The Pharmacokinetic and Pharmacological Profiles	Sho Kouyama	Received

2142-PB	Thrombin Exosite 1 Inhibition with JNJ-375 Causes Anti-coagulation and Inhibits Thrombus Formation in a Human Translational Model of Thrombosis	Jennifer Banks	Received

2143-PB	Vena Cava Filter Retrieval Rates and Factors Associated with Retrieval in the United States	Joshua Brown	Received

2144-PB	Dabigatran Neutralizing Antibody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood	Debra Hoppensteadt	Received

2145-PB	ONO-5450598, an Orally Available Small-molecule Inhibitor of Activated Blood Coagulation Factor XI, Inhibits Arterial Thrombus Formation without Increasing Bleeding when Used in Combination with Clopidogrel in Rabbits	Takehiro Ono	Received

2147-PB	Inter-individual Variation in Plasma Levels of Direct Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation	Ivanka Paskaleva	Received

2148-PB	Idarucizumab, a Specific Antidote for Dabigatran, Cross-reacts with Melagatran and May also Interact with other Benzamidine-containing Compounds	Jawed Fareed	Received

2149-PB	Influence of Dabigatran on Rotational Thromboelastometry	Mojca Bozic Mijovski	Received

2150-PB	Direct Oral Anticoagulants for Thromboprophylaxis in Orthopedic Surgery in the Real World: A Systematic Review of Population Based Studies	Alejandro Lazo-Langner	Received

2151-PB	Heparin Calibrated Anti-Xa Assays for the Measurement of Low Levels of Direct Factor Xa Inhibitors	lina sabor	Received

2152-PB	Efficacy of a Novel Contact Pathway Inhibitor, Ir-CPI, on in vitro Clotting Induced by PCI Catheter Segment	Stéphanie Demoulin	Received

2154-PB	INR Might Be a Useful Predictor for Upcoming Minor to Major Bleedings in Patients Treated with NOAC	Priya Bhardwaj	Received

2156-PB	Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and their Neutralization by FEIBA as Measured by Thromboelastography	Walter Jeske	Received

2157-PB	Diclofenac for the Treatment of Acute Symptomatic Intermediate-risk Pulmonary Embolism	David Jimenez	Received

2158-PB	Anticoagulant and Antiaggregation Effect of New Aminoestrogen	Mirthala Flores-Garcia	Received

2159-PB	Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and their Neutralization by FEIBA	Walter jeske	Received

2162-PB	ISTH DIC Score is Associated with Mortality in Children with Disseminated Intravascular Coagulation	Bunchoo Pongtanakul	Received

2163-PB	Out of Sight, Out of Mind - The Acquired von Willebrand Syndrome is a Bleeding Cause in Disguise during Congenital Heart Disease Surgery	Vanya Icheva	Received

2165-PB	Efficiency and Safety of Off-label Use of Recombinant Activated Coagulation Factor VII (rFVIIa) in Pediatric Oncological and Hematological Patients	Daria Fedorova	Received

2166-PB	Intracranial Hemorrhage in Children with Immune Thrombocytopenic Purpura: A Systematic Review	sehar khaliq	Received

2167-PB	Comparison of 3 Current Disseminated Intravascular Coagulation (DIC) Scores in Pediatric Intensive Care Unit (PICU)	Rungrote Natesirinilkul	Received

2169-PB	Clinical Utility and Mechanism of Thrombin Generation in Children with Liver Disease	Ignjatovic Vera	Received

2170-PB	Carotid Intima Media Thickness and Obesity Phenotypes among Children and Adolescents	Golaleh Asghari	Received

2171-PB	Acquired von Willebrand Syndrome (aVWS) in Severely Ill Pediatric Patients with Bleeding Complications	Ivonne Wieland	Received

2172-PB	Thrombopoietin Receptor Agonists for Children with Refractory Immune Thrombocytopenia	Joud Zanabili Al-Sibai	Received

2173-PB	An Unusual Cause of Bleeding in a Young Girl with Systemic Lupus Erythematosus: Lupus Anticoagulant Hypoprothrombinemia Syndrome	Surjit Singh	Received

2174-PB	Cost-benefit Relationship of the Collagen-binding Assay on von Willebrand Disease Study in Children	José Gaspar Martínez Órdenes	Received

2175-PB	Severe Factor VII Deficiency in Lebanon: The Impact of Molecular Studies, Prenatal Diagnosis and Primary Prophylaxis	Roula Farah	Received

2180-PB	Tailored Prophylaxis in Children with Hemophilia A: A New Approach for the Future	Samantha Pasca	Received

2184-PB	The Differential Diagnosis of Acute Rheumatic Fever in a Hemophilic Child	Melike Sezgin Evim	Received

2185-PB	Proteomic Analysis of Changes Induced by Infant Cardiopulmonary Bypass	Uttara Nag	Received

2186-PB	Spatial Clot Propagation in Neonates and Adults	Axel Schlagenhauf	Received

2187-PB	Platelet-leukocyte Aggregates as Possible Biomarkers of Thrombotic Risk in Children with Hereditary Spherocytosis and Splenectomy	Antonio Moscardó	Received

2188-PB	Pediatric Chronic Kidney Disease: Assessment of Endothelial Function and Hemostasis	Luci Dusse	Received

2189-PB	Derivation of a Clinical Prediction Rule to Use with D-dimer to Exclude Pulmonary Embolism in Children	jeffrey kline	Received

2190-PB	Thrombin Generation in Pediatric Patients with Generalized Infectious Diseases and Multiple Organ Dysfunction Syndrome	Ludmila Papayan	Received

2191-PB	A New ADAMTS13 Mutation and Pharmacokinetic Properties in Congenital Thrombotic Thrombocytopenic Purpura (TTP)	Jorge David Aivazoglou Carneiro	Received

2192-PB	Thromboelastographic (TEG) Parameters in Newly Diagnosed Pediatric Patients with Acute Lymphoblastic Leukemia (ALL) and Central Venous Catheters (Cvcs)	Richard Ko	Received

2197-PB	Potentiation of TRAP-6-induced Platelet Dense Granule Release by Blockade of P2Y12 Signaling with MRS2395	Annachiara Mitrugno	Received

2198-PB	Discovery and in vitro Pharmacology of BAY-386 - A Novel, Reversible PAR-1 Antagonist	Christoph Gerdes	Received

2199-PB	Selective Serotonin Reuptake Inhibitors Inhibit Convulxin- and Fibrinogen-induced Phosphorylation of Syk in Human Platelets	Yu-Lun Tseng	Received

2203-PB	The Effect of Vorapaxar on Platelet-mediated Inflammatory Response	Aikaterini Tsouka	Received

2205-PB	Citrated Iron Oxide Nanoparticles Inhibit Thrombin-evoked Ca2 Signalling in Human Platelets	Alan Harper	Received

2206-PB	Induction of Diabetes Attenuates the Antithrombotic Effect of Clopidogrel in Apolipoprotein E-deficient Mice	Atsuhiro Sugidachi	Received

2208-PB	With an ASA Dose that Inhibits Prostacyclin Formation, Clopidogrel Has a Lesser Antithrombotic Effect	PETER GROSS	Received

2210-PB	Looking for the Best Experimental Conditions for Studying the Effect of Aspirin on Murine Hemostasis	Benoit Decouture	Received

2211-PB	Platelet Microvesicle Formation during the Hemostatic Response is Regulated by P2Y12 Signaling	Maurizio Tomaiuolo	Received

2212-PB	Convection through Platelet Thrombi	Shunichi Kobayashi	Received

2213-PB	Different Prothrombotic Phenotypes of Atherosclerosis-prone Apoe-/- and Ldlr-/- Mice	Johanna van Geffen	Received

2216-PB	Elevated Activity of Fibrinogen-like Protein 2, (FGL2/fibroleukin) in Platelets of Cancer Patients	Esther Rabizadeh	Received

2218-PB	Comparison of Reticulated and Non-reticulated Platelet Function and Releasates	Melissa Hayman	Received

2219-PB	Platelet S1P: Evidence for the Involvement of the Membrane Transporter MRP4 during S1P Secretion, and Identification of Surface Receptors	Benoit Decouture	Received

2221-PB	Polyphosphate Nanoparticles on the Platelet Surface Trigger Contact System Activation	Coen Maas	Received

2223-PB	Shear-mediated Platelet Activation (SMPA) Yields a Differing Activation Signature than that of Biochemical Agonists	Yana Roka Moiia	Received

2226-PB	Sickle Cell Disease Patients under Regular Transfusion Program Have Decreased in vitro Platelet Aggregation	Roberta Casagrande Saez	Received

2228-PB	Characterization of in Vitro Cell-free Induced Fibrillar Fibronectin: Morphology Dependent Effects on Platelet Function	Khon Huynh	Received

2229-PB	Extracellular Histones Stimulate Clot Retraction and Induce Resistance to Fibrinolysis	FABRIZIO SEMERARO	Received

2230-PB	Evaluation of the Total Thrombus-formation System (T-TAS): Application to Human and Mouse Blood Analysis	Rashid Al Ghaithi	Received

2231-PB	The Mechanisms Underlying Core-and-Shell Architecture of Arterial Thrombus and its Dynamics Described with Computational Modeling	Valeriia N. Kaneva	Received

2232-PB	Effects of pH and Concentration of Sodium Citrate Anticoagulant on Platelet Aggregation Measured by Light Transmission Aggregometry Induced by Adenosine Diphosphate	gian marco podda	Received

2233-PB	Idelalisib and Platelet Aggregation in Patients with Chronic Lymphocytic Leukemia (CLL)	Andrea Artoni	Received

2234-PB	Platelet Investigations in Patients with Essential Thrombocytosis	Oliver Pedersen	Received

2235-PB	Computational Analysis of Shear Stress Distribution during Thrombus Formation in a Blood Vessel and Parallel Plate Flow Chamber	Andrey Megalinskiy	Received

2236-PB	Platelet Function during Prolonged Targeted Temperature Management after Cardiac Arrest: A Randomised Clinical Trial	Anni Nrgaard Jeppesen	Received

2237-PB	An Absence of Platelet Activation Following Thalidomide Treatment in vitro or in vivo	Jianlin Qiao	Received

2238-PB	Reduced Left Ventricular Function Compared to Preserved Function after Myocardial Infarction is Associated with a Different Platelet Pattern	Christina Christersson	Received

2241-PB	Detection and Characterization of Extracellular Vesicles at Different Stages of Platelet Concentrate Storage Using High-resolution Flow Cytometry	Olga Sirotkina	Received

2243-PB	Comparing Platelet Reactivity in Patients with Chronic Kidney Disease to that in Healthy Volunteers	Harriet Elizabeth Allan	Received

2244-PB	Disaggregation Following Agonist-induced Platelet Activation in Patients on Dual Antiplatelet Therapy	Patricia Pia Wadowski	Received

2247-PB	Amniotic Fluid-derived Mesenchymal Stem Cells (AF-MSCs) Decrease Agonists Platelet Response	Noemi M Atucha	Received

2248-PB	Clopidogrel Does Not Protect Mice from Sepsis or Septic Shock	Yannick Rabouel	Received

2249-PB	Dysregulation of NET Formation Following Thermal Injury and its Association with Multiple Organ Failure	Robert Dinsdale	Received

2251-PB	Differential Impact of Triggers on the Risk of Incident Venous Thromboembolism in Hospitalized Subjects with and without Acute Infection - Results from a Population-based Case-crossover Study	Gro Grimnes	Received

2253-PB	RNA and Histones in Dead Cells Synergistically Provoke FSAP Activation in Serum	Ingrid Bulder	Received

2254-PB	Impact of Acute Infection during Hospitalization on the Risk of Incident Venous Thromboembolism - Results from a Population-based Case-crossover Study	Gro Grimnes	Received

2255-PB	C-reactive Protein and Risk of Venous Thromboembolism - Results from a Population-based Case-crossover Study	Gro Grimnes	Received

2257-PB	Nucleated Platelet Response to a Single Stranded RNA Viral Product through Pattern Recognition Receptors Revealed by RNA Sequencing	Farzana Ferdous	Received

2258-PB	MiR146a-5p Deficiency Exacerbates Neutrophil Extracellular Trap Formation	ANA BELÉN ARROYO RODRÍGUEZ	Received

2259-PB	Inflammation Augments NFkB Dependent Production of TF in Preadipocytes	Timofey Sovershaev	Received

2260-PB	Evaluation of the Impact of Hypofibrinolysis Induced by Tranexemic Acid in Murine Experimental Sepsis	Yzabella Alves Campos Nogueira	Received

2261-PB	Elevated Levels of Endogenous Activated Protein C Predict Mortality in Septic Shock	Jens Mller	Received

2263-PB	In vitro Disruption of Endothelial Barrier Integrity by Serum from Patients with Septic Shock	Maiara Marx Luz Fiusa	Received

2264-PB	The Potential Roles of IL-33 and TGF-1 in the Pathogenesis of Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis	Omer Iqbal	Received

2265-PB	Assessment of the Concentration and the Functional Activity of Plasma Inter-alpha Trypsin Inhibitor in Patients with Inflammatory Diseases	Jean-Luc Plantier	Received

2266-PB	2,3-dihydroxy-5-methoxybiphenyl Suppresses fMLP-induced Superoxide Anion Production and Cathepsin G Release by Targeting the -subunit of G-protein in Human Neutrophils	Hsiang Ruei Liao	Received

2267-PB	A Comparison of Scoring Systems and Surrogate Markers of Death in a Cecal Ligation and Puncture Sepsis Model	Dhruva J Dwivedi	Received

2269-PB	Aint No Mountain High Enough :High Altitude Venous Thromboembolism	Medha Singh	Received

2270-PB	Venous Involvement in Behcets Disease: A Retrospective Analysis of 75 Cases	Leila Belhadj	Received

2271-PB	Arterial Involvment in Behcets Disease: A Retrospective Study of 75 Cases	Leila Belhadj	Received

2273-PB	Neutrophil Extracellular Trap (NET) Formation in Patients with Behcets Disease	YACINE BOULAFTALI	Received

2274-PB	A Basal-state Monocyte Gene Transcription Profile Is Associated with Circulating Levels of Th1 Cells: The Multi-Ethnic Study of Atherosclerosis (MESA)	Nels Olson	Received

2275-PB	Proinflammatory Polarized Macrophages Have Reduced Microvesicles and Coagulatory Function	Philipp Hohensinner	Received

2277-PB	Interleukin-6 in the Development of Venous Thrombosis	KARBACH SUSANNE	Received

2278-PB	The First Year after Diagnosis of Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis is Critical for Development of Venous Thromboembolism (VTE) in These Patients	Jovan P Antovic	Received

2279-PB	Protein Arginine Deiminase-4 Does Not Influence Antibacterial, Inflammatory or Procoagulant Responses during Gram-negative Pneumonia Derived Sepsis	Theodora A.M. Claushuis	Received

2280-PB	NETs, FSAP and their Complicity in the Context of Immunity and Thrombosis	Simona Grasso	Received

2282-PB	Luminex Bead-based Assay for Early Detection of GPIIbIIIa Allo-immunization in Glanzmann Thrombasthenia	Arnaud Dupuis	Received

2283-PB	Tranexamic Acid Blocks Fibrinolysis but Not Overall Plasmin Generation and Modulates the Immune Response in Patients Undergoing Coronary Artery Surgery. A Sub-study of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial	Dominik Draxler	Received

2284-PB	Impact of Systemic Inflammation in Lung Transplant Outcome	Walter Jeske	Received

2285-PB	Protease Activated Receptor-2 (PAR-2) Serves as a Dominant Receptor for Factor VII Activating Protease (FSAP)	Kristina Byskov	Received

2286-PB	Protective and Detrimental Effects of Anticoagulation in a Mouse Model of Multiple Sclerosis	Rafal Pawlinski	Received

2287-PB	Crosstalk between Epidermal Growth Factor Receptor (EGFR) and TF/FVIIa/PAR2 Pathway Mediates Chemotherapy Resistance in Cervical Cancer	Robson Monteiro	Received

2288-PB	Monocyte Activation by Thrombin Leads to an Upregulation of Molecules Involved in Fibrinolysis	Barbara Thaler	Received

2289-PB	Activated Protein C (APC) via PAR1 Protects Neurons from Death in the Model of Neuroinflammation in vitro	Irina Babkina	Received

2290-PB	Role of Protease-Activated Receptor 4 in Regulating Platelet-Leukocyte Interactions in Whole Blood	Rachel Rigg	Received

2291-PB	Activation of PAR2 by Factor Xa Increases the Permeability across Cultured Endothelial Cell Monolayers	Naima Benelhaj	Received

2292-PB	The Influences of Diabetes and Inflammation on the Effects of Thrombin and Activated Protein C on Mast Cell Secretion	Ivan Goliako	Received

2293-PB	External Validation of Generic and Cancer-Specific Risk Stratification Tools for Predicting 30-day Mortality in Patients Presenting with Pulmonary Embolism and Active Cancer	Christine Kohn	Received

2294-PB	Predictors of 30-day Mortality among Patients with Cancer-associated Thrombosis in the RIETE Database	alfonso tafur	Received

2295-PB	Thrombosis after Orthotopic Liver Transplantation for Hepatocellular Carcinoma: Incidence, Implications and Risk Factors	ALBERTO MAINO	Received

2296-PB	Predicting the Risk of Recurrent Venous Thromboembolism in Patients with Cancer: The REMARK Study	Nick van Es	Received

2297-PB	Comparative Analysis of Predictive Models for Thromboembolic Events in Lymphoma Patients	Darko Antic	Received

2298-PB	Outcomes of Subsegmental Pulmonary Embolism (SSPE) in Cancer Population	Cristhiam Mauricio Rojas Hernandez	Received

2299-PB	Screening for Cancer in Patients with Unprovoked Venous Thromboembolism: A Systematic Review and Individual Patient Data Meta-Analysis	Nick van Es	Received

2300-PB	Cancer Cell Derived Extracellular Vesicles Increase Extracellular Vesicle Dependent Tissue Factor Activity of Peripheral Blood Mononuclear Cells in the Presence of Platelets	Thomas Dullary	Received

2301-PB	Impact of Regular Physical Activity on the Risk of Cancer-related Venous Thromboembolism - The Scandinavian Thrombosis and Cancer (STAC) Cohort	Line Holtet Evensen	Received

2303-PB	Elevated Risk of Venous Thrombosis Post Allogeneic Transplantation for Leukemia: Patient Characteristics of a Single Centre Cohort	Rick Ikesaka	Received

2304-PB	Combination of Podoplanin Expression and IDH-1 Mutation Status in Primary Malignant Brain Tumors Identifies Patients at Risk of Venous Thromboembolism	Julia Riedl	Received

2305-PB	Podoplanin Promotes Oral Cancer Malignancy by Inducing Intravascular Coagulation in Orthotopic Xenograft Mice Model	Hsing Ying Lee	Received

2307-PB	Impact of the Extensive Cancer Screening in Patients with a First Episode, Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis	Chatree Chai-Adisaksopha	Received

2309-PB	The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-associated Thrombosis from the Swiss VTE Registry (SWIVTER)	Adriano Alatri	Received

2310-PB	Predictive Value of D-dimers and Microparticle-associated Tissue Factor Activity for the Risk of Thrombosis in Pancreatic Cancer	Dorothée Faille	Received

2311-PB	Venous Thromboembolism Leads to Poor Survival in Patients with High Grade B Cell Lymphoma: A Seven Year Single Centre Analysis	Mark Grech	Received

2315-PB	Audit: Use of Khorana Score in Newly Diagnosed Patients with Pancreatic Cancer	Carrie Carson	Received

2316-PB	Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: A Meta-analysis of Randomized Controlled Trials	Francesco Dentali	Received

2317-PB	Podoplanin-dependent Platelet Aggregation Mediated by Human Glioblastoma Cell Lines	Julia Riedl	Received

2318-PB	Tumor cell-induced Platelet Secretion: Role of Protease-activated Receptors	Annachiara Mitrugno	Received

2319-PB	Can NETs or miRNAs Predict Early Surgery-related Pulmonary Embolism in Patients with Intracranial Tumors?	Julia Oto	Received

2320-PB	Thromboprophylaxis Strategy in Cancer Outpatients: CAT AXIS, a Case-vignette Study on Clinical Practice In France	Ismail Elalamy	Received

2321-PB	Peripherally Inserted Central Catheter (PICC) Related Thrombosis in 230 Patients with Hematological Malignancies. A 6 Years Single Experience Center	Mónica Baile	Received

2323-PB	Bioinformatic Analysis of Collaborative Interaction between Platelet and Cancer Cell Derived Microparticles in Evolving a Post Code Mechanism for Breast Cancer Metastasis and Identification of CD9 as Potential Drug Resistance Marker	Rajani Kanth Vangala	Received

2324-PB	Tumour Microvesicles Interact with Endothelial Cells under Venous Flow in vitro	ABDULRAHMAN EID ALGARNI	Received

2325-PB	The STEP-CAT Cohort Management Study: Step-Down to Prophylactic Doses of Enoxaparin after a Minimum of 3-6 Months of Anticoagulation for the Treatment of Cancer-associated Thrombosis	Vicky Tagalakis	Received

2328-PB	Usefulness of D-dimer in the Diagnosis of Deep Vein Thrombosis after Neurosurgery for Glioblastoma and Meningioma	Maria Teresa Sartori	Received

2330-PB	Patients with Venous Thromboembolism Events Admitted in a Tertiary Care Hospital: Follow-up for One Year and Correlation with Cancer	Luciana Gonalves	Received

2331-PB	Cement Pulmonary Embolism as a Complication of Percutaneous Vertebroplasty in Cancer Patients	Hikmat Abdel-Razeq	Received

2332-PB	Renal Cell Carcinoma with Neoplastic Thrombosis: A Treatment Challenge for a Rare Entity	Verónica Pons	Received

2334-PB	Demographic Data and Outcomes of Pediatric Patients with Tumor and Thrombosis	Patcharee Komvilaisak	Received

2335-PB	Retrospective Cohort Study of Venous Thromboembolism (VTE) Rates in Ambulatory Cancer Patients, and Association with Khorana Score	Lucinda Blake	Received

2337-PB	Subclinical Portal Vein Thrombosis in Liver Cirrhosis Patients Increase Risk of 30 Days Mortality: Preliminary Study	Andree Kurniawan	Received

2338-PB	Relationship of Platelets Parameters with JAK2 V617F Mutation Status and Thrombotic Risk in Myeloproliferative Disorders	Héla Baccouche	Received

2340-PB	Acute Pulmonary Embolism in Cancer Patients: Clinical Findings and Outcome	Barbara Vitola	Received

2341-PB	Subarachnoid Hemorrhage and General Anesthesia Inhibit the Brain (G)Lymphatic System in Mice and Non-human Primates	Maxime Gauberti	Received

2343-PB	Portal Vein Thrombosis Associated with Abdominal Inflammatory Conditions	Henny Billett	Received

2344-PB	Role of ADAMTS13 Deficiency in the Pathogenesis of Portal Vein Thrombosis Complicating Liver Cirrhosis	stefano lancellotti	Received

2345-PB	Haemostatic Changes in Cirrhotic Patients Treated with Direct-acting Antiviral Therapy	Elena Campello	Received

2347-PB	Fibrinogen Estimation in Patients with Liver Disease	Alexander Gatt	Received

2348-PB	A Rat Model to Evaluate Formation of Venous Thromboembolism after Prolonged Tourniquet Application	Owais Mian	Received

2349-PB	Increased Baseline TF Activity in Women with Unexplained Pregnancy Loss: An Additional Argument for a Basal Endothelial Dysfunction?	Elisabeth Pasquier	Received

2353-PB	Upper Regulation of Plasma Endocan and D-Dimers in Individuals with Compensated Liver Disease	Jawed Fareed	Received

2355-PB	Effect of Extract Ethanol of Poguntano Leaves in Hemostasis Disturbances in Alloxan Induced Diabetic Rats	sry suryani widjaja	Received

2356-PB	Recurrent Budd-Chiari Syndrome in a Patient with Polycythemia Vera (PV), Protein S Deficiency and Hyperhomocysteinemia and Abnormal Resistance to Activated Protein (APCR) in the Absence of (FVL) Following Liver Transpla	Anna Sikorska	Received

2357-PB	Knock down the CD70 Expression in DCs Could Inhibit the CD4 T Cells Differentiating to Tregs in ITP	Zeping Zhou	Received

2358-PB	IL-10 Producing B Cells Induced by CD72 Ligation Suppress Th1 and Th17 Polarization in Primary Immune Thrombocytopenia	Mingen Lyu	Received

2360-PB	Isolation of a Monoclonal IgG Kappa with Functional Autoantibody Activity against Platelet Factor 4/Heparin from a Patient with a Monoclonal Gammopathy of Undetermined Significance and Clinically Overt Heparin Thrombocytopenia	Dorothée Faille	Received

2361-PB	Anticoagulation Stewardship Program for Heparin Induced Thrombocytopenia: A Cooperative Effort between a Community Hospital System Pharmacy Anticoagulation Service and an Associated Reference Laboratory	Charles Mahan	Received

2362-PB	IP-10 and MCP-1 Gene Polymorphisms in Chinese Patients with Chronic Immune Thrombocytopenia	Xian Zhang	Received

2363-PB	Decreased TLR4 Expression on Monocytes May Cause Regulatory T Cells Abnormality in Patients with Primary Immune Thrombocytopenia	Yating Hao	Received

2364-PB	The Abnormal Expression of Rap1 in Various Cells of Patients with Immune Thrombocytopenia	Wenjie Liu	Received

2365-PB	Resequencing of GWAS Loci Identifies New Candidate Genes on Chromosome 5 for Heparin-induced Thrombocytopenia	Anika Witten	Received

2366-PB	Elevated Plasma sCXCL16 Correlated with Th1 Polarization in Patients with Primary Immune Thrombocytopenia	Yating Hao	Received

2367-PB	Time to Disappearance of Platelet-activating Antibodies Depends on the Strength of Their Platelet Activating Properties in Patients with Heparin-induced Thrombocytopenia	Takuma Maeda	Received

2368-PB	Predictive Factors for Successful Splenectomy in Immune Thrombocytopenic Purpura	Mirjana Mitrovic	Received

2369-PB	The Th17/Treg Imbalance and Fatigue in Primary Chronic Immune Thrombocytopenia	Yang Li	Received

2370-PB	Predictors of Fatigue among Individuals with Primary Immune Thrombocytopenia in China	Yang Li	Received

2371-PB	Elevated Plasmacytoid DCs Proportion and Plasma IFNa Concentration in Active ITP Patients	Huiyuan Li	Received

2372-PB	A Prospective, Double-blind, Multicenter Study on FCM-based Measurement of Circulating Reticulated Platelets as a Diagnostic Assay for Immune Thrombocytopenia	Yu Hou	Received

2373-PB	Comparison Head-to Head of Two Functional Assays in the Assessment of Heparin-induced Thrombocytopenia	Nadine Ajzenberg	Received

2375-PB	Vitamin D Receptor Gene Polymorphisms in Adult Primary Immune Thrombocytopenia	mohamed sakr	Received

2376-PB	Anti-PF4/Heparin Antibodies and Platelet Derived PF4 Bearing Microparticles in Acute Sepsis	Maria Teresa Sartori	Received

2377-PB	Monocyte Subsets and Platelet Apoptosis in Patients with Primary Immune Thrombocytopaenia	Nora Butta	Received

2378-PB	BAFF-TACI Signaling Promotes the Differentiation of Terminal Effector T Cells in Primary Immune Thrombocytopenia (ITP)	Yanan Min	Received

2379-PB	Delayed Clearance of Argatroban in Patients with Heparin Induced Thrombocytopenia	Emma Groarke	Received

2380-PB	Sleep Quality in Chinese Patients with Primary Immune Thrombocytopenia: Contributing Factors and Effects on Health-related Quality of Life	Yang Li	Received

2381-PB	Immune Thrombocytopenia in Patients with Chronic Hepatitis C Virus Infection and Non-alcoholic Fatty Liver Disease	Tamar Saralidze	Received

2382-PB	Epidemiology and Management of Immune Thrombocytopenia: A Nationwide Population-based Study in Korea	Soo-Mee Bang	Received

2383-PB	Laboratory Identification of Heparin Induced Thrombocytopenia: A Re-evaluation	Leonardo Pasalic	Received

2384-PB	Experience in Diagnostic Assays for Heparin-induced Thrombocytopenia	Anat Keren Politansky	Received

2385-PB	Prevalence of Heparin Induced Thrombocytopenia among Iranian Patients with Cardiac Surgery	Minoo Ahmadinejad	Received

2386-PB	HIT or Miss: Improving the Quality of Diagnosing Heparin-induced Thrombocytopenia at an Academic Medical Center	Meredith Schaffner	Received

2389-PB	Efficacy and Safety of a New 10 Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenic Purpura	OH Doyeun	Received

2390-PB	Quantification of Specific T and B Cells Immunological Markers in Children with Chronic and Transient ITP	Nurit Rosenberg	Received

2391-PB	Risk of Cancer Occurrence and Survival in Patients with Primary Immune Thrombocytopenia	Jiaan-Der Wang	Received

2392-PB	Bleeding Outcome during Pregnancy in Patients Diagnosed with Immune Thrombocytopenia	Bundarika Suwanawiboon	Received

2395-PB	When Cancer Patients are HIT: A Literature Review of Heparin-induced Thrombocytopenia (HIT) and Clinical Outcomes in Cancer Patients	Thein Hlaing Oo	Received

2396-PB	Evaluation of Increased Incidence of Heparin Induced Thrombocytopenia at a Large Academic Teaching Hospital	Jessica Rimsans	Received

2398-PB	rhTPO is Conductive to Remission from Acute Hemorrhage Phase of Children Severe ITP	Ma Jingyao	Received

2399-PB	Neuropilin-1 Expression on Regulatory T Cell Can Affect its Immunosuppressive Function in ITP	Hu ZHOU	Received

2400-PB	Thrombotic Events in Patients Treated with Eltrombopag	Tamara Arias Fernández	Received

2401-PB	Familial Thrombocytopenia - Course of 3 Subsequent Pregnancies in an Idiopathic Thrombocytopenic Purpura (ITP) Patient; Case Report	Justyna Magdalena Teliga-Czajkowska	Received

2404-PB	Childhood Immune Thrombocytopenic Purpura (ITP) in Gorgan Taleghani Hospital	Nargesbeigom Mirbehbahani	Received

2405-PB	Pharmacokinetic Variations, Fc Receptor Polymorphisms and their Impact on Response to IVIG in Pediatric Immune Thrombocytopenia	DAVID SCHMIDT	Received

2407-PB	Variable Impairment of Platelet Function in Patients with Severe, Genetically Linked Immune Deficiencies	Magdolna Nagy	Received

2408-PB	Whole Blood Aggregometry to Assess Platelet Function in Children on Cardiopulmonary Bypass	Rachel Bercovitz	Received

2409-PB	Platelet PAC1 expression and dense granules function reflects bleeding severity in children	Pavel Zharkov	Received

2411-PB	Assessment of platelet function in adolescent women with heavy menstrual bleeding	Anne Rocheleau	Received

2412-PB	Novel Mutations in Thai Patients with Glanzmann Thrombasthenia	Darintr Sosothikul	Received

2414-PB	Pregnancy Management of Fetal Alloimmune Thrombocytopenia (NAIT): A Case Report	Oriana Paoletti	Received

2418-PB	Role of SerpinE2 (PN-1) in Diabetic Microangiopathy	Veronique Arocas	Received

2419-PB	Human Aortic Valvular Interstitial Cells: Evidence of Vasculogenic Potential during Aortic Valve Stenosis	Nicolas Gendron	Received

2420-PB	Nestin Is an Endothelial Enriched Protein in the Nonproliferative Vasculature with Potential Role in Endothelial Apoptosis	Philip Dusart	Received

2421-PB	Shiga Toxin Type 2, a Causal Agent of Hemolytic Uremic Syndrome, Improved Angiogenic and Repair Abilities of Late Outgrowth Endothelial Progenitor Cells	Agustina Mena	Received

2422-PB	Osteoprotegerin Promotes Tumour Development by Increasing Neovascularization	Catherine Boisson-Vidal	Received

2424-PB	Angiostatin Demonstrates Differential Hypoxic-dependent Anti-angiogenic Effects on Cardiac Endothelial Cells Derived from Non-vs Type 2 Diabetics	Natasha Govindasamy	Received

2425-PB	Structural and Functional Study of Hypochlorous Acid Modified Human Antithrombin: Possible Role in Cancer	Parvez Ahmad	Received

2426-PB	Frequency of Post Thrombotic Syndrome (PTS) in Patients with Proximal Deep Venous Thrombosis (DVT) - A Prospective Observational Study from a Tertiary Care Hospital in North India	Subhash Varma	Received

2428-PB	Intracellular von Willebrand Factor Predominately Influences Angiogenesis	Soundarya Selvam	Received

2430-PB	Oroxin A Effectively Inhibits Breast Cancer Cell-mediated Tumor Vasculogenic Mimicry	JUN HE	Received

2431-PB	Acidic preconditioning improves endothelial progenitor cell survival and angiogenesis under proinflammatory conditions and post-ischemic tissue regeneration in a murine model of type II diabetes	Soledad Negrotto	Received

2433-PB	Role of Circulating Endothelial Progenitor Cells at the Early-stage of Neovascularization in Post-menopausal Luminal-A-Type Breast-cancer Patients	Barbara Ruszkowska-Ciastek	Received

2434-PB	Pro-Angiogenic Biomarkers are Upregulated in Patients with Advanced Osteoarthritis Undergoing Orthopedic Surgery	Matthew Rondina	Received

2437-PB	CCL5 and CXCL4 Are Rapidly Internalized in Endothelial Cells	Annemiek Dickhout	Received

2441-PB	Free Heme Triggers the Disruption of the Endothelial Barrier	Maiara Marx Luz Fiusa	Received

2443-PB	Plasma microRNA (miRNA) Profiling in Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin Receptor Agonists (TPO-RA)	Lamya Garabet	Received

2446-PB	Circulating Extracellular Vesicles microRNA Profile in Transfusion Dependent -Thalassemia	Anat Aharon	Received

ISTH 2017 Congress

8-13 July 2017 Berlin

About us

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 13/07/2017 TO 08/07/2017

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum

DOI: 10.3252/pso.eu.ISTH2017.2017



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions

Special Access

Commercial Web Access